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ABSTRACT 
 
Stephanie Marie Moore: Separation and Identification Techniques for Membrane Proteins using 
Ultra-High Pressure Liquid Chromatography coupled to Mass Spectrometry 
(Under the direction of James W. Jorgenson) 
 
 
 Due to the importance of membrane proteins in biological pathways, the development of 
analytical techniques to improve membrane protein identifications is essential.  For such 
complex mixtures, high resolution liquid chromatography (LC) is commonly utilized along with 
mass spectrometry (MS) for comprehensive proteomic analysis.  However, commercial LC 
systems cannot provide the peak capacity required for such complex mixtures.  With the advent 
of ultra-high pressure liquid chromatography (UHPLC) and multidimensional chromatography 
applications, peak capacities and protein identifications have increased.  This dissertation will 
examine aspects of membrane protein sample preparation as well as instrumental analysis.  
Sample preparation techniques, specifically for membrane proteins, are crucial for proper 
protein analysis.  Techniques involved with cell lysis, membrane protein extraction, 
solubilization, and digestion, are discussed (Chapter 2).  Ultimately an optimized membrane 
protein sample preparation protocol was developed involving the use of high frequency 
sonication and the detergent sodium deoxycholate to improve solubilization.   
Peptides were ultimately analyzed on a modified (in-house) UHPLC constant pressure 
system.  To improve proteomic separations, a new freeze/thaw valve and gradient storage loop 
were introduced to the UHPLC system, improving membrane protein identifications, 
instrumental reproducibility, and ruggedness (Chapter 3).  To improve membrane protein 
digestion, an immobilized enzyme reactor (IMER) was introduced to the current 
multidimensional proteomic workflow.  The IMER, placed after the protein separation, digested 
iv 
 
proteins as they eluted from the first dimension.  This provided proteins with equivalent 
coverage to traditional in-solution digestions, yet avoided the 15 hr in-solution incubation 
process.  Overall, the IMER produced high protein coverage (for both model and complex 
sample analysis) in a ~10 sec volumetric residence time on column (Chapter 4).  Finally, a fully 
on-line two dimensional chromatographic system including IMER digestion was developed 
(Chapter 5).  This system also provided equivalent coverage and protein identifications to in-
solution off-line digestion, yet eliminated not only the overnight 15 hr digestion process as 
before, but also the ~4 hr fractionation and overnight lyophilization procedure from the 
workflow.  Ultimately this saved the workflow about 35 hr and demonstrated the utility of the 
IMER. 
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CHAPTER 1.  Introduction to Membrane Proteomic Analysis Using 
Multidimensional Liquid Chromatography – Mass Spectrometry 
 
1.1 Introduction to Proteomics  
 The basic functions of biological systems are controlled by extremely complex gene 
expression and the resulting activities of their protein products.1  Proteins consist of one or more 
long chains of amino acids and are responsible for vital cellular activities.  Proteins act as 
catalytic enzymes, take on a regulatory role for gene expression, provide cellular structural 
components, and act as messengers within and between cells.2, 3  The importance of these roles 
makes the identification of proteins beneficial to a wide range of disciplines; ranging from 
fundamental biological studies, pharmaceutical development,4 to clinical diagnostics.1  
Proteomics is defined as the study of multiprotein systems in an organism and how these 
systems can change with time and condition.  The entirety of proteins that can be expressed by 
an organism is termed the proteome.  A major challenge in proteomics is the dynamic nature of 
the proteome itself.  It can be expected that different cells (i.e. from different tissues) can 
express different proteins; however, the same cells may also express different proteins 
depending on the stage of the cell.  The stage of the cell can be interpreted as the lifecycle of the 
cell or the response of the cell to the state of the organism (for example a diseased state).  
Therefore the proteome is defined by the state of the organism, tissue type, or cell where it 
originates.  Since these states are constantly changing, so are the proteomes themselves.  Adding 
another level of complexity, the proteins within the system can exist in multiple forms 
(proteoforms).  An example is posttranslational modifications (PTMs), which include changes to 
a protein via covalent additions, proteolytic cleavage, or degradation.  These PTMs are extremely 
important for cell survival as they regulate the activity and function of the protein.  Each stage of 
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the protein lifecycle can involve distinct modifications to the protein structure.  A single protein 
can carry multiple modifications, and each modification can be permanent or transient, all of 
which add additional levels of complexity to the system under study.1, 3  The degree to which a 
protein can be modified varies based on regulatory mechanisms within the cell, environmental 
factors (drugs/chemical influences), and the protein itself.  The overall result is any protein can 
be present in multiple forms at any time within a cell, presenting a large analytical challenge.1 
1.2 Membrane Proteins  
Although cytosolic proteins are the easiest to identify due to their solubility, most cell 
signaling proteins are associated with the membrane.  The hydrophobic nature of membrane 
proteins, which contributes to the difficulty of their extraction and analysis, is mainly due to the 
α-helices that traverse the bilayer (~15-25 amino acids in length).5, 6  It has been estimated that 
transmembrane proteins constitute ~30% of the total proteins within a cell.7  While certain 
proteins are strongly hydrophobic and intrinsic to the membrane, others are more amphipathic 
and merely membrane associated.  Membrane proteins lie in junctions between cells and 
intracellular components where they mediate communication and control cell adhesion for 
tissue formation.  In addition, membrane proteins dictate immune response recognition, 
metabolic processes, vesicle trafficking, ion transport, protein translocation/ integration, and 
propagation of signaling cascades.4, 8  These cellular ―doorways‖5 are extremely important for 
pharmaceutical drug targeting,4 including G-protein coupled receptors and cytochrome p450s.6   
Despite their usefulness, these proteins are difficult to extract and analyze from their 
native hydrophobic environment.  Membrane proteins often precipitate during sample handling, 
are not soluble in commonly used solvents, and tend to transfer contaminants such as lipids 
from their native environment during their extraction from the cell.  Because of the difficulty 
involved and the importance of working with membrane proteins, there are multiple suggested 
sample preparation methods to aid in identification.5  The major focus of Chapter 2 is comparing 
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multiple sample techniques for all four stages of sample preparation including cell lysis, protein 
enrichment, solubilization, and digestion, for membrane proteomic analysis. 
1.3 The Tools of Proteomics 
Since the phrase was coined by Wilkins in 1990, ―proteomics‖ has expanded far beyond 
the Western blots and Edman degradations of its beginnings.1, 3  The modern proteomic toolbox 
(Figure 1.1) consists of four areas: sample preparation, chromatographic separation, mass 
spectrometry (MS), and data analysis.  Accurate protein identification relies heavily on all four 
areas, and improvement in any one aspect will enhance the capabilities as a whole.  Thus the 
focus of this dissertation was to develop improved methods for sample preparation and 
chromatographic separations for biologically complex membrane protein mixtures. 
In order to measure the efficiency of a gradient separation, peak capacity (nc) is used.  
The peak capacity is defined as the number of peaks that can be resolved in a defined separation 
window9, 10 and is given by the formula: 
     
  
  
   (1-1) 
The separation window (tg) can be defined as the gradient time or the time between the 
first and last eluting peak.  The peak width (or average peak width) is determined at the width 
4σ, which corresponds to 11% of the maximum peak height and is defined for two overlapping 
adjacent peaks having a resolution of 1 (unit resolution).11  Thus, the greater the peak capacity, 
the more analytes can be resolved successfully and ultimately identified within a specific time 
frame. 
The overall goal of any separation technique is to develop a method to detect a large 
number of distinct molecular species.  This is especially difficult for proteomics, for which most 
species of interest are at low levels and exist in various modified forms.  Due to the complex 
nature of protein mixtures, proteins and peptides are separated using high resolution 
chromatographic techniques.1  With high resolution techniques, the goal is to reduce the number 
of analytes entering the detector at once, thus increasing the dynamic range.12  The separation 
4 
 
can be performed on proteins as a whole or after digestion, both of which take advantage of the 
differences in physical properties.1  Protein properties commonly exploited for separations in 
proteomics include size, charge, hydrophobicity, and affinity.13  When mass spectral detection is 
performed on the intact protein the method is referred to as top-down and typically requires 
expensive high resolution mass spectrometers.  More commonly, the proteins are digested into 
peptides (bottom-up) and these smaller fragments are detected and compared to a proteomic 
database for protein identification.  The digestion is primarily performed with the enzyme 
trypsin due to its specificity.  A typical protein might have approximately 30 tryptic peptides 
(each peptide typically consists of 10-15 amino acids) and there are on average 10-12 thousand 
proteins expressed in a human cell.12, 14-16  The result of a bottom-up experiment is 
differentiating a large number of peptides, which can lead to a complex sample with numerous 
analytes requiring high resolution separation strategies.  Common types of separation and 
detection techniques are described below for both protein and peptide analyses. 
1.3.1  Separation Techniques 
Despite the high resolution of mass spectrometers, in order to fully understand the 
biologically complex system of the proteome, the mixture must be separated prior to detection.  
Traditional protein separation methods such as polyacrylamine gel electrophoresis (PAGE), 
high-pressure liquid chromatography (HPLC), capillary electrophoresis (CE), and isoelectric 
focusing (IEF) are common along with more modern approaches involving more than one 
separation technique in tandem.  The latter, referred to as a multidimensional analysis, was a 
major breakthrough in protein and peptide separations.1 
Throughout the history of proteomics, 2D-PAGE has been the fundamental technique for 
protein separation.  In this technique, proteins are first separated based on their isoelectric 
point (pI) and then transferred to a polyacrylamide gel and separated according to size.  It is 
extremely difficult for the proteins to not precipitate around the pI value, a problem which is 
enhanced when large sample volumes are used in order to increase the visualization of minor 
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components.17  Precipitation becomes even more problematic with hydrophobic/non-polar 
proteins (such as membrane proteins), which tend to form insoluble complexes and precipitate 
prior to loading.3  Despite difficult protein recovery from the gel matrix18 and incomplete 
resolution for complex samples,19 2D-PAGE remains the gold standard compared to more 
current protein separation strategies.13 
High pressure liquid chromatography (HPLC) is an attractive alternative to 2D-PAGE 
due to its high resolving power, reproducibility, various commercially available stationary 
phases, and compatibility with electrospray ionization mass spectrometry (ESI-MS).20  Out of 
the multiple modes of analysis available for separation, reverse-phase (RP) HPLC is most 
utilized because of solvent compatibility (polar) with protein/peptide dissolution.21  Greater 
than 98% protein recovery and reproducibly high resolution have been reported using high 
temperature RP macroporous columns for intact protein analysis.22  Additional modes 
commonly used for protein separation include size exclusion chromatography (SEC), affinity 
chromatography, and ion exchange chromatography. 
Size exclusion chromatography is used to purify, estimate molecular weight, and study 
interactions between proteins.  While SEC can separate proteins based on size and aid in 
identifying protein folding, structure, and stability,23 the low resolution of SEC makes it less 
desirable than reverse phase or ion exchange.  Another common method of protein purification 
is affinity chromatography, which separates proteins based on specific physical interactions 
between an immobilized ligand and binding partner in order to retain compounds of interest.3  
Typically the ligands utilized for affinity chromatography consist of antibodies.   Due to its use of 
antibodies, this technique can be extremely expensive and typically is used to specifically target 
analytes of interest (such as analytes with specific PTMs).13  A major contributor in protein 
separations is ion exchange chromatography.  Ion exchange chromatography consists of strong 
or weak, anionic or cationic ion exchangers.  Strong cation exchange (SCX) is used most often 
for protein and peptide analysis.  In SCX chromatography, the stationary phase is typically a 
6 
 
negatively charged sulfonic acid modified surface.  The positively charged peptides interact with 
the column with a strength dependent on their respective charge.  A salt solution or pH gradient 
is applied to the column to compete for charge sites or alter the protein/peptide charge state for 
elution, respectively.3, 12  Previous work in the Jorgenson lab, investigated protein separation 
with ion exchange and reverse phase.24  When the sample was separated by reverse phase, 546 
proteins were identified compared to only 262 with anion exchange.  Therefore, reverse phase 
separation of proteins became the standard procedure for the proteomic workflow in our lab 
(Figure 1.2).   
As expected, the separation of intact proteins (vs. peptides) has the advantage of 
producing a less complex sample.  However, there is limited information that can be obtained 
from this approach and traditionally protein digestion into peptides is preferred for large scale 
proteomic analyses.2  Digestion of the protein prior to separation is advantageous since peptides 
are generally more soluble than their intact protein counterparts.  On the other hand, the 
mixture is now more complex, as there are more species to resolve and the protein of origin for 
ambiguous peptide sequences (along with cleaved PTMs) are difficult to determine.12  The 
increased solubility of peptides in common RP solvents, high resolution, and the amenability of 
RP chromatography to ESI-MS detection make it the most prevalent mode of separation for 
peptide analysis.  Thus, in the proteomic workflow presented in Figure 1.2, this mode is also 
employed for peptide separations.  
1.3.2 Mass Spectrometry 
Today, protein and peptide detection is primarily performed via mass spectrometry.  
Popular ionization techniques to obtain mass spectra of large biological molecules include 
electrospray ionization and matrix assisted laser desorption ionization (MALDI).  ESI is what 
initially allowed HPLC to be directly coupled to MS, with the effluent of the HPLC column being 
continuously ionized.21  Ions for ESI are produced as the sample flow stream is passed over a 
heated fine tip at high voltage into a strong electric field at atmospheric pressure.1, 3 Samples 
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that are in aqueous solution exist as ions because they contain certain functional groups whose 
ionization is controlled by the pH of the solution.25  The ions produced by this process are then 
desolvated by either heat or nitrogen gas and as the droplets become smaller, the increasing 
electric field causes the analytes to desorb from the surface.  The resulting desolvated analyte 
ions are fed into the MS under vacuum.  Ultra-low flow sample inlet systems for ESI, termed 
nanospray (50-500 nL/min), allow for more efficient transfer of ions (lower limits of detection) 
from solution to the mass analyzer.  ESI is applied extensively in top-down protein and bottom-
up peptide proteomic analyses.1, 3   
Types of mass analyzers that are typically used for proteomics include time-of-flight 
(TOF), quadrupole filters, orbitraps, and ion cyclotron resonance.  Combining two or more mass 
analyzers in tandem allows the investigator to select a precursor ion of interest and subject it to 
further fragmentation in a collision cell followed by detection.  Subjecting the ion of interest to 
further fragmentation provides additional structural information for the analyte.  For tandem 
MS (designated as MS/MS), the first mass analyzer selects a specific m/z range.  These ions 
undergo fragmentation and the resulting fragments are measured according to their m/z by a 
second mass analyzer.3  When ESI is paired with tandem MS, the resulting mass analyzers are 
typically a triple quadrupole, an ion trap (MSn), or a quadrupole-time of flight (Q-TOF).1  
In a tandem proteomic MS analysis, the two most common fragmentation methods are 
collision-induced dissociation (CID) and electron capture dissociation (ECD).  For CID, a 
collision cell with an inert gas builds potential energy with repeated collisions of the analyte ion 
until the ion reaches a threshold and fragments.  For proteins and peptides, CID generally 
targets weak noncovalent bonds, covalent bonds responsible for PTMs, and the peptide bond.  
The fragment ions are then analyzed based on their m/z and an ion spectrum is produced.1  
Although CID is the most common technique (especially for peptide analysis), ECD can be 
useful for intact protein analysis to directly identify the N- versus C-terminal fragment and 
provides information complementary to CID methods.  Because ECD excites proteins near a 
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cleavage site, rearrangements are minimized and cleavage of the backbone is favored over the 
noncovalent bonds (weak noncovalent bonds and hydrogen bonds) responsible for secondary 
and tertiary conformational structure of protein ions.  Since the conformational bonds are less 
likely to be broken, ECD is useful in providing primary structure as well as studying secondary 
and tertiary structure of protein ions.26  For peptide analysis, ECD is useful for preserving PTMs.  
A type of MS that utilizes ECD fragmentation is Fourier transform ion cyclotron resonance mass 
spectrometry (FTICR-MS).27  FTICR-MS is the preferred method for accurate mass 
measurements of intact proteins, detecting masses with extremely good mass accuracy (~0.5-1 
ppm).28  The advantages of this technique include sensitivity, dynamic range, 
comprehensiveness, and throughput.4, 29  However, FTICR mass spectrometers are expensive to 
purchase and maintain.  Alternatively, protein identifications can be performed via bottom-up 
analyses with less costly equipment.  With a bottom-up approach, at times only a single peptide 
is required to identify a protein and competitive ionization of analytes can be decreased if high 
resolution capillary chromatography (nano-LC) with ESI is applied.20   
The type of mass analyzer used for the research presented here is the Waters Q-Tof 
PremierTM.  This type of instrument performs parallel alternating scans which are acquired at 
either low or high collision energy.   This process of simultaneously collecting parent and 
product ion spectra is referred to as MSE.  MSE maximizes the instruments duty cycle by rapidly 
switching between low and high collisional energy, producing alternate precursor and fragment 
ions to maximize data collection efficiency. 30, 31, 32  MS/MS is a serial approach to interrogating 
ions, which switches between observing all precursor masses within a range and selecting the 
most intense for sequential fragmentation scans.  In contrast, MSE fragments all precursor ions 
with a continuous unbiased approach.  Overall, MSE is a robust way to obtain qualitative and 
quantitative data and has provided enhanced protein sequence coverage and higher quality 
product ion spectra than typical MS/MS.33  
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MS quantification includes isotopic labeling and label-free techniques.  A metabolic 
labeling process referred to as SILAC (Stable Isotope Labeling by Amino acids in Cell cultures) is 
commonly used in vitro.  This technique labels the peptide with stable isotopic nuclei 2H, 13C, 
15N and is commonly used to study PTMs. 31, 34  Chemical and enzymatic tags are also used for 
peptide and protein labeling.34   Isotope-coded affinity tags (ICATs) is a chemical technique that 
takes advantage of differential tagging of cysteine residues by affinity and ion-exchange 
chromatography.  As a way to avoid sample modification, label-free quantification monitors an 
internal standard, such as BSA (bovine serum albumin).  By entering the known quantity of a 
standard into the MS software, certain instruments will monitor the spectral counts from the 
internal standard and report amounts of proteins and peptides based on a relative comparison.  
Label-free quantification has been well documented in the literature as a valid method of 
quantification with lower cost and reduced sample modifications.35, 36  
  Once spectral data is obtained, computer algorithms are utilized to quickly identify the 
protein mass and identity.  For top-down experiments, deconvolution algorithms report the 
protein mass.  In bottom-up experiments, the protein is identified by comparing the amino acid 
sequence to a proteomic database.  There are many theoretical and known peptide masses in 
established databases, with the most common being UniProt, Swiss-Prot, TrEMBL, National 
Center for Biotechnology Information (NCBI), and International Protein Index (IPI).  Vendor 
software using data reduction algorithms help the user select parameters for database searches.  
Information such as the number of possible missed cleavages, enzyme used to cleave the 
proteins, and description of possible PTMs can be taken into account with the software.  For 
example, a typical modification that occurs during tryptic digestion is the reduction and 
alkylation of cysteine thiols with iodoacetamide or iodoacetate.  This results in cysteine residues 
that may contain different masses and including such a possibility in the search can greatly 
improve the confidence of the reported match.  Once a tolerance of m/z values is selected, the 
software begins by excluding all data outside of the specified range to narrow the search.  The 
10 
 
resulting database hits are then subject to calculation of match scores for user comparison.  
Scoring is typically based on the intensity of the ion, the number of peptides detected, and 
pattern of fragmentation compared with the database.  How well a protein sequence is 
represented by MS data is referred to as protein coverage.3  Typically 20-40% sequence coverage 
is experimentally obtained and statistics and confidence intervals are based on the calculated 
coverage.3 
1.4 Multidimensional Separations  
To further decrease the complexity of proteomic samples, multidimensional separation 
techniques are employed.  In these configurations, a sample is subjected to more than one type 
of separation.  A common example of this is 2D-PAGE, where a sample is first separated by 
isoelectric point and then by size.  Since these two separation characteristics (isoelectric point 
and size) are not directly related, these techniques are considered orthogonal and should give 
optimal separation efficiency.3  Multidimensional analyses apply two or more orthogonal 
separation techniques in tandem.13  According to Giddings’ criteria for an ideal two dimensional 
system, the separations must be orthogonal and resolution gained in the first dimension cannot 
be lost in the second dimension.25, 37  Relying on two or more independent techniques, 
multidimensional analysis provides a better separation than either single dimension alone 
would allow.  Ideally, the resulting peak capacity is the product of the peak capacities for the 
individual methods, albeit difficult to achieve in practice.13  A multidimensional analysis 
performed by Link, et al. utilized SCX and RP prior to MS analysis.  The authors directly 
compare proteins identified using one dimensional and two dimensional LC techniques.  
Overall, 3.5 times more peptides and 1.7 times more proteins were identified by subjecting the 
analytes to separation in a second dimension.38 
Considerations for multidimensional separation techniques are whether they will be 
performed on-line or off-line.  When a separation is on-line the effluent of the first dimension 
flows directly to the second dimension, while for off-line separations fractions are collected from 
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the first dimension and stored for later application onto the second dimension.12, 37  
Comprehensive on-line techniques have the additional challenges of solvent compatibility 
between dimensions, band broadening in valves/loops, and a need for a second dimension that 
is faster than the first.39  Although on-line techniques are faster than off-line, there are less 
mobile phase restrictions for off-line methods.12, 37  The goal of the overall experiment, whether 
it be speed, protein recovery, or better resolution, will determine which technique is applied.  
The original off-line multidimensional approach utilized in the Jorgenson lab is shown in Figure 
1.2.  Although reverse phase chromatography is employed in both dimensions, orthogonality 
was demonstrated due to the enzymatic digestion between the first and second dimensions.24 
Aside from 2D-PAGE, among all the combinations of separation modes reported in the 
literature, ion exchange chromatography (specifically strong cation exchange) coupled with RP-
HPLC is the most common for protein and peptide analysis.  Because RP-HPLC utilizes 
stationary phases that allow for high optimum flow rates and mobile phases that align with MS, 
it is commonly placed in the second dimension due to the capability of fast sampling speeds and 
detector compatibility.1  The most familiar configuration of this setup is MudPIT or 
Multidimensional Protein Identification Technique.1, 13, 6, 8  Unique to MudPIT, the two stationary 
phases (SCX and RP) are packed sequentially into a single microcapillary column, of which the 
tip is pulled for direct ESI coupling.37  Digested peptides are first subjected to SCX in which the 
peptides adsorb with affinities proportional to the overall number of positive charges and elute 
in a step gradient of increasing salt concentration.  Each step in the gradient releases a group of 
peptides that pass onto a RP column, where the peptides are separated based on hydrophobicity 
and analyzed by MS.  This tandem approach not only aids in providing better separation, but 
also allows for low-abundance proteins to be identified.1, 13, 29 MudPIT is an unbiased, biphasic, 
online 2D-LC/MS/MS system2,11 that has been capable of identifying over 1,000 proteins in a 
sample and has a theoretical peak capacity of ~23,000.37, 39  While SCX and RP have been the 
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only modes applied to MudPIT (due to gradient restrictions), it has been suggested that a three-
phase MudPIT column with an additional RP can further improve separation.37   
Although ion-exchange is most often coupled with RPLC, other two dimensional 
combinations can include affinity-RPLC, SEC-RPLC, and RP-capillary zone electrophoresis 
(CZE).20, 40  Hypothetically, any of the separation modes described to separate peptides and 
proteins can be linked in two dimensional analysis; however, by doing so the instrument 
becomes increasingly more complex.  The differences in pressure, run time, gradient phases, 
and peptide solubility between modes can make operation difficult.  Thus, column-switching 
valves have proved valuable to multidimensional separation, providing better flexibility than 
directly coupled systems.  Described by Bushey and Jorgenson in 1990, a comprehensive system 
for LC was used to analyze protein mixtures with a SCX coupled to SEC in the second dimension 
via an eight port switching valve.  The valve was designed to switch between the storage loop, 
columns, pump, and waste with computerized control.37  
When considering off-line multidimensional techniques, prefractionation is suggested 
for cleaner mass spectra and better chromatographic separation.12, 14, 15  Instead of complete 
separation and analysis of proteins or peptides on multidimensional systems, intact proteins can 
be prefractionated, digested into peptides, and introduced to a second analytical separation.  
These hybrid techniques take full advantage of the different physiochemical characteristics 
between proteins and peptides.  However, deciding on the number of protein fractions to collect 
in the first dimension is crucial.  Too many fractions increase experimental time and labor, while 
too few fractions do not reduce sample complexity as desired.22  The optimal number of 
fractions depends on many things, such as the complexity of the sample, sample size, gradient, 
available experimental time, MS mode, and the purpose of the analysis.  Although fractions 
anywhere from 5 to 20 are typical, up to 96 fractions have been reported for a complex protein 
sample.12, 41 
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1.5 Fully Automated On-line Proteomic Workflows 
Recently, efforts have been made to include proteomic sample preparation steps in 
multidimensional workflows.  Off-line aspects of a bottom-up analysis, typically performed prior 
to chromatographic separation, include protein reduction, alkylation, and in-solution enzyme 
digestion.  By implementing these steps into an automated multidimensional scheme, one 
reduces the potential for sample contamination and sample loss, speeds up the analysis, and 
provides the ease of automation.  One major area of interest for employing on-line digestion is 
Immobilized Enzyme Reactors (IMERs).  These reactors contain immobilized enzyme on a 
substrate.  The substrate can consist of a variety of materials for diverse applications (described 
in more detail in Chapter 4); however, one of the more common configurations involves the 
substrate in a chromatography column for rapid flow-through on-line digestion of the protein 
sample.   
 Ideal protein digestion cleaves at specific amino acids, providing fragments suitable for 
MS analysis (6-20 amino acids) and database comparisons.  A few of the proteases available for 
protein digestion are trypsin, chymotrypsin, Lys C, and Asp N.  Trypsin is the most widely used 
since it has high specificity, produces peptides of suitable length, and is easily purified from 
porcine or bovine pancreata.  Trypsin cleaves proteins at lysine and arginine residues unless 
either amino acid is followed by proline in the C-terminal direction.1, 3  Although IMERs can be 
developed from a multitude of enzymes, trypsin is the most popular.  IMER columns have been 
developed for microfluidic devices42, on a capillary scale43, and in more traditional standard bore 
chromatography columns (2.1-4.6 mm).44  The standard bore columns usually consist of a 
monolithic material or a particle packed substrate with trypsin immobilized.  These columns are 
highly successful at protein digestion due to the high enzyme to substrate ratio, with low trypsin 
autolysis products, and reduced missed cleavages.  Placing these columns in an on-line 
workflow, either before or after the protein separation, is common (Figure 1.3).  The application 
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of such an IMER to our multidimensional proteomic workflow is described in Chapter 4.  A level 
of difficulty arises when attempting to perform a fully automated multidimensional proteomic 
analyses with on-line digestion.  Obstacles such as solvent compatibility, pH requirements for 
digestion and ionization, and preconcentration of peptides in the second dimension are not 
trivial to overcome.  Chapter 5 outlines a fully automated on-line multidimensional workflow 
involving IMER on-line digestion for proteomic analysis of membrane proteins. 
1.6 Introduction to Ultra High Pressure Liquid Chromatography 
 The development of Ultra High Pressure Liquid Chromatography (UHPLC) by the 
Jorgenson group45 has been a major advancement for the separation of proteomic samples, 
doubling the peak capacities achieved with standard HPLC.  Using the same column, faster flow 
rates can be achieved at higher pressures (Figure 1.4) which reduces analysis time.  The ability to 
work at higher pressures also allows for the use of longer chromatographic columns (~1 m), 
which increases separation space (Figure 1.5), and smaller diameter stationary phases (dp < 2 
μm), which increases efficiency.  These gains in efficiency are demonstrated by the simplified 
van Deemter equation below: 
       A                     
 or (1-2) 
       dp 
2   m
u
   
u dp
2
6 m
   
Where   is the geometric factor, dp is the particle diameter, u is the mobile phase linear 
velocity,   is the tortuosity factor, and Dm is the diffusion coefficient in the mobile phase.  The A, 
B, and C terms are van Deemter coefficients that describe band broadening contributions from 
eddy dispersion, longitudinal diffusion, and resistance to mass transfer, respectively.  The height 
equivalent to a theoretical plate (H) and number of theoretical plates (N) are parameters used to 
determine and compare column efficiency. 
      
 
 
 (1-3) 
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By increasing the number of theoretical plates (N), and as a result decreasing the size of 
the height equivalent of a theoretical plate (H), there is an observed increase in efficiency.  As 
expressed in the equations above, by decreasing the particle size (dp) or increasing the length (L) 
of the column, this is accomplished.  However, this gain in efficiency with smaller particles and 
longer columns is not without a cost as there are practical and instrumental limitations.  
Practically, users want to perform the best analysis possible in the shortest amount of time, and 
longer columns with smaller particles on a commercial system (limited to ~10–15 kpsi) will 
result in low flow rates and long run times.  In order to achieve the gain in performance from 
these long columns with smaller particle diameters, higher pressures are required to perform 
the analysis in a reasonable time frame.  
Built in-house, the UHPLC gradient system developed in the Jorgenson lab operates at 
~35 kpsi (Figure 1.6).41, 46, 47  A commercial pump is utilized to inject the sample and gradient 
volume into an externally plumbed system.  Then a pneumatic amplifier pump is used to apply 
the ultra-high pressure placing the sample and gradient volume onto the column for separation.  
Typically meter long capillary columns with sub-2 μm particle sizes are employed for proteomic 
analyses.  The UHPLC system is a constant pressure system, always flowing at the maximum 
possible flow rate.  This is contrary to commercial systems which operate at a specific flow rate 
and vary the pressure.  In order to compare between commercially available systems and the 
UHPLC system, gradients are considered as volumes rather than times.  For example, a 30 min 
gradient run on a standard 25 cm Waters nanoAcquity capillary column (column volume ~0.74 
μ ) would not be equivalent to the same 30 min gradient on a meter long capillary column 
(column volume ~3.3 μ ).  In order to remain consistent with the extra separation space, the 
gradient would need to be adjusted according to the extra column volume.  Therefore, all 
gradient volumes are normalized by the column volume for a designated gradient length and 
flow rate.  By normalizing the gradient, equivalent gradient profiles and peak capacities can be 
compared between any column.  Therefore, all gradients expressed in this dissertation are 
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reported as percent change in organic (B) per column volume, where an aggressive gradient is 
considered ≥4% change in B per column volume and a shallow gradient is ≤ 1% change in B per 
column volume. 
Overall, the advent of UHPLC greatly increased peak capacity compared to commercial 
systems (Figure 1.7).  However, UHPLC does require external valves and specialty high-pressure 
fittings.  Routine use over time at high pressures can also take its toll on the instrumentation, 
causing valves to leak and fittings to clog with heavy usage.  Therefore, Chapter 3 focuses on 
advancements made to the UHPLC system to address such issues.  This includes a high pressure 
valve featuring freeze/thaw technology and an improved gradient storage system, with the main 
goal to improve the reproducibility, longevity, and separation efficiency of the system. 
1.7 Scope of Dissertation 
 The scope of this dissertation is to improve membrane protein sample analysis.  This will 
include membrane protein sample preparation strategies and instrumental advances.  Chapter 2 
focuses on developing an optimized membrane protein sample preparation protocol including 
strategies for cell lysis, extraction from the membrane, solubilization for LC analysis, and 
digestion.  Since the UHPLC system is utilized in the proteomic workflow for membrane protein 
analysis, Chapter 3 focuses on modifications to the UHPLC system including the introduction of 
a freeze/thaw valve and capillary gradient storage system.  Chapter 4 implements an IMER into 
the proteomic workflow, demonstrating the ability to digest membrane proteins on-line with 
high efficiency.  In Chapter 5, this concept is expanded by developing a fully automated on-line 
two dimensional proteomic platform with IMER digestion.  The benefits provided by all topics 
discussed within are evaluated through comparison of proteome coverage and number of 
identified proteins with previous analyses.  The concepts presented here can also be applied to 
additional applications outside of proteomics.  Improved UHPLC separations are applicable to a 
variety of fields which contain highly complex sample analysis (such as metabolomics) and 
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IMER development can be used to immobilize enzymes other than trypsin (such as RNAse for 
RNA mass mapping). 
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1.8 FIGURES 
 
 
 
Figure 1.1  Modern toolbox for proteomic analyses including sample preparation, 
chromatographic separation, mass spectrometry detection, and data analysis. 
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Figure 1.2  Standard proteomic workflow for the Jorgenson lab.  Proteins are first separated on 
a reverse phase column followed by fraction collection and lyophilization.  The proteins are 
digested in-solution with trypsin and the peptides are separated on a second dimension reverse 
phase column with mass spectrometry detection and data analysis. 
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Figure 1.3  Common workflows implementing immobilized enzyme reactors (IMERs) placed 
before or after the separation column.  
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Figure 1.4  A sample of Mass PREPTM E. coli digest standard injected on the UHPLC system 
with a 50 cm x 75 μm I. . column packed with 1.7 μm  E   18 particles at three various 
pressures.  Gradient was from 5-40% acetonitrile. 
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Figure 1.5  Gain in peak capacity seen by implementing longer chromatographic columns, 
increasing the separation space for complex sample analysis.  Reproduced with permission from 
the dissertation of K. Fague.41   
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Figure 1.6  Original design of the ultra-high pressure liquid chromatography system (UHPLC).  
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Figure 1.7  Comparison of three columns of different length analyzed with MassPREPTM 
digestion standard expression mixture 2.  Due to the length of these columns the pressure was 
increased (~30 kpsi) using the UHPLC system.  For comparison (black line) a commercial 
column packed with the same material (1.9 μm  E   18) was used to separate the mixture at 
commercial pressures (~8 kpsi).  Reproduced with permission from the dissertation of K. 
Fague.41  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
1.9 REFERENCES 
 
1.  Liebler, D.C. Introduction to Proteomics: Tools for the New Biology; Humana Press 
Inc.: Totowa, New Jersey, 2002. 
 
2. Zhang, X.; Fang, A.; Riley, C.; Wang, M.; Regnier, F.; Buck, C. Multi-dimensional liquid 
chromatography in proteomics—A review. Anal. Chim. Acta 2010, 2, 101-113. 
 
3. Eidhammer, I.; Flikka, K.; Martins, L.; Mikalsen, S. Computational methods for mass 
spectrometry proteomics; John Wiley & Sons, Ltd.: England, 2007. 
 
4. Chen, G.; Pramanik, B.; Liu, Y.; Mirza, U. Applications of LC/MS in structure 
identifications of small molecules and proteins in drug discovery. J. Mass Spec. 2007, 3, 
279-287. 
 
5. Molloy, M. Two-dimensional electrophoresis of membrane proteins using immobilized 
pH gradients. Anal. Biochem. 2000, 1, 1-10. 
 
6. Speers, A.; Wu, C. Proteomics of integral membrane proteins – Theory and application. 
Chem. Rev. 2007, 8, 3687-3714. 
 
7. Santoni, A.; Molloy, M.; Rabilloud, T. Membrane proteins and proteomics: Un amour 
impossible? Electrophoresis 2000, 6, 1054-1070. 
 
8. Gilmore, J.; Washburn, M. Advances in shotgun proteomics and the analysis of 
membrane proteomes. J. Proteomics 2010, 11, 2078-2091. 
 
9. Giddings, J. Unified separation science; John Wiley & Sons, Inc.: USA, 1991. 
10. Neue, U. HPLC Columns: Theory, Technology, and Practice; Wiley-VCH, Inc.: New 
York, 1997. 
11. Neue, U. Theory of peak capacity in gradient elution. J. Chrom. A 2005, 1, 153-161. 
12. Issaq, H.; Chan, K.; Janini, G.; Conrads, T.; Veenstra, T. Multidimensional separation of 
peptides for effective proteomic analysis. J. Chrom. B 2005, 1, 35-47. 
13. Link, A. Multidimensional peptide separations in proteomics. Trends Biotechnol. 2002, 
12, 8-13. 
14. Hsieh, S.; Dreisewerd, K.; Van Der Schors, R.; Jiménez, C.; Stahl-Zeng, J.; Hillenkamp, 
F.; Jorgenson, J.; Geraerts, W.; Li, K.  Separation and identification of peptides in single 
neurons by microcolumn liquid chromatography-matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry and postsource decay analysis. 
Anal. Chem. 1998, 9, 1847-1852. 
15.  Sandra, K.; Moshir, M.; D'hondt, F.; Verleysen, K.; Kas, K.; Sandra, P. High efficient 
peptide separations in proteomics: Part 1. Unidimensional high performance liquid 
chromatography. J. Chrom. B 2008, 1-2, 48-63. 
26 
 
16. Wilhelm, M.; Schlegl, J.; Hahne, H.; Gholami, A.; Lieberenz, M.; Savitski, M.; Ziegler, E.; 
Butzmann, L.; Gessulat, S.; Marx, H.;  Mathieson, T.; Lemeer, S.; Schnatbaum, K.; 
Reimer, U.; Wenschuh, H.; Mollenhauer, M.; Slotta-Huspenina, J.; Boese, J.; Bantscheff, 
M.; Gerstmair, A.; Faerber, F.; Juster, B. Mass-spectrometry-based draft of the human 
proteome. Nature, 2014, 509, 582-582. 
17.  Righetti, P.; Bossi, A. Isoelectric focusing of proteins and peptides in gel slabs and in 
capillaries. Anal. Chim. Acta 1998, 1-2, 1-19. 
18.  Anderegg, R.; Wagner, D.; Blackburn, R.; Opiteck, G.; Jorgenson, J. A multidimensional 
approach to protein characterization. J. Protein Chem. 1997, 5, 523-526. 
19.  Yanagida, M. Functional proteomics: current achievements.  J. Chrom. B 2002, 1-2, 89-
106. 
20.  Shi, Y.; Xiang, R.; Horváth, C.; Wilkins, J. The role of liquid chromatography in 
proteomics. J. Chrom. A 2004, 1, 27-36. 
21.  Whitelegge, J. HPLC and Mass Spectrometry of Integral Membrane Proteins. In The 
Protein Protocols Handbook; Walker, J. M., Ed.; Humana Press: New York, 2009; 1149-
17. 
22.  Martosella, J.; Zolotarjova, N.; Liu, H.; Nicol, G.; Boyes, B. Reversed-phase high-
performance liquid chromatographic prefractionation of immunodepleted human serum 
proteins to enhance mass spectrometry identification of lower-abundant proteins. J. Pro. 
Res. 2005, 5, 1522-1537. 
23.  Underberg, W.; Hoitink, M.; Reubsaet, J.; Waterval, J. Separation and detection 
techniques for peptides and proteins in stability research and bioanalysis.  J. Chrom. B 
2000, 2, 401-409. 
24.  Stobaugh, J.; Fague, K.; Jorgenson, J. Prefractionation of intact proteins by reversed-
phase and anion-exchange chromatography for the differential proteomic analysis of 
Saccharomyces cerevisiae.  J. Pro. Res. 2013, 2, 626-636. 
25.  Opiteck, G.; Lewis, K.; Jorgenson, J.; Anderegg, R. Comprehensive on-line LC/LC/MS of 
proteins. Anal. Chem. 1997, 8, 1518-1524. 
26.  McLafferty, F.; Horn, D.; Breuker, K.; Ge, Y.; Lewis, M.; Cerda, B.; Zubarev, R.; 
Carpenter, B. Electron capture dissociation of gaseous multiply charged ions by fourier-
transform ion cyclotron resonance. J. Am. Soc. Mass Spectrom. 2001, 3, 245-249. 
27.  Careri, M.; Mangia, A. Analysis of food proteins and peptides by chromatography and 
mass spectrometry. J. Chrom. A 2003, 1, 609-635. 
28. Jing, L.; Li, C.; Wong, R.; Kaplan, D.; Amster, I.  Improved mass accuracy for higher 
mass peptides by using SWIFT excitation for MALDI-FTICR mass spectrometry. J. Am. 
Soc. Mass Spectrom. 2008, 19, 76-81. 
27 
 
29.  Romijn, E.; Krijgsveld, J.; Heck, A. Recent liquid chromatographic-(tandem) mass 
spectrometric applications in proteomics. J. Chrom. A 2003, 1, 589-608. 
30.  Dowell, J.; Frost, D.; Zhang, J.; Li, N. Comparison of two-dimensional fractionation 
techniques for shotgun proteomics. Anal. Chem. 2008, 17, 6715-6723. 
31.  Ning, Z.; Zhou, H.; Wang, F.; Abu-Farha, M.; Figeys, D. Analytical aspects of proteomics: 
2009-2010. Anal. Chem. 2011, 12, 4407-4426. 
32. Plumb, R.; Johnson, K.; Rainville, P.; Smith, B.; Wilson, I.; Castro‐Perez, J.; Nicholson, 
J. UPLC/MSE; A new approach for generating molecular fragment information for 
biomarker structure elucidation. Rapid Com. Mass Spect. 2006, 20, 1989-1994. 
33.  Blackburn, K.; Cheng, F.; Williamson, J.; Goshe, M. Data-independent liquid 
chromatography/mass spectrometry (LC/MSE) detection and quantification of the 
secreted Apium graveolens pathogen defense protein mannitol dehydrogenase. Rapid 
Comm. Mass Spec. 2010, 7, 1009-1016. 
34.  Abu-Farha, M.; Elisma, F.; Zhou, H.; Tian, R.; Zhou, H.; Asmer, M.; Figeys, D. 
Proteomics: From technology developments to biological applications. Anal. Chem. 
2009, 12, 4585-4599. 
35.  Wolters, D.; Washburn, M.; Yates III, J. An automated multidimensional protein 
identification technology for shotgun proteomics. Anal. Chem. 2001, 23, 5683-5690. 
36.  Washburn, M.; Ulaszek, R.; Deciu, C.; Schieltz, D.; Yates, J. Analysis of quantitative 
proteomic data generated via multidimensional protein identification technology. Anal. 
Chem. 2002, 7, 1650-1657. 
37.  Evans, C.; Jorgenson, J. Multidimensional LC-LC and LC-CE for high-resolution 
separations of biological molecules. Anal. Bioanal. Chem. 2004, 8, 1952-1961. 
38.  Link, A.; Eng, J.; Schieltz, D.; Carmack, E.; Mize, G.; Morris, D.; Garvik, B.; Yates, J. 
Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999, 7, 
676-682. 
39.  Stroink, T.; Ortiz, M.; Bult, A.; Lingeman, H.; de Jong, G.; Underberg, W. On-line 
multidimensional liquid chromatography and capillary electrophoresis systems for 
peptides and proteins. J. Chrom. B 2005, 1, 49-66. 
40.  Bushey, M.; Jorgenson, J. Automated instrumentation for comprehensive 2-dimensional 
high-performance liquid-chromatography capillary zone electrophoresis. Anal. Chem. 
1990, 10, 978-984. 
41.  Fague, K. Multidimensional separations with ultrahigh pressure liquid chromatograph-
mass spectrometry for the proteomics analysis of Saccharomyces cerevisiae. University 
of North Carolina at Chapel Hill, 2014. 
42.  Matosevic, S.; Szita, N.; Baganz, F. Fundamentals and applications of immobilized 
microfluidic enzymatic reactors. J. Chem. Tech. Biotech. 2011, 3, 325-334. 
28 
 
43.  Sproß, J.; Sinz, A. A capillary monolithic trypsin reactor for efficient protein digestion in 
online and offline coupling to ESI and MALDI mass spectrometry. Anal. Chem. 2010, 4, 
1434-1443. 
44.  Ahn, J.; Jung, M.; Wyndham, K.; Yu, Y.; Engen, J. Pepsin immobilized on high-strength 
hybrid particles for continuous flow online digestion at 10,000 psi. Anal. Chem. 2012, 
16, 7256-7262. 
45.  MacNair, J.; Patel, K.; Jorgenson, J. Ultrahigh-pressure reversed-phase capillary liquid 
chromatography: Isocratic and gradient elution using columns packed with 1.0-μm 
particles.  Anal. Chem. 1999, 3, 700-708. 
46.  Franklin, E. Utilization of long columns packed with sub-2 um particles operated at high 
pressures and elevated temperatures for high-efficiency one-dimensional liquid 
chromatographic separations. University of North Carolina at Chapel Hill, 2012. 
47.  Stobaugh, J. Strategies for differential proteomic analysis by liquid chromatography-
mass spectrometry. University of North Carolina at Chapel Hill, 2012. 
 
 
 
 
 
29 
 
 
 
 
 
 
CHAPTER 2. Extraction, Purification, Solubilization, and Digestion 
Techniques for Membrane Proteomics  
 
 
2.1  Introduction 
Membrane proteins control biochemical processes, facilitate interactions between cells 
and their environment,1-4 and are important pharmaceutical targets.1, 5-8  Although it has been 
widely recognized that membrane proteins provide critical functions within biological systems, 
the progress of their analysis has been slow compared to their soluble counterparts.  This is 
predominantly due to their amphipathic quality, making membrane proteins extremely difficult 
to adequately extract, enrich, and solubilize from their native environment.2, 3, 9-13  In addition to 
their amphipathic nature, membrane proteins are present in low levels,1, 4, 5, 13, 14 increasing the 
difficulty of their detection in cell lysates.  Despite the difficulties involved in their investigation, 
their important roles in biological processes and as drug targets make them an important focus 
of proteomic analyses.  Although liquid chromatography coupled with mass spectrometry (LC-
MS) plays a central role in proteomics, optimized sample preparation is required.1, 2, 7  The 
sample preparation for membrane proteins typically encompasses extraction via cell lysis, 
enrichment, solubilization, and digestion steps for intact proteins; with the goal for these steps 
to be performed efficiently, without sample loss and residual interferences.15   
It is well established in the literature that sample preparation is extremely important (if 
not the most important) step in proteomic data acquisition.2, 8  This is especially true for 
membrane proteins which require careful preparation to avoid precipitation and aggregation for 
adequate digestion and supplemental identification.  Though interest in the field of membrane 
proteins has increased, detailed and comparative sample preparation protocols are scarce. 
Typically, descriptions in the literature provide specialized protocols for the isolation of a 
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specific type of membrane protein, compare relatively few methods, or focus on a specific aspect 
of the sample preparation process (cell lysis, enrichment, solubilization, or digestion).  The 
comparison is further complicated since authors rarely use the same sample or instrumental 
methods across various studies.4  The goal of this study was to investigate the major techniques 
of membrane protein sample preparation and determine a simple and efficient protocol that can 
be applied to increase the number of membrane protein identifications for the model organism 
Saccharomyces cerevisiae.  The techniques were required to be reproducible, discourage sample 
loss, and promote high throughput analysis.  As depicted in Figure 2.1, cell lysis, enrichment, 
solubilization, and digestion techniques were compared to determine an improved protocol for 
the analysis of membrane proteins. 
2.1.1 Cell Lysis Techniques 
In order to physically break through yeast’s cell wall and plasma membrane, a lysis 
procedure is required.  Traditional physical disruption methods of protein extraction from the 
cell wall/plasma membrane include performing freeze/thaw cycles, cryo-pulverization, glass 
bead-beating, high frequency sonication, and pressure assisted lysis (French press cell).  An 
alternative to physical disruption is in-solution cell lysis, which involves detergent-based, 
buffered reagents.  Since the detection method of choice for the proteomic workflow is mass 
spectrometry, involving popular lysis detergents such as Triton-X, CHAPS, and SDS for 
solution-based cell lysis was avoided.  Detergents can be extremely difficult to remove from the 
protein sample, and if present when performing mass spectrometry, will suppress ionization of 
the sample itself.  With consideration for the downstream application of mass spectrometry, the 
sample would require extensive dialysis for detergent removal after solution-based lysis 
techniques.  Therefore, physical disruption methods were focused on.  These techniques are not 
without their disadvantages, however, often causing localized heating within the sample during 
lysis.  When these techniques are applied, the yeast sample is constantly chilled on ice at all 
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times to reduce protein denaturation and aggregation due to heating.  The addition of protease 
inhibitors is also crucial whenever cells are manipulated to avoid sample degradation. 
Although freeze-thaw is commonly used on bacterial and mammalian cells, the readily 
available resource (a -80 °C freezer) for this application promoted its endeavor.  For this 
application, a sample is frozen at -80 °C followed by thawing at room temperature.  As this cycle 
continues, the freezing swells the cells followed by cell contraction during thawing.  The 
formation of ice crystals during the freezing results in breaking the cell wall and plasma 
membrane; however, it is well observed that multiple cycles can be required for an efficient, yet 
lengthy, lysis process.  A more aggressive approach to cell lysis is cryopulverization.  This 
technique, typically used with plant cells, involves freezing the sample in liquid nitrogen while 
grinding with a mortar and pestle.  The result is a fine powder, but the contents can vary widely 
depending on the strength of the force applied.   
Glass bead-beating is typically performed in a lysis buffer, where 100-500 μm glass 
beads are added to the sample followed by forceful vortex mixing.  As the beads beat against 
each other any sample between will undergo cell disruption.  This can cause excessive sample 
heating, thus short bursts of vortexing are intermittent with ice bath submersion.  As for 
sonication, a pulsed, high frequency probe is placed in the sample and the mechanical energy 
from the probe initiates formation of microscopic vapor bubbles which implode.  This implosion 
causes a shock wave to emit through the sample resulting in massive heat production.  Thus 
again, the sample is sonicated in short bursts while submerged in an ice bath. 
The final physical lysis approach investigated utilized a French Press cell.  This is 
pressure-assisted lysis where the sample is placed in a cell and pressed with a piston through a 
small hole in the cell.  As the cells exit the narrow opening of the French Press they experience 
shear stress and decompression, causing disruption.  Typically only a few passes of the sample 
through the press are required.  Following all lysis techniques, ultracentrifugation steps are used 
to isolate the cellular fragments, soluble proteins, and membrane proteins.  Since centrifugation 
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is a crude process, cellular components such as ribosomes and lipids can contaminate the 
membrane protein layer collected.  This can require a subsequent enrichment technique in order 
to further isolate membrane proteins from lipid, ribosomal, or non-membrane protein 
contamination. 
2.1.2 Enrichment Techniques 
Once the insoluble portion of the cell lysate is collected, an enrichment process can be 
used to isolate membrane proteins from lipid contaminates, which generally accompany the 
membrane proteins during ultracentrifugation.  The presence of lipids can decrease 
performance in chromatographic separations and cause ion suppression in the mass 
spectrometer.5, 16, 17  Chloroform/methanol partitioning18-20 and acetone precipitation are the 
most common forms of delipidation.12, 21  Chloroform/methanol partitioning works by providing 
an aqueous layer for soluble proteins, an organic layer to attract lipids, and an amphipathic 
interface to isolate membrane proteins.  This technique works even in high concentrations of 
detergents yet membrane proteins have been shown to disperse into multiple layers.20, 22  One 
advantage of chloroform/methanol partitioning, aside from removing lipids, is that it can 
possibly eliminate the presence of soluble proteins that centrifuged along with the membrane 
proteins as well.  Acetone precipitation involves the addition of cold acetone to a buffered 
protein sample, causing the proteins to precipitate leaving the lipids, salts, and other small 
molecules in the acetone solution for elimination.  Studies have shown, however, that a 
significant amount of lipids can remain with the sample after this procedure.11    
2.1.3 Solubilization Techniques 
Enriching the membrane proteins from the lipid bilayer and attempting to resolubilize 
them into an aqueous environment for enzymatic digestion could cause protein precipitation or 
the formation of hydrophobic aggregates.  Therefore, most membrane protein solubilization 
techniques utilize detergents (0.1-10% w/w) to mimic the lipid-membrane,4, 5, 7, 14 but the 
performance of detergents is variable.1, 7, 14, 15  Also the detergent must be removed prior to 
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analysis, since it can affect chromatographic separation and suppress ionization in the mass 
spectrometer.5, 10, 12, 16, 17, 23  The acid-labile surfactant RapiGestTM SF (Waters Corporation) has 
been shown to greatly enhance membrane protein solubility,3 allow 100% enzyme digestion at 
surfactant concentrations of 0.1%, and can be easily removed prior to mass spectral analysis via 
acidification.24  RapiGestTM surfactant undergoes hydrolysis in acidic conditions producing 
dodeca-2-one (water insoluble) and sodium-3-(2,3-dihydroxypropoxy) propanesulfonate (water 
soluble).  The insoluble compound is removed by centrifugation and the soluble compound is 
unretained in reverse-phase separations.25  The acid-insoluble detergent sodium deoxycholate 
(SDC) has also been reported to improve protein solubility, retain trypsin digestion efficiency at 
extremely high concentrations9, 10, 15, 26 (with 10% SDC, trypsin retained 77.4% activity),27 and 
SDC can be removed prior to MS analysis via acidification or by ethyl acetate phase transfer.4, 26, 
28  Ethyl acetate phase transfer was an interesting alternative to acidification, since acidification 
involves precipitation of the detergent which can allow for membrane proteins to precipitate as 
well.  Overall both of these detergents (RapiGestTM and SDC) are appropriate as they can be 
easily removed after the digestion step and prior to mass spectral analysis.   
Many other common surfactants, such as sodium dodecyl sulfate (SDS), can be utilized; 
however most require thorough removal via dialysis or chromatography techniques, which can 
be problematic for high-throughput analyses and low abundance proteins.10, 13, 29, 30  SDS is a 
traditional surfactant that performs extremely well solubilizing membrane proteins, yet is 
difficult to remove from the sample prior to LC-MS and can deactivate digestion enzymes.10, 13, 31, 
32  One popular method utilizing SDS is FASP or filter-aided sample preparation33, 34 for shotgun 
digestion of proteins.  Samples reduced in the presence of SDS are placed on a filter of 
appropriate size (typically 30 kDa).  Several washing steps will remove the SDS detergent; 
however, the proteins will remain behind on the filter.  The proteins can then undergo alkylation 
and digestion on the filter itself.  Once digested, solution is added and the resulting smaller 
peptides are easily centrifuged through the filter for collection and analysis.  Due to the 
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popularity of this method, it was compared to the improved protocol for shotgun membrane 
protein samples (samples that did not undergo fractionation).   
Either alone or in combination with detergents, organic solvents are often employed to 
aid in membrane protein solubilization.12, 13, 31, 35-38  The most common organic additive is ~60% 
methanol.  Methanol dominates as the organic solvent of choice due to its amphipathic nature as 
it induces lipid bilayer swelling and dissolution of membrane proteins.36, 39, 40  Another, less 
common, solubilization technique during the sample preparation process is the use of 
sonication.6, 16, 39  By applying sonication, hydrophobic vesicles can be dispersed, potentially 
releasing membrane protein clusters and allowing them to better interact with detergents (and 
therefore digestion enzymes) in solution.  Overall, as seen in Figure 2.1, two types of MS friendly 
detergents (RapiGestTM and SDC), the application of sonication, and the addition of organic 
solvent (60% methanol) solubilization techniques were compared. 
2.1.4 Digestion Techniques 
As for the digestion itself, there have been reports of increasing protein coverage by 
using alternative protein digestion enzymes and applying tandem digestion techniques.  The 
efficiency of an enzymatic digestion is determined by the sequence coverage.  Sequence coverage 
is the percent of the identified amino acids relative to the number of amino acids in the entire 
protein sequence and the higher the sequence coverage, the more certain the protein 
identification. 
   sequence coverage  
amino acids identified
total amino acids in protein database sequence
  (2-1) 
The standard digestion protease is trypsin, cleaving at the carboxy-terminal of lysine and 
arginine residues.  Sequencing grade trypsin can be easily acquired, from bovine or porcine 
sources, and is used mainly due to its reasonable specificity and stable activity.23  With portions 
of the proteome difficult to reach with a single protease, various proteases can be used either 
individually or in tandem with trypsin to increase protein identifications and sequence 
coverage.4, 13, 41-43  For example, Swaney et al. discovered that by using multiple proteases for S. 
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cerevisiae they achieved an additional 595 protein identifications and a 3-fold increase in 
sequence coverage.43  The three commonly applied enzymes tested in this study were trypsin, 
chymotrypsin, and pepsin.  Chymotrypsin is less specific than trypsin, however, it cleaves 
proteins at more hydrophobic amino acids (such as phenylalanine and tryptophan)13 and 
therefore may be a useful enzyme for membrane protein analysis.  Non-specific enzymes (such 
as pepsin) have also been studied, with the expectation that the production of overlapping 
peptides could increase protein sequence coverage44, 45; however, this typically results in 
increased sample complexity for analysis.42, 43 
2.1.5 Workflow Summary 
In the field of proteomics, proteins can be analyzed intact (top-down proteomics), 
digested into peptides prior to analysis (bottom-up or shotgun approaches),2, 11 or a combination 
of both (such as prefractionation techniques).46  Traditional shotgun approaches are ideal for 
membrane proteomics since the resulting peptides are easier to solubilize and separate than 
intact membrane proteins.  While shotgun analyses are most common,12 incorporating a 
prefractionation technique allows for an increase in protein identifications.46-49  In our 
prefractionation approach (Figure 2.2), fractions are collected after a first dimension reverse 
phase chromatographic separation of intact proteins, these fractions are digested in solution, 
and the peptides submitted to a second dimension reverse phase separation prior to mass 
spectral analysis.  Prefractionation, that is collecting fractions from a single chromatographic 
dimension and analyzing them on a second dimension, reduces sample complexity, increases 
overall peak capacity of the separation, and allows a greater amount of sample to be loaded for 
the possibility of finding low abundance proteins (such as membrane proteins).4, 23, 46, 50  As 
shown in Figure 2.1, the cell lysis and enrichment techniques previously discussed were 
performed prior to protein separation, whereas solubilization and digestion techniques were 
applied prior to peptide separation.  Each group of techniques (lysis, enrichment, solubilization, 
digestion) was tested sequentially while keeping the remaining categories constant according to 
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the default protocol (Table 2.1).  The default protocol will be further described in the materials 
and methods. 
2.2  Materials and Methods 
The experimental design is separated into four categories: cell lysis, enrichment, 
solubilization, and digestion, as shown in Figure 2.1.  Each category was tested sequentially in 
the order listed above.  The sample preparation techniques within each category were compared 
to determine which sample preparation method proved paramount.  Once a technique was 
selected, the subsequent comparison within the next category utilized sample prepared from the 
optimized technique from the previous category.  Prior to determining which sample 
preparation technique proved optimal, a default protocol was followed in the interim (Table 2.1).  
For example, an optimal solubilization or digestion strategy had not been determined when 
comparing the enrichment methods.  Therefore, as the enrichment methods were varied, the 
solubilization and digestion steps that followed were performed according to the default 
protocol until the next category was consecutively optimized.  This resulted in changing only one 
variable in the protocol at a time while moving through the workflow shown in Figure 2.1.  For 
the purposes of performing comparisons, the standard operating procedure (SOP) for our 
laboratory was chosen as it was previously followed in the lab and provided an acceptable 
general procedure to optimize specifically for membrane protein sample analysis (Table 2.1).  
The SOP involved French press cell lysis, no enrichment, solubilization with 0.15% RapiGestTM, 
and digestion with trypsin at 37 °C.  The solubilization and digestion steps51 are described in 
detail in Table 2.1.  Once optimal techniques were selected from all four experimental categories 
(cell lysis, enrichment, solubilization, and digestion) the completed improved protocol was 
compared to the default protocol in its entirety.  
2.2.1  Cell Culture and Extraction 
Saccharomyces cerevisiae (strain BY4741) was grown on glucose media until stationary 
phase was achieved (optical density >2).  Cells were washed, resuspended in 50 mM ammonium 
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bicarbonate and samples were divided evenly (~25 mL) for cell lysis comparison.  Sample that 
was not used for this study was flash frozen (-80°C) until the appropriate method of cell lysis 
was determined.  When each lysis method was performed, protease inhibitors (Pierce Protease 
Inhibitor Mini Tablets, 88665) were added and prepared to the manufacturer’s 
recommendations.  In total, 5 cell lysis techniques were compared for yeast protein extraction 
(Figure 2.1): freeze/thaw, cryopulverization, bead-beating, sonication, and French press cell 
lysis.  (1) For the freeze/thaw cell lysis, a 25 mL sample was allowed to freeze/thaw through 
three cycles reaching room temperature and returning to -80°C without flash freezing to 
promote crystal lysis of cells.  (2) Cryopulverization was conducted by pouring liquid nitrogen 
over a 25 mL sample in a mortar while grinding the sample into a powder using the pestle.  The 
addition of liquid nitrogen was repeated to avoid thawing of the sample while grinding.  (3) 
Another sample (25 mL) was placed in a centrifuge tube along with an equal volume of acid-
washed 150-200 µm glass beads (Sigma, Type III glass beads, No. G-5255).  The mixture was 
vortexed for 30 sec periods for a total of 5 min and placed on an ice bath for 2 min in between 
bead-beating.  (4) High frequency sonication (Fischer Scientific Sonic Dismembrator Model 
500) was performed on two 12.5 mL volumes (to avoid pulsation out of the 50 mL centrifuge 
tube) using a 1/8 sonication probe for 3 cycles (10 sec sonication at 30% power followed by 2 
min incubation on ice).  (5) Pressure assisted cell lysis utilized a French press cell, where the 
entire 25 mL sample was passed dropwise at 20,000 psi 3 times through the cell.  The cell itself 
was chilled (4°C) and elutant was kept on ice throughout the process.  
Each lysed sample was centrifuged at ~1,200 g for 10 min at 4°C min to remove 
unbroken cells (Beckman, L8-70 Ultracentrifuge).  The supernatant was isolated and underwent 
ultracentrifugation at ~120,000 g (38,000 rpm Beckman 60Ti rotor) for 90 min at 4°C twice 
before the pellets (insoluble portions) were collected.  To determine the amount of protein 
present a Bradford assay52 (Coomassie Protein Assay Kit, Thermo Scientific) was performed 
once the pelleted cells were resuspended in 50 mM ammonium bicarbonate buffer pH 8.  The 
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resulting concentrations were balanced through the addition of buffer and 100 μg of each 
sample was enzymatically digested according to the digestion protocol.51  The resulting peptides 
were processed on the modified ultra-high pressure liquid chromatography (UHPLC) mass 
spectrometry (MS) system described below.  Once French press cell lysis was determined to be 
the optimal method, it was performed (along with the ultracentrifugation steps previously 
described) to prepare the remaining sample for all further sample preparation techniques 
tested. 
2.2.2  Enrichment 
The two methods compared for the enrichment of membrane proteins were acetone 
precipitation and chloroform/methanol partitioning.  These were compared to using no 
enrichment technique prior to injection of intact proteins onto the first dimension separation 
column (Figure 2.2).  The acetone was precooled (-20°C) for at least one hour prior to use and 
0.5 mL was added to 1 mL of 0.5 mg/mL membrane protein solution (in pH 7.8 ammonium 
bicarbonate buffer).  After acetone was added to these samples, the solution was vortexed and 
allowed to sit for 1 hr at 4°C.  The sample was then centrifuged at 15,000 rpm for 5 min at 4°C 
and the supernatant removed.  The resulting pellet was dried under nitrogen, resuspended in 
buffer, and 80% formic acid was added immediately prior to intact protein separation.  
For chloroform/methanol partitioning,21 1 mL of 0.5 mg/mL membrane protein solution 
was added to 4 mL of methanol (vortexed, centrifuged for 30 sec at 9,000 g).  Two milliliters of 
chloroform was added (vortexed, centrifuged 2 min) followed by 3 mL of water (vortexed, 
centrifuged 2 min).  The water layer was then removed and another 1 mL of methanol was added 
(vortexed, centrifuged 5 min).  The sample was then centrifuged for 2 min at 9,000 g to pellet 
the protein.  The chloroform/methanol supernatant was removed, the remaining layers dried 
under nitrogen, and resuspended in buffer with 80% formic acid prior to injection onto the first 
dimension protein separation column.  The injection onto the first dimension for the 
chloroform/methanol enriched sample required four separate injections (0.250 mL each) of this 
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particular sample.  This had to be done as separate tandem injections loaded onto the head of 
the column with gradient starting conditions to avoid this technique clogging system tubing.  
Throughout the injection process the sample was kept chilled (10-15°C) to avoid degradation.  
2.2.3  Protein Separation and Fractionation 
For the first dimension protein separation (Figure 2.2) intact membrane proteins were 
placed in 80% formic acid (MS grade, Fluka Analytical) and injected onto a PLRP-S (300 Å, 5 
µm, 250 x 4.6 mm, Agilent Technilogies) polymeric reverse phase column at 80°C.  The sample 
was not allowed to sit idle for more than 2 min in formic acid to avoid protein formylation (+28 
Da)11 prior to separation.  Mobile phase A consisted of 80% water, 10% isopropanol, 10% 
acetonitrile, and 0.1% trifluoroacetic acid (TFA).  Mobile phase B consisted of 50% isopropanol, 
50% acetonitrile, and 0.1% TFA.  Beginning at 10% B, the gradient ramped to 60% B in 60 min 
at 1 mL/min followed by a further increase to 90% at 65 min where it held for 5 min before 
returning and stabilizing at 10% B.  The total run time was 80 min to allow for re-equilibration. 
The progress of elution was monitored via UV detection (Waters CapLC2487, Waters 
Corporation, Milford, MA) at 214 nm and 1 min wide fractions were collected for the 60 min 
gradient.  Once the fractions were collected they were flash frozen and lyophilized to concentrate 
the protein sample and remove MS-incompatible solvents.  The fractions collected at one 
minute intervals did not contain equal protein mass.  It has been shown that by dividing the 
sample into even amounts of protein resulted in more appropriate loading of the second 
dimension separation and a higher number of protein identifications.53, 54  Therefore the 60 
lyophilized fractions were recombined into 10 fractions of equal protein concentration.  The 
protein concentration was determined by integration of the UV absorbance signal collected 
during fractionation (Figure 2.3).54  The fractions were then solubilized and digested51 using the 
various techniques described below.  This process was, of course, completed multiple times to 
individually test each enrichment, solubilization, and digestion technique. 
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2.2.4  Solubilization 
A large amount (2 mg) of protein (without prior enrichment) was loaded onto the first 
dimension protein separation (PLRP-S) column and the resulting fractions lyophilized and 
recombined into 10 equal mass fractions as described above.  These ten fractions were then 
further split into 4 equal sample sets (of 10 fractions each) to equitably compare solubilization 
techniques (Figure 2.1).  Therefore, each solubilization technique was tested on a set of 10 
fractions that had originated from the same first dimension protein separation to reduce sample 
variability. 
First, the application of detergents 1% sodium deoxycholate (SDC) and RapiGestTM SF 
were investigated.  RapiGestTM SF acid-labile surfactant (Waters Corp.) at 0.15% w/v was used 
to solubilize a set of 10 fractions (total ~0.5 mg protein) and was removed post digestion via 
acidification with trifluoroacetic acid (TFA) to a pH of ~2.  The same acidification protocol was 
also used to precipitate the 1% SDC sample set (0.5 mg total), followed by centrifugation for 
sample collection.  For the organic solvent analysis, a sample set was solubilized with the 
addition of 60% methanol.  The fourth and final sample set of 10 fractions was further split into 
identical pairs (total ~0.25 mg protein each set) to compare vortex mixing to the administration 
of sonication.   Both sets of these 10 fractions were solubilized with 0.15% w/v RapiGestTM SF in 
accordance with the default protocol.  While one set of 10 fractions were vortexed between steps 
of the default digestion protocol,51 the other set were sonicated.  High frequency sonication was 
performed before and between the steps of the digestion protocol using an Elmasonic P (Elma 
Hans Schmidbauer GmbH & Co. KG) sonicator in sweep mode at 80 kHz.  
To quickly determine whether ethyl acetate phase transfer provided a better option for 
SDC removal than precipitation, two shotgun samples were compared.  One sample underwent 
the SDC precipitation as previously described, while the second experienced phase transfer 
removal of SDC.  During the phase transfer, 100 µL of ethyl acetate was added to the 100 µL of 
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digested solution, acidified to pH ~2 with TFA, mixed and centrifuged at 15,000 g for 5 min.26  
This was simply followed by the removal of the ethyl acetate layer. 
2.2.5  Digestion 
To reduce sample variability, 2 mg of protein (without enrichment) was injected onto the 
first dimension protein separation column.  The resulting fractions were lyophilized and 
recombined into the 10 equal mass fractions.  These 10 stock fractions were split into 5 
equivalent sample sets of 10 fractions (each ~0.4 mg total protein) and solubilized with 1% SDC.  
For the digestion process, three enzymes were investigated: trypsin (TPCK-treated from 
Affymetrix #22725), chymotrypsin (TLCK treated Sigma-Aldrich #C3142), and pepsin (Sigma-
Aldrich #P7000).  While trypsin and chymotrypsin easily followed the standard in-solution 
digestion protocol51 which takes place at pH 8, solutions had to be acidified with TFA to a pH of 
2 prior to the addition of pepsin.  Typically this required only 1-2 microliters of 8% TFA solution 
after the iodoacetamide incubation step.  The trypsin and chymotrypsin were added at a ratio of 
1:30 enzyme:protein and pepsin was added at a ratio of 1:10.  All incubations of single enzyme 
digestions took place at 37°C overnight.  A trypsin digestion at elevated temperature (60°C) was 
also performed on a sample set for comparison. 
In addition to the single enzyme digestions, a tandem digestion using multiple enzymes 
was performed.  A sample set was processed using untreated trypsin (Sigma-Aldrich #T8658), 
halted with acidification after overnight digestion at 37°C, and the pH was re-adjusted to a pH of 
7.8 using 1 M NaOH followed by the addition of chymotrypsin for a second overnight 
incubation.  For all digestions the reduction, alkylation, and incubation steps not described in 
detail were followed according to the default digestion protocol.   
2.2.6  Peptide Separation and Protein Identification 
For the second dimension peptide separation following all digestions (Figure 2.2), the 
resulting peptides were analyzed and identified using a modified UHPLC coupled to MS.54  In 
this modified high pressure separation system, the LC gradient and sample are placed into a 
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gradient storage loop using a commercial nanoAcquityTM UPLC (Waters, Corporation).  The 
ultra-high pressure (30,000 psi) is achieved by pushing the gradient and sample from the loop 
using a pneumatic amplifier (DSHF-300, Haskel  International LLC, Burbank, CA).  The 
peptides were separated on a 75 μm I.D. x 111 cm (manufactured in-house) capillary column 
packed with 1.7 µm 130 Å BEH C18 particles (Waters Corporation).  The column was held at 65°C 
and the eluting peptides were detected using a QToF PremierTM mass spectrometer (Waters 
Corporation).  Mobile phases consisted of water and acetonitrile with 0.1% formic acid (optima 
grade, Fisher Scientific) and a gradient of 4 - 40% organic was run over 110 min.  The column 
was connected to a silica nanospray emitter with a 20 µm I.D. and a 10 µm tip (New Objective, 
Woburn, MA).  The mass spectrometer operated in MSE mode55 performing parent ion scans 
from 50 to 1990 m/z over 0.6 sec at 5.0 V.  The collision energy then ramped from 15 to 40 V 
over 0.6 sec.  Data was collected using MassLynx V4.1 SCN 872 and processed via ProteinLynx 
Global Server 2.5 (PLGS, Waters Corporation) set to a 4% false positive rate for peptide 
identification with a reversed yeast proteome database obtained from Uni-Prot protein 
knowledgebase (www.uniprot.org).  The Uni-Prot knowledgebase contained 7,256 entries for 
Saccharomyces cerevisiae collected on 2/3/11 and was used as the basis for classification of 
each protein as “membrane” or “non-membrane.”  Proteins were classified as “membrane” if 
they were associated with the lipid bilayer in any way1 (this includes intrinsic and peripheral 
membrane proteins).  Proteins were classified as “non-membrane” if located in the cytoplasm, 
nucleus, mitochondria, and ribosomes.  If the same proteins were identified in multiple fractions 
within a sample set, the duplicates containing the lower identification score were not counted.  
Further processing parameters are outlined in Table 2.2.  A list of all identified proteins and raw 
MS data can be found at http://jjorg/web/unc/edu/ following the instructions under the Shared 
Data tab.  Once in the server, all data can be found under the Membrane Protein public file.  
Data is also available on www.proteomeXchange.org. 
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2.3  Results and Discussion 
2.3.1 Cell Lysis 
The lysis process was initially monitored using a microscope (400 X) as it was a fast and 
simple way to determine whether a method was effective.  For the sonication probe lysis and the 
freeze/thaw lysis, all cells observed beneath the microscope were still intact and therefore these 
techniques were not investigated further.  The cryopulverization, glass bead-beating, and French 
press pressure cell methods, however, contained few whole cells per magnified view.  Once the 
membrane portions of these methods were collected, a sample from each method was diluted to 
equal protein concentration and digested.  The results of the proteins identified are shown in 
Table 2.3.  Out of the three methods, the French press cell pressure-assisted lysis technique was 
the most effective and this method was used to lyse the remaining yeast for this study. 
2.3.2 Enrichment 
For the prefractionation onto the first dimension column, initial difficulties of clogging 
in-line filters and the column itself with membrane protein injections was remedied by placing 
the sample in ~80% formic acid.11, 44  This allowed for much larger volumes of intact membrane 
proteins to be injected onto the column for analysis and was performed despite the enrichment 
procedure analyzed.  To further reduce the likelihood of clogging, techniques such as 
centrifugation and filtration were attempted and compared to samples that were directly 
injected.  Centrifugation and filtration have the potential to remove protein aggregates in 
solution prior to injection; however, both could eliminate proteins and reduce the number of 
identifications.  In a preliminary study, protein (28 μg protein in 1 mL of 80% formic acid) was 
directly injected onto the first dimension column.  This was compared to the same amount of 
sample that was centrifuged (1000 rpm for 1 min) and filtered (0.2 μm PTFE) prior to injection.  
The centrifuged sample had an 8% decrease in protein identifications while the filtered sample 
had an 81% decrease in protein identifications compared to the sample that was directly 
injected.  Therefore, direct injection of the sample was determined to provide the best results 
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and was used as the injection method of choice for comparison to the chemical enrichment 
processes described below. 
Three separate fractionations of equal protein concentration (0.5 mg) were performed 
where the membrane protein sample was injected without any enrichment, after performing 
acetone precipitation, and after chloroform/methanol partitioning.  As shown in Figure 2.4, 
both the acetone precipitation and chloroform/methanol partitioning resulted in decreased 
protein identifications compared to using no prior enrichment step.  Both the acetone and 
chloroform/methanol enrichment procedures required either precipitation or pelleting/drying 
of the membrane proteins.  Since these techniques alter the protein’s native environment, they 
could result in difficultly for the proteins to reconstitute prior to injection.  It can be expected 
that once the lipid environment is removed and the proteins are precipitated, some of the 
membrane proteins may not re-dissolve into the buffered environment10 despite the presence of 
formic acid prior to injection.  To support this, a Bradford assay was performed before and after 
the acetone precipitation step and the concentration of the sample decreased by approximately 
half after precipitation.  This is important to realize since the protein concentration determines 
the amount of digestion enzyme added.  If too much enzyme is added, peptides resulting from 
trypsin autolysis can add increased complexity for sample analysis. 
2.3.3 Solubilization 
Although sonication is traditionally used as a cell lysis step, it can be applied prior to 
digestion in order to aid with membrane protein solubilization in the presence of detergents.  To 
improve solubilization, sonication applied prior to digestion moderately yet reproducibly 
increased the number of protein identifications compared to simply vortex mixing (Table 2.3).  
The second solubilization study focused on two types of MS compatible detergents and the 
addition of 60% methanol.  In accordance with the standard digestion protocol, 0.15% w/v of 
RapiGestTMSF was tested.  To determine the appropriate concentration of SDC, three 
concentrations (0.15%, 1%, and 5%) were previously tested for digestion efficiency (Figure 2.5).  
45 
 
Similar to reports in the literature,9, 27 the 1% concentration of SDC produced the most 
membrane protein identifications, while 0.15% and 5% showed a marked decrease.  No matter 
the concentration of SDC (0.15%, 1%, or 5%), however, it consistently outperformed or was 
equivalent to RapiGestTM SF in preparative studies.   
When the solubilization techniques were applied to fractions collected from the 
workflow, the 1% SDC identified 404 membrane proteins (941 total proteins) and 0.15% 
RapiGestTM SF identified 279 membrane proteins (625 total proteins) (Figure 2.6).  In addition 
to more membrane protein identifications, SDC was extremely convenient, turning the solution 
visibly cloudy when acidification occurred, and was less expensive.  Since SDC is a bile salt, 
becoming insoluble upon protonation, the precipitation could potentially cause protein loss.  
However, SDC can also be removed from solution via ethyl acetate phase transfer rather than 
precipitation.4, 26, 28  During the phase transfer, 100 µL of ethyl acetate was added to the 100 µL 
of digested solution, acidified to pH ~2 with TFA, mixed and centrifuged at 15,000 g for 5 min.26  
Similar to published findings,28 when phase transfer was compared to precipitation of SDC, both 
performed similarly with no marked difference in the number of proteins identified.  Finally, 
both RapiGestTMSF and SDC outperformed 60% methanol for protein identifications (Figure 
2.6).  No matter the concentration of methanol attempted, the samples containing organic 
solvent for solubilization never out performed any detergent tested in this study. 
2.3.4 Digestion 
Due to the variability in hydrophobicity of the amino acids at which certain enzymes 
cleave, as well as the frequency/specificity of these cleavages, three different enzymes were 
tested on the fractions collected from the insoluble portion of a yeast cell lysate.  Although 
trypsin is the most common and reproducible of the three, chymotrypsin cleaves at more 
hydrophobic residues (phenylalanine, tryptophan, and tyrosine) and pepsin’s non-specificity 
could produce overlapping peptides which could aid in identification.  Out of the three digestion 
enzymes tested individually (trypsin, pepsin, and chymotrypsin), trypsin outperformed all for 
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protein identifications (Table 2.3).  For membrane proteins, trypsin identified 228 proteins, 
chymotrypsin identified 12, and pepsin identified one.  It is important to note that although the 
PLGS software allows for the selection of alternative enzymes, most statistical models for data 
acquisition are developed based on the behavior of tryptic peptides.  Therefore, since software is 
designed for identifying tryptic peptides, it generally does a more successful job at finding them.  
It was extremely important to use fresh enzyme as well as freshly prepared chemicals during the 
digestion procedure (iodoacetamide, dithiothreitol, detergent, etc.), to achieve reproducible and 
optimal results.   
Tandem digestions were also attempted to increase proteome coverage.  Multiple 
combinations of the three enzymes were outlined (Table 2.4).  Initial studies with model 
proteins (BSA, cytochrome C, myoglobin, and RNAse A) were encouraging (Table 2.5).  As 
shown in Table 2.5, many of the tandem digestions of the model proteins resulted in a higher 
number of digest peptides and higher average percent coverage when compared to the 
individual enzymatic digestions.  By applying Kyte and Doolittle scores, a protein can be 
displayed based on its hydropathic character.  The hydrophobicity of each amino acid residue is 
assigned a value based on reported interactions with solvents from the literature.   A computer 
program systematically evaluates a protein chain to determine the average hydropathy of these 
values for a segment of predetermined length as it moves along the protein sequence.  The result 
is a visualization of the hydropathic character of a protein and these plots are commonly used to 
determine the membrane-spanning segments of a protein sequence.  For the Kyte and Doolittle 
scale, the more positive the score the more hydrophobic the region of the protein.56  Displayed in 
Figure 2.7 is the scale for RNAse A, plotted as peptide hydropathy score vs. peptide position 
within the protein.  As shown in Figure 2.7, the increased coverage of RNAse A that underwent a 
double digestion is obvious since the highlighted peptides (red bars) scan almost the entire 
protein.  On the other hand, the peptides present for the individual digestions with trypsin and 
pepsin contained areas where no peptides were identified.  The most difficult area to digest was 
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the large hydrophobic region from 0-20 amino acids, which contains several leucine and valine 
residues. 
Although tandem digestions seemed to improve coverage for model proteins, a more 
complex, “real” sample must be investigated.  For fractions collected from the insoluble portion 
of a yeast cell lysate, trypsin and chymotrypsin were selected to perform a trypsin-chymotrypsin 
tandem digestion.  Work with pepsin was attempted; however, the data could not be processed 
by the PLGS algorithm due to sample complexity.  For proteins identified for both trypsin alone 
and trypsin-chymotrypsin, trypsin alone produced more protein identifications (membrane and 
non-membrane) and identified more digest peptides (7741 total digest peptides for trypsin and 
1651 total digest peptides for trypsin-chymotrypsin) (Table 2.3).  This outcome could be 
different from the model proteins tested due to the complexity of the sample itself.  Therefore, 
utilizing trypsin as a single enzyme remained the digestion strategy of choice.   
For the temperature of the trypsin digestion, trypsin at 37°C identified 6 times more 
membrane proteins (228 membrane proteins) compared to trypsin at 60°C (30 membrane 
proteins) (Table 2.3).  Also, 27 of the 30 membrane proteins identified in the high temperature 
digestion were also identified at 37°C, with only 3 unique membrane protein identifications at 
60°C.  It has been reported that trypsin can experience thermal denaturation affecting 
stability.57  Therefore the digestion temperature remained at 37°C for the workflow. 
2.3.5 Protocol Comparison 
Overall, multiple sample preparation techniques were tested and compared in order to 
determine the most efficient and reproducible method for the cell lysis, enrichment, 
solubilization, and digestion of membrane proteins for S. cerevisiae processed using the 
prefractionation workflow.  It was determined that lysing yeast cells using a French press cell, 
separation of proteins without a prior enrichment step, solubilization with 1% SDC with the 
application of sonication, and digestion with trypsin at 37°C provided the highest number of 
protein identifications.  For a final comparison, this improved protocol implementing all of the 
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selected sample preparation techniques was compared to the original default protocol previously 
utilized in the lab.  To make an impartial comparison, cells were lysed with a French press cell 
and the insoluble portion of the yeast cell lysate was collected as previously described.  No prior 
enrichment step was administered and a 1 mg protein sample was injected onto the first 
dimension column.  The sample was fractionated and the fractions recombined into a 10 
fraction sample set so that each fraction contained an equal mass of protein per fraction (Figure 
2.3).  These 10 fractions were split into two equivalent sample sets (~0.5 mg total protein in each 
set).  One set was processed with the improved protocol and the second set was processed with 
the default protocol.  Each digested fraction was run on the UHPLC-MS three times, with a 
protein identification resulting only if the protein was identified in at least 2 of the 3 runs.  As 
shown in Figure 2.8, applying the improvements discussed increased the prefractionation 
workflow’s membrane protein identifications by 26%.  In addition, 68 membrane proteins were 
unique to the improved protocol, while only 18 membrane proteins were unique to the default 
protocol.  For the membrane proteins that were identified using both protocols (176 membrane 
proteins) the peptide intensity sum was higher for 93% (163 proteins) of the proteins identified 
by the improved method.  As depicted in Figure 2.9, many of the proteins had more than twice 
the intensity when identified with the improved method.  Therefore, not only did the improved 
protocol identify more unique membrane proteins (and peptides), the proteins that were 
identified by both methods were present in a higher abundance when applying the improved 
protocol.  The improved protocol was also compared to the popular FASP method (Table 2.6) for 
shotgun membrane protein samples (samples that did not undergo fractionation).  However, 
very few proteins were identified utilizing the FASP method (<10), while the improved protocol 
resulted in 202 ± 9 total protein identifications. 
2.4 Conclusions 
The membrane proteome can be considered the entirety of membrane proteins present 
in a cell at a specific time and condition.44  Although there is no single solution for the analysis 
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of membrane proteins, this research demonstrated the effects of cell lysis, enrichment, 
solubilization, and digestion techniques for prefractionated samples of yeast in order to 
determine an expedient and reproducible workflow to increase the number of unique membrane 
protein identifications.  It is well established that the user’s optimal conditions may depend on 
the protein profile.  However, for the model organism S. cerevisiae extraction via a French press 
cell, no further enrichment step, solubilization with 1% sodium deoxycholate while applying 
sonication, and digestion utilizing trypsin at 37°C enhanced the number of proteins identified 
when compared to the application of alternate sample preparation techniques.  Cell lysis 
techniques such as high frequency sonication, cryo-pulverization, freeze/thaw lysis, and bead-
beating did not produce as many proteins as the application of the French press cell. 
Enrichment techniques such as chloroform/methanol partitioning and acetone precipitation 
seemed to remove proteins when compared to a sample that did not undergo an enrichment 
process.  Although this non-enriched sample surely contained contaminants (lipids, etc.), it 
proved beneficial to let the sample remain in its initial state post lysis.  Furthermore, 
solubilization with methanol and using trypsin-alternative enzymes for digestion did not prove 
advantageous.  Overall, solubilization improvements such as utilizing sonication and sodium 
deoxycholate resulted in an increase in membrane and non-membrane protein identifications 
for S. cerevisiae.  The resulting improved protocol not only increased the unique membrane 
protein identifications, but 93% of the proteins commonly identified via the SOP and the 
improved method had a much higher intensity when identified using the improved protocol.  
Since this protocol was beneficial for yeast, which contains a relatively tough cell wall, the 
potential for its success with mammalian cells and tissue samples is expected. 
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2.5 TABLES 
 
Table 2.1  Default digestion protocol adapted from: 
http://www.genome.duke.edu/cores/proteomics/sample-preparation51 
 
Procedure: 
 
a) Perform Bradford assay to determine protein concentration of each solution.  
Normalize concentrations for samples within a group using 50 mM AmBic. 
 
b) In order to maximize solubility of proteins, add calculated volume of Waters 
RapiGest to have 0.15 % RapiGest in final concentration pre-digestion.  Make 
up RapiGest with 50 mM AmBic.   
 
c) Heat at 40°C for 10 minutes.  Spin down condensate. 
 
d) Make up 100 mM DTT in 50 mM AmBic for reduction step.  Add DTT to each 
solution to make the final DTT concentration 10 mM. 
 
e) Heat solution at 80°C for 15 minutes. 
 
f) Remove from heat and cool for 5 minutes (to room temp).  Spin down 
condensate. 
 
g) Make up 200 mM iodoacetamide (IAM) in 50 mM AmBic for alkylation step.  
Add IAM to each solution to make the final IAM concentration 20 mM (2X 
molar excess of DTT). 
 
h) Incubate the solutions in the dark at room temperature for 30 minutes. 
 
i) Add trypsin to each solution at 1:30 trypsin:protein concentration.  Make 
trypsin stock in 50 mM AmBic. 
 
j) Digest overnight at 37°C. 
 
k) Following digestion, centrifuge condensate to bottom of vial.  Add TFA and 
MeCN to give 0.5-1.0% TFA and 2% MeCN by volume. 
 
l) Samples sit for 2 hours at 60°C.  Centrifuge at 15,000 rpm for 5 min, and 
pipette supernatant into an autosampler vial. 
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Table 2.2  Software Processing Parameters 
Processing Parameters in PLGS V2.5 
Chromatography peak width automatic  
MS TOF resolution automatic 10,000 
Lock Mass  785.84265 Da/e Glu-1-Fibrinopeptide 
Lock Mass Window 1 Da 
Low Energy Threshold 150 counts 
Elevated Energy Threshold 50 counts 
Intensity Threshold 750 counts 
Workflow Template in PLGS V2.5 
Databank 
S.cerevisiae from 
http://www.expasy.org/proteomics 
Peptide tolerance automatic* 
Fragment tolerance automatic* 
Minimum fragment ion matches per peptide 3 
Minimum fragment ion matches per protein 7 
Minimum peptide matches per protein 1 
Maximum hits 20 
Maximum Protein Mass 250,000 
Primary Digest Reagent 
(selection varied depending on study: 
trypsin, chymotrypsin, or pepsin) 
Secondary Digest Reagent (used for tandem digestions) 
Missed Cleavages 1 
Fixed Modifications Carbamidomethyl C 
Variable Modifications 
Oxidation M, Deamidation N, Deamidation 
Q 
False Positive Rate 4 
* When “automatic” is selected the proprietary PLGS algorithm interrogates each data set to 
determine an ideal value for the analysis. 
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Table 2.3  Overall results for extraction, enrichment, solubilization, and 
digestion experiments. Experimental details held constant for each study are 
outlined. 
Procedure 
Total 
Proteins 
Membrane 
Proteins 
Experimental 
Details 
Cell Lysis 
Sonication N/A N/A 
Shotgun 
analysis (1D) 
100 μg sample 
RapiGestTM SF 
trypsin (37°C) 
Freeze/Thaw Cycles N/A N/A 
Bead-beating 58 33 
Cryopulverization 35 17 
French Press Cell 196 80 
Enrichment 
None 941 354 Fractions (2D) 
0.5 mg protein 
RapiGestTM SF 
trypsin (37°C) 
Acetone Precipitation 578 236 
Chloroform/Methanol Partition 626 225 
Solubilization – sonication study 
Vortex Mixing 191 55 
Fractions (2D) 
0.25 mg protein 
No enrichment 
RapiGestTM SF 
trypsin (37°C) 
Sonication 80 kHz sweep mode 216 60 
Solubilization – detergents 
0.15 % RapiGestTM SF 625 279 Fractions (2D) 
0.5 mg protein 
No enrichment 
trypsin (37°C) 
Sonicated 
60 % Methanol 88 33 
1 % Sodium deoxycholate 941 404 
Digestion 
High temperature trypsin (60 °C) 101 30 
Fractions (2D) 
0.4 mg protein 
No enrichment 
1% SDC 
Sonicated 
Pepsin 2 1 
Chymotrypsin 31 12 
Trypsin 620 228 
Trypsin-Chymotrypsin Tandem 124 34 
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 Table 2.4  Experimental design to determine the most promising 
 candidate for tandem digestions. 
 
Primary Enzyme 
Trypsin Pepsin Chymotrypsin 
S
e
c
o
n
d
a
r
y
 E
n
z
y
m
e
 
None X X X 
Trypsin 
   
Pepsin X 
  
Chymotrypsin X 
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Table 2.5  Experimental results for preliminary digestions with model proteins. 
Protein Enzymatic Digestion 
Average Percent 
Coverage 
Average Digest 
Peptides 
BSA 
Trypsin 92 % 100 
Pepsin 14 % 16 
Chymotrypsin 47 % 40 
Trypsin-Pepsin 91 % 153 
Trypsin - Chymotrypsin 93 % 129 
CYC 
Trypsin 84 % 26 
Pepsin 55 % 24 
Chymotrypsin 96 % 20 
Trypsin-Pepsin 82 % 41 
Trypsin - Chymotrypsin 96 % 41 
MYO 
Trypsin 88 % 26 
Pepsin 63 % 32 
Chymotrypsin 57 % 15 
Trypsin-Pepsin 94 % 44 
Trypsin - Chymotrypsin 91 % 33 
RNAse A 
Trypsin 85 % 26 
Pepsin 87 % 51 
Chymotrypsin 86 % 23 
Trypsin-Pepsin 86 % 50 
Trypsin - Chymotrypsin 100 % 41 
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Table 2.6  Shotgun digestion protocols: Improved Protocol vs. FASP Protocol for the 
insoluble portion of a yeast cell lysate. 
Improved Protocol 
 
1. 50 μL of lysed yeast cell lysate (2.24 
mg/mL), 40 μL ammonium 
bicarbonate (50 mM, pH 7.8) and 20 
μL of 5  sodium deoxycholate 
solution. 
2. Sonicated solution for 10 min and 
placed at 80 °C for 10 min. 
3. Add 10 mM dithioerythritol, sonicate 
10 min, place at 80 °C for 10 min. 
4. Add 20 mM iodoacetamide, sonicate 
10 min, incubate in dark 30 min at 
room temperature. 
5. Add trypsin 1:30 trypsin:protein 
concentration.  Digest overnight 37 
°C. 
6. Acidify to give 0.5-1 % TFA. 
7. Sit for 2 hr at 60 °C, centrifuge 
15,000 rpm for 5 min and collect 
supernatant. 
 
Shotgun Protein Identification Results: 
Sample 1 = 193 
Sample 2 = 211 
Sample 3 = 202 
 
FASP Protocol [15, 33, 34] 
1. 50 μL of lysed yeast cell lysate (2.24 
mg/mL) and 150 μL of lysis solution 
containing 4 % SDS in 100 mM 
Tris/HCl pH 7.6 and 0.1 M 
dithioerythritol placed in centrifuge 
tube. 
2. Placed at 95 °C for 3 min, centrifuged 
15,000 rpm for 15 min. 
3. 30 k filters (Microcon YM-30) were 
washed twice with 200 μL of UA 
solution (8M urea in 0.1 Tris/HCl pH 
8.5) by centrifugation 15,000 rpm for 
15 min. 
4. Reduced yeast protein solution was 
added to filter with 200 μL of UA 
solution, centrifuged 14,000 rpm for 15 
min.  Wash again with 200 μL of UA 
solution. 
5. 100 μL of 0.05 M iodoacetamide 
solution in UA was added and allowed 
to incubate for 20 min at room 
temperature. 
6. Two washings of 100 μL of UA solution, 
centrifuged 14,000 rpm for 15 min. 
7. Two washings of 100 μL of 50 mM 
ammonium bicarbonate solution, 
centrifuged 14,000 rpm for 10 min. 
8. 40 μL of trypsin stock (0.4 μg/μL) 
added to solution with 80 μL of 50 mM 
ammonium bicarbonate to wet/cover 
filter.  Sample was mixed and 
incubated overnight at 37 °C room 
temperature. 
9. Sample was centrifuged at 14,000 rpm 
for 10 min to collect peptides, washed 
with 40 μL of 50 mM ammonium 
bicarbonate and acidified to give 0.5-1 
% TFA. 
 
Shotgun Protein Identification Results: 
Sample 1 = 5 
Sample 2 = 1 
Sample 3 = 3 
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2.6  FIGURES 
 
 
Figure 2.1  Experimental outline. Sample preparation techniques from four categories (cell 
lysis, enrichment, solubilization, and digestion) of the membrane protein workflow were 
compared. Each category was tested sequentially while keeping the remaining categories 
constant according to the default protocol (Table 2.1). 
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Figure 2.2  Off-line two dimensional prefractionation workflow for membrane protein 
analysis. 
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Figure 2.3  Calculating equal mass fractions from equal time fractions. The UV trace for the 
gradient elution of intact membrane protein sample (red line), where each minute 
represents one fraction collected (x-axis). The intensity of the UV trace is integrated and 
normalized to the most intense signal (y-axis).  The blue line represents the summed 
integrated area.  Since this area is proportional to concentration, the area is split into the 
number of desired fractions along the y-axis (for example 10 as shown here and used in this 
study).  To determine which of the collected minute-wide fractions to combine for equal 
mass fractionation, the y-axis is followed over until it reaches the summed integrated area 
and dropped down as shown.  For example, equal mass fraction seven should contain equal 
time fractions 32.5-35.5.  Equal time fractions are not further divided to account for this, so 
fraction 7 becomes 32-35 or 33-36 as per the users’ discretion.  
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            (I)              (II) 
 
Figure 2.4  Results comparing enrichment techniques: (I) total protein identifications and (II) 
membrane protein identifications. 
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Figure 2.5  Determining the appropriate amount of detergent.  A variety of concentrations 
were tested for both sodium deoxycholate (SDC) and RapiGest SF.  Amount of protein used was 
~30 μg of the insoluble portion of yeast cell lysate (shotgun digestion). 
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Figure 2.6  Membrane protein identifications comparing 1 % SDC, 0.15% RapiGestTM SF, and 
60% methanol solubilization. 
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Figure 2.7  Experimental results for digestions of RNAse A with(a)  trypsin, (b) pepsin, and (c) 
a tandem digestion (trypsin followed by pepsin).  RNAse A is plotted based on the average 
amino acid hydropathy score vs. peptide position within the protein.  Separate red bars 
represent two replicates of each digestion and areas where peptides were identified are 
highlighted in red.  The scores are plotted from amino (left) to carboxy (right) terminus. 
 
(a) 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
(c) 
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Total Protein Identifications 
 
 
 
 
Total Peptide Identifications 
 
 
 
Membrane Protein Identifications 
 
 
 
Membrane Protein 
Peptide Identifications 
 
 
 
Figure 2.8  Fractions collected from 1 mg of insoluble cell lysate were split into two sets of 10 
fractions. One set was processed according to the default protocol and the other with the 
improved protocol. Results are shown for total protein identifications, membrane protein 
identifications, total peptide identifications, and membrane protein peptide identifications. 
 
 
 
 
 
 
64 
 
 
Figure 2.9  The log of the intensity ratio vs. molecular weight for the 176 membrane proteins 
identified using both the improved and default protocol.  Proteins represented above zero (163 
proteins) had a higher intensity using the improved protocol and proteins represented below 
zero (13 proteins) had a higher intensity using the default protocol. 
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CHAPTER 3. Advances in Ultra-High Pressure Liquid Chromatography 
(UHPLC)  
 
3.1  Introduction 
In order to achieve higher peak capacities and more efficient separations, long (~ 1 
meter) capillary columns with smaller (< 2 µm) particle sizes are utilized.  However, these 
longer columns require higher pressures than presently available with commercial systems (~22 
kpsi or 1500 bar).  Over the past two decades, the Jorgenson lab1, 2 has been developing Ultra-
High Pressure Liquid Chromatography (UHPLC) systems capable of running at high pressures 
for both isocratic (100 kpsi) and gradient (40 kpsi) separations.  Both types of separations rely 
on the use of hydraulic amplifiers to achieve these pressure conditions.  The UHPLC gradient 
system uses a lower pressure (10 kpsi) commercial nanoflow solvent pump to produce a high 
precision gradient followed by valve manipulation to store and isolate the gradient before it is 
introduced to the column via the high pressure hydraulic amplifier (Figure 3.1).  In order to 
accomplish this, previous UHPLC system designs within our lab included a high volume 
stainless steel gradient storage loop and commercially available pneumatically actuated pin 
valves to store the gradient and manipulate fluidics respectively.   Although this system did 
acquire highly efficient separations, acquiring reproducible chromatograms was challenging.  
The large gradient storage loop caused gradient mixing and had connections that routinely 
leaked.  One of the largest issues was the use of the mechanical pin vales, which consistently 
failed at holding high pressure.  By routinely failing to hold pressure over time, the pin valves 
caused poor chromatography due to leaks.  As shown in Figure 3.2, a system, when performing 
well, can produce intense peaks in the expected retention window (Figure 3.2a).  However, if a 
leak is experienced (Figure 3.2b) the intensity is reduced and peak retention times increase.  If 
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the leak continues to worsen (Figure 3.2c), the effects are intensified.  Lower intensities also 
typically result in lower protein/peptide identifications via mass spectrometry (MS).  Since the 
UHPLC system is a nanoflow system, leaks are rarely observed with the eye.  Instead, we rely on 
the chromatography.  For example, with an 80 cm BEH column (75 μm I.D.) at 65°C and a 
pressure of 30,000 psi, a volumetric flow rate of ~400 nL/min is expected based on the 
equation below. 
                         
    
    
      
       (    ) 
              (3-1) 
If the interparticle porosity (εi) is 0.4, particle diameter (dp) is 1.7 μm, and viscosity (η) is 0.0048 
g/cm·s (poise). 
 For an aggressive peptide gradient of 4-40% B, with 4% change in organic per column 
volume, a gradient volume of ~25 μL is loaded.  With a flow rate of ~400 nL/min this would 
make the run ~63 min for the gradient.  However, in Figure 3.2 (c) it is clear that peaks continue 
to elute after 63 min, and the intensity is much lower in comparison to (a).  In actuality, the flow 
rate for this chromatographic run (c) was calculated to be ~300 nL/min.  Although the leak was 
not visible to the eye, the chromatography was telling.  In order to continue to use meter long 
columns with sub-2-micron particle sizes with UHPLC, efforts were made to reduce extra 
column volume and provide more robust valve technology. 
3.1.1 Previous UHPLC System Operation and Considerations 
 For the original UHPLC design (Figure 3.1) a commercial nanoAcquity Ultra 
Performance Liquid Chromatography pump (Waters, Corporation) was used to produce the 
gradient and inject the sample.  This system is specifically designed to create high quality 
nanoflow gradients and inject small sample volumes (0.2 μL) ideal for capillary chromatography 
methods.  External plumbing for fluid manipulation (not including the gradient storage loop) 
consisted of 50 μm internal diameter (I.D.) capillary tubing with 360 μm outer diameter (O.D.).  
This size tubing was easily coupled to unions and valves with proprietary high pressure, 
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stainless steel fittings and provided a pressure within the limits (10 kpsi) of the commercial 
system to load the gradient.  The nanoAcquity loads a gradient and the sample into an external 
gradient storage loop in reverse order.  This is because it needs to be “played back” through the 
column in the correct order (sample  gradient  wash) once the pneumatic amplifier is 
activated.  A typically loaded gradient is shown in Figure 3.3, where the “wash” (i.e. high percent 
organic/B) is loaded, followed by the gradient in reverse order, and finally the sample.  The 
sample is typically sandwiched between two portions of aqueous solvent to deter mixing with 
the gradient prior to the chromatographic separation.  As this profile is generated by the 
nanoAcquity, the mechanical pins valves direct fluid through the external capillary plumbing.  
For the gradient and sample loading configuration (Figure 3.4), the nanoAcquity vent valve is 
closed while the other two mechanical pin valves (high pressure vent valve and the high pressure 
isolation valve) are open.  Since the diameters of the plumbing capillary is known (50 μm), the 
amount of “push solvent” for the gradient and sample to reach the gradient storage system can 
be calculated.  With the current setup and distances between instrument sections, this volume is 
typically ~3 μL. 
 Once the gradient and sample have been loaded into the storage loop, the valves are 
switched for the high pressure run configuration (Figure 3.5).  Now the nanoAcquity vent valve 
is open to allow for an open flow path for the commercial system and the remaining two valves 
(high pressure vent and high pressure isolation) are closed.  The pneumatic amplifier can now 
be activated to push the sample and the gradient onto the analytical column.  The analytical 
column is joined with small diameter capillary tubing (“pigtail”) via a union for electrospray 
(ESI) ionization and MS detection.  Since this system typically utilizes long (~1 m) capillary 
columns with sub-two micron particle sizes, the analytical column is heated (~45-65°C) and 
subjected to pressures in the range of 25-35 kpsi (1700-2500 bar).  This provides a flow rate of 
~300 nL/min, which is appropriate for nanospray ESI applications.  Since this is a constant 
pressure system, however, the flow rate will vary slightly with gradient composition due to the 
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change in viscosity.3, 4  The result is a high pressure separation system that is always operating at 
the maximum flow rate, providing more efficient separations than constant flow systems.4, 5 
3.1.2 Valves and Fittings 
 For achieving UHPLC, all components of the system facing extreme pressures (30 kpsi) 
must be compatible and operable at these pressures.  This includes all fittings, nuts, ferrules, 
unions, connectors, tubing, etc.6, 7  Although the high pressure isolation mechanical pin valve 
utilized to isolate the high pressure side of the instrument from the commercial nanoAcquity is 
rated to hold at 40 kpsi, leaks are routinely seen between 30-40 kpsi.  According to the 
manufacturer, there is a recommended direction of flow within the valve.  The high pressure 
isolation valve, whose function is crucial to the performance of the system, allows flow in one 
direction during the gradient/sample loading and blocks flow in the opposite direction during 
the high pressure run configuration.  However, when it is opened to release the pressure and 
begin the next gradient loading, flow travels from the outlet to the inlet.  So in actuality the valve 
sees flow in both directions.  This is extremely demanding of the valve, and along with repeated 
use of the valve for multiple runs, places a large amount of strain on the pin valve mechanism.  
This can lead to pin deformation resulting in the valve’s inability to hold high pressure over 
time.  Although the valves are rated to withstand pressures up to 40 kpsi, with repeated use 
realistic limits are ~25-30 kpsi.   
Each mechanical pin valve also holds ~2 μL of dead volume where mixing of the gradient 
can occur upon loading.  Working primarily with membrane proteins (insoluble portions of 
yeast cell lysates), this dead volume containing mechanically moving parts of the valve also 
provides surfaces where sample can precipitate and clog the system.  Each pin valve requires 
two capillary high pressure connections, providing potential locations for leaking and additional 
surfaces for sample adsorption.  Making “good” capillary connections is critical to the 
performance of the UHPLC.6  While each individual has their own method for making a “good” 
capillary connection, the result is typically the same.  The tip of the capillary must be cut as flat 
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as possible without spurs of the polyimide.  If micro-cracks are present on the tip of the 
capillary, making the connection could result in pieces of capillary breaking off into the 
plumbing of the system, potentially clogging the mechanical pin valves or unions.  Although 
fused silica capillary is itself a very strong material (tensile strength of ~700 kpsi8), these 
imperfections at the capillary connections to the unions and pin valves are detrimental to 
UHPLC system performance.  It is these locations that routinely break over continued use, 
producing difficult to detect nanoscale leaks throughout the system.  Thus, when redesigning the 
system, it was beneficial to remove as many of these capillary connections as possible to improve 
system performance. 
3.1.3 Freeze/Thaw Valve 
Freeze/thaw (FT) technology is a more sustainable option for the UHPLC system.  With 
a FT valve, the liquid inside of the capillary tubing is used as the plug when frozen and allows 
flow when thawed.9  This contains no mechanical moving parts, has rapid response time, does 
not add additional dead volume to the system,10, 11 and would reduce the potential for leaks for 
high pressure applications12 due to the lack of capillary connections within the valve.  
Freeze/thaw valves have been extremely useful in microfluidics and capillary applications.9, 13-16   
In 2004, a freeze/thaw valve designed by Waters Corporation was used in an injector block to 
turn capillary flow on and off.  The valve used the liquid inside of the capillary to switch on/off 
flow to the system by freezing (on/closed valve) or thawing (off/open valve) the liquid with a 
cryogen.1, 11  This design was ideal for implementation into the current UHPLC arrangement.   
Originally, the FT valve was placed behind the high pressure isolation valve (Figure 3.6).  
The idea was the mechanical pin valve would instantaneous cut off flow so the FT valve would 
freeze the fixed mobile phase inside the capillary.  Connected to a tank of liquid carbon dioxide, 
this valve would freeze the liquid and hold high pressure throughout the entire length of the 
gradient run and thaw the plug of frozen liquid when the run was complete.  This design was 
sought initially as prior efforts within the lab suggested the FT valve did not work well when 
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attempting to freeze a moving liquid.1  However, it was soon determined that if the flow rate of 
the liquid was low, the FT valve could effectively close.  As explained further in this chapter, the 
FT valve was so successful at holding high pressure it soon replaced two mechanical pin valves 
entirely without the need for the mechanical pin to instantaneously halt liquid flow within the 
system. 
Previous attempts at implementation of a FT valve to the UHPLC system involved the 
use of Peltier cooling.  A series-arrangement of Peltier stages was designed so the capillary after 
the high pressure isolation valve came into contact with a thermoelectrically cooled surface.17, 18 
Peltier cooling acts as a heat pump, transferring heat from the capillary, and as a result 
cooling/freezing the liquid.  Although this device did successfully freeze the liquid in the 
capillary and hold high pressure, it built up massive amounts of ice due to condensation of water 
vapor from the surrounding air over time.  This resulted in long wait times for the Peltier driven 
FT device to thaw between chromatographic runs.  The device was also bulky due to the large 
fans used to dissipate heat and the attachment of an external power supply.  Therefore, a 
simpler design11 was implemented.  Similar to the design described in Patent Number US 
7,841,190 B2, the capillaries are fed through the base of a copper cup.  Copper was chosen based 
on its high thermal conductivity (~400 W/m·K).  The liquid carbon dioxide comes in through 
the top of plastic housing and sprays into a porous frit within the copper cup, bringing the 
copper and thus to liquid in the capillaries to approximately -60°C.  The porous frit allows rapid 
flow of the cryogen to freeze the liquid, yet when the cryogen solidifies, the frit serves as a 
restrictor to flow.  This greatly reduces the amount of cryogen required for freezing.11  The 
copper is placed inside of plastic housing and flushed with nitrogen to avoid the buildup of ice 
around the device over time.  This design required no additional external power supply for the 
freezing process and was much smaller in size than the previous Peltier setup.   
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3.1.4 Gradient Storage System 
 It is imperative when loading the gradient into the storage loop that it remains as 
unaltered as possible prior to high pressure chromatographic separation.  Mixing of the gradient 
would reduce the resolution and reproducibility of the chromatographic runs.  Once the final FT 
valve design was implemented into the UHPLC system, the gradient would travel through two 
tee unions before entering the gradient storage loop (Figure 3.7).  Originally the loop on the 
UHPLC system was 40 m of 250 μm I.D. stainless steel (later reduced to 127 μm I.D.).  It was 
previously determined by K. Fague in the Jorgenson lab that by placing 10 m of 50 μm capillary 
before the stainless steel portion of the loop, the desired gradient profile was better retained 
during high pressure chromatographic runs.17  The 10 m of capillary was connected to the 
stainless steel loop via a microvolume union which allowed for storage of high volume gradients 
up to 2 mL.  Previously described in Chapter 1, gradients utilized for high pressure separations 
are determined based 1, 2, or 4% change in organic per column volume.  For a meter long 
column, with a column volume of ~3 μL, the longest gradient (1% change in organic per column 
volume) for a typical 4-40% peptide elution would be 108 μL.  With these same parameters, a 
2% change would require 54 μL gradient volume, and 4% would require 27 μL.  All of these 
gradient volumes would fill the 10 m of 50 μm I.D. capillary (20 μL) and extend into the wider 
bore stainless steel loop.  Therefore, gradient linearity could still be affected.  
 Installing 10 m of capillary to the head of the gradient storage system (instead of 20 or 
30 m, etc.) was initially selected due to the pressure limitations of the current system.  Since this 
system still employed the mechanical pin valves, partial clogs and crushed capillary connections 
forced the nanoAcquity to load the gradient and sample at higher pressures than theoretically 
calculated for the 50 μm I.D. open tubular connective capillary.  By implementing the FT valve 
described above, many of these connections were eliminated, resulting in overall lower pressure 
requirements for gradient and sample loading.  This unlocked the opportunity to further 
improve gradient linearity by replacing the entire loop with 50 m of 50 μm I.D. capillary.  Not 
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only would this eliminate yet another capillary union from the system (which connected the 10 
m of capillary to the stainless steel tubing) but would allow for the entire gradient to remain in a 
single diameter of tubing upon loading.  All three of these systems (1) stainless steel loop, (2) 10 
m of 50 μm I.D. capillary followed by stainless steel loop, and (3) 50 m of 50 μm id. capillary 
were investigated in order to improve gradient linearity and reduce mixing upon loading.  
Overall, to determine the effect of implementation of a FT valve and narrow bore capillary 
storage loop, complex mixtures of analytes were tested along with standards to gauge the 
effectiveness for the various system configurations.     
3.2 Materials and Methods 
3.2.1 Original UHPLC System 
 Many variations of the original UHPLC system have been previously described.2, 3, 17  An 
outline of the system is shown in Figure 3.1.  A commercial nanoAcquity (Waters Corporation, 
Milford, MA) is used to produce the gradient and inject the sample into external plumbing.  All 
external plumbing (aside from a single section directly before of the pneumatic amplifier) 
consisted of 50 μm capillary (Polymicro Technologies, Phoenix, AZ) and all capillary fittings 
were connected to stainless steel tees/unions via proprietary high pressure fittings provided by 
Waters Corporation.  The union and connection tees were 1/32” stainless steel nanovolume 0.15 
mm bore (VICI Valco Instruments, Houston, TX).  The union itself is not displayed in Figure 3.1 
but was placed after 1 meter of 50 μm capillary before the gradient storage loop.  The 
mechanical high pressure vent valve and the high pressure isolation valve were rated to 40 kpsi 
while the nanoAcquity vent valve was rated to 10 kpsi (VICI Valco).  The gradient storage loop 
originally consisted of 1/32” O.D. x 250 μm I.D. stainless steel tubing (VICI Valco Instruments); 
however this was later replaced with smaller diameter 1/32” O.D. x 127 μm I.D. stainless steel 
tubing.  The pneumatic amplifier was a DSXHF-903 (Haskel, Burbank, CA) with an 
amplification ratio of 1:1038.  The fittings connecting the head of the Haskel pump to the 
capillary tubing involved stainless steel 316 reducers (1/4” to 1/8” and 1/8” to 1/32”) and nipple 
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tubing (High Pressure Equipment Company, HIP, Erie, PA).  The latter fitting from the Haskel 
pump was connected to a proprietary 1/32” high pressure fitting acquired from Waters 
Corporation and directly connected to 15 μm I.D. x 60 cm x 360 μm O.D. capillary (Polymicro 
Technologies).  All high pressure fittings utilized PEEK ferrules (VICI Valco Instruments) drilled 
out manually with a 380 μm drill bit (McMaster Carr). 
 The 15 μm I.D. x 360 μm O.D. capillary was installed between the pneumatic amplifier 
and the connecting tee as a safety precaution.  This served as a safety feature due to the fact that 
it would act as a flow restrictor (dropping all high pressure) if any of the fittings succeeding the 
pneumatic amplifier failed.  Columns will be described in detail depending on the experiment 
conducted, however, mostly 75 μm I.D. x 360 μm O.D. x ~1 m long capillary columns packed 
with 1.7 μm, 130 Å bridged ethyl hybrid (BEH) particles (Waters Corporation) were employed.  
All columns were packed in house using a 20 mg/mL acetone slurry concentration and 
proprietary packing vessel.  With these column dimensions, the pneumatic amplifier routinely 
ran between 30-35 kpsi and a column flow rate of ~300 nL/min was standard.  In order to 
acquire this flow rate (depending on the length of the column and pressure applied) the 
temperature of the column (controlled via a Waters Temperature Control Module II with 
heating unit) was held between 45-65°C.  The end of the column was connected to a segment of 
20 μm I.D. x 360 μm O.D. capillary (“pigtail”) via 254 μm I.D. flexible fluoropolymer tubing 
(HPFA, IDEX Health & Science, Oak Harbor, WA) which was drilled out manually to 360 μm.  
The pigtail was then connected to the electrospray ionization (ESI) source of a QTof Premier 
mass spectrometer (Waters Corporation).   When UV detection was required the end of the 
column was connected to a Waters CapLC2487 (Waters Corporation). 
 Nitrogen was controlled to the pneumatic pin valves via 24 V DC solenoid valves 
(Humphrey Products, Kalamazoo, MI) in the normally closed configuration.  The same nitrogen 
was sent to the pneumatic amplifier by a 24 V DC NPT solenoid valve (1/2” Livingston & Haven, 
Charlotte, NC) also in the normally closed configuration.  An in-line regulator was used to 
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control the amount of nitrogen sent to the pneumatic amplifier, keeping in mind that it would be 
amplified by x 1038.  Therefore a pressure of 30 psi on the regulator from the nitrogen tank 
would produce a pressure of 31,140 psi from the pneumatic amplifier. 
Activation of solenoid valves to control the release of nitrogen (and operate the 
valves/pneumatic amplifier) was controlled by the nanoAcquity software.  Mass Lynx (version 
4.1 SCN 872) software was used to operate the nanoAcquity controls output contact closures in 
the rear of the instrument that can operate external devices with +/- 5 V DC pulse.  Since all 
pneumatic valving was controlled by 24 V DC, a N-Ch power MOSFET switch v1.0 
(www.circuitstew.com/pcbs/ power_mosfet_switch.html) was used to allow the low voltage 
pulse from the nanoAcquity to control the large DC load of the solenoid valves.  The column 
heater was placed on a metal shelf.  All valves and shelves used to operate and hold the system 
were bracketed to the commercially provided cart containing the nanoAcquity with an in-house 
built aluminum frame.   
3.2.2 Freeze/Thaw Valve 
 The first FT valve UHPLC configuration contained all of the specifications described 
above with the addition of a FT valve (and corresponding liquid CO2 tank) as shown in Figure 
3.6.  For the FT valve, a copper cup 6.57 mm tall and 8.91 mm wide is drilled with a 5.60 mm 
diameter leaving a 1.50 mm base.  In the base of the cup three holes are drilled.  Two are for 360 
μm O.D. capillary passage and the middle is for placement of the thermocouple (T-type, Omega 
Engineering, Stamford, CT).  Inside of the copper cup is a 10 μm sintered stainless steel filter 
cup (Waters Corporation) used to disperse the liquid carbon dioxide.  The copper cup with the 
stainless steel filter is placed inside of UltemTM housing 25.42 mm round by 22.75 mm high.  
Inside of the housing is an 11.34 mm wide hole where the copper cup is placed.  The liquid CO2 is 
fed in through the top of the plastic housing with a peek nut, ferrule, and tubing (VICI Valco 
Instruments).  The base of the housing is also UltemTM (5.77 mm base height), and is held in 
place by two screws.  A picture of the housing and the copper cup are shown in Figure 3.8.  The 
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PEEK tubing responsible for bringing in the liquid CO2 is attached via a union (1/32” to 1/16” 
stainless steel) to stainless steel tubing connected to a cryogenic solenoid valve described below. 
The thermocouple placed inside of the copper cup is connected to a temperature 
controller (Omega Engineering) which detects the desired temperature range.  A set point of -50 
°C was ultimately chosen with a ± 10°C dead band.  A metal oxide varistor (Digi-Key Electronics) 
was crucial for the controller to operate the solenoid valve.  When the temperature inside the FT 
valve rose above -40°C a relay switch on the temperature controller would open a cryogenic 
solenoid valve (normally closed, ASCO Valve).  This valve would remain open until the desired 
set point (-50°C) was again reached, closing the valve.  This is an open-loop system, meaning 
that as long as the temperature controller is powered on, freezing the capillaries will commence 
depending on the set temperature and dead band.  When thawing was required, the temperature 
controller can simply be turned off.  The temperature controller is controlled by the same series 
of MOSFET switches described above that operate the pneumatic solenoid valves.  Typically, 
room temperature thawing requires 5-7 min depending on the temperature inside of the lab.  
Using ambient heating can be an issue, since it is notably slower than electrical heating.19  
Therefore, a faster (~1 min) system was engineered incase rapid thawing was required.  For this 
system a miniature thermoelectric heater (Minco) powered by an external DC power supply 
(Extech Instruments) was activated using a mechanical relay switch (CII technologies).  The 
relay switch was operated by the nanoAcquity contact closures and MOSFET switch board 
described previously.  This setup is displayed in Figure 3.9.  The FT Valve was ultimately placed 
inside of a plastic box and flushed with a light stream of nitrogen gas (Figure 3.10) to avoid the 
buildup of ice.  Ice, however, was ultimately not an issue; yet the FT valve remained in the 
plastic box since it was convenient. 
To determine the pressure limits of the FT valve, it was attached directly to a pneumatic 
amplifier and pressurized up to a maximum value of 60 kpsi (Figure 3.11).  In this configuration 
multiple mobile phase compositions were tested to determine the temperature required for 
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proper freezing.  As explained in the section above, after the gradient and sample are injected by 
the nanoAcquity system a specific amount of “push” solvent is used to place the gradient and 
sample inside of the gradient storage loop.  This push solvent consists of 99.5% aqueous (A) 
phase (water with 0.1% formic acid, Fisher Optima grade) and 0.5% organic (B) phase 
(acetonitrile with 0.1% formic acid, Fisher Optima grade).  Although this should be the only 
liquid present inside of the capillaries of the FT valve, 0.5%, 50%, and 85% acetonitrile were 
tested to determine the limits of the valve in the presence of various mobile phase compositions. 
3.2.3 Gradient Storage Comparison 
 After the FT valve was successfully implemented into the UHPLC system, three different 
gradient storage loop configurations were compared.  The first consisted of 40 m of 127 μm I.D. 
stainless steel tubing (VICI Valco).  The second, 10 m of 50 μm I.D. capillary (Polymicro 
Technologies) was placed before the 40 m of 127 μm I.D. stainless steel tubing.  The final design 
removed the stainless steel loop altogether, consisting of only 50 m of 50 μm I.D. capillary (360 
O.D., Polymicro Technologies).  These configurations are outlined in Figure 3.12, a-c. 
 Gradient volumes consisting of 5, 10, 20, 30, and 40 μL were loaded with mobile phase A 
(water with 0.1% formic acid) and B (90% acetonitrile, 10% acetone with 0.1% formic acid).  
Acetone was added to the organic mobile phase so the gradient profile could be monitored by 
UV detection at 265 nm (Waters CapLC2487, Waters Corporation).  The gradient program for 
the UHPLC system is shown in Table 3.1.  In Table 3.1, certain cells are highlighted, these rows 
on the gradient program determine the volume of the gradient itself.  The gradient outlined in 
Table 3.1 is for a 5 μL gradient.  When a larger gradient volume was desired the corresponding 
time (2.8 to 3.8 min) would be changed so a loading flow rate of 5 μL/min would produce the 
desired volume.  The UV detection cell consisted of a 40 μm I.D. tubing and cell (Waters Corp.).  
The inlet capillary to the detection window was 20.5 cm resulting in an extra column volume of 
0.26 μL.  The column was replaced by an open tube restrictor capillary 5 μm I.D. x 55 cm x 360 
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μm O.D.  The flow rate from the outlet of the UV detection cell was measured at 300 nL/min for 
an applied pressure of 30 kpsi. 
The union used to connect the restrictor capillary to the capillary leading to the detector 
cell was purchased from New Objective.  The PicoClearTM union is a true zero dead volume 
connection for 360 μm O.D. capillaries.  This technology uses radial compression which is 
uniformly applied and eliminates contaminants which may clog a nanospray emitter.  Due to the 
success of this union for this experiment, the PicoClearTM union was compared to the 
fluoropolymer tube union previously used to connect the outlet of capillary columns to the 
pigtail prior to electrospray ionization. 
3.2.4 Comparison of UHPLC Systems Using a Yeast Cell Lysate 
Two setups were compared (Figure 3.13).  The first configuration (Figure 3.13, Setup 1) 
consisted of three mechanical pin valves and a capillary/stainless steel gradient storage loop.  
The storage loop in this configuration led with 10 m of 50 μm I.D. capillary followed by 40 m of 
127 μm I.D. stainless steel tubing.  The two sections were joined by a microvolume 0.15 mm bore 
union (VICI Valco).  The second configuration (Figure 3.13, Setup 2) implemented the FT valve 
in place of two mechanical pin valves and had a gradient storage loop entirely of 50 μm I.D. 
capillary tubing.  The same 10 samples of the insoluble portion of a yeast cell lysate were 
processed on both systems and compared.  The same column, mass spectrometer, nanoAcquity, 
and pneumatic amplifier were used for both studies.  Only the valving and plumbing were 
altered between setups.   
Saccharomyces cerevisiae (strain BY4741) was grown on glucose media until stationary 
phase was achieved (optical density >2).  Cells were washed, resuspended in 50 mM ammonium 
bicarbonate pH 8 and protease inhibitors (Pierce Protease Inhibitor Mini Tablets) were added 
and prepared to the manufacturer’s recommendations.  Pressure assisted cell lysis utilized a 
French press cell, where the entire 25 mL sample was passed dropwise at 20,000 psi 3 times 
through the cell.  The cell itself was chilled (4°C) and elutant was kept on ice throughout the 
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process. Each lysis sample was centrifuged at ~1,200 g for 10 min at 4°C to remove unbroken 
cells (Beckman, L8-70 Ultracentrifuge).  The supernatant was isolated and underwent 
ultracentrifugation at ~120,000 g (38,000 rpm Beckman 60Ti rotor) for 90 min at 4°C twice 
before the pellets (insoluble portions) were collected.  To determine the amount of protein 
present a Bradford assay20 (Coomassie Protein Assay Kit, Thermo Scientific) was performed 
once the pelleted proteins were resuspended in 50 mM ammonium bicarbonate buffer pH 8.  A 
sample of 0.5 mg of protein underwent acetone precipitation (described in Chapter 2) and 
proteins were separated on a PLRP-S reverse phase column (300 Å, 5 µm, 250 x 4.6 mm, Agilent 
Technologies, Santa Clara, CA).  Elution of the proteins was monitored at 214 nm via UV and 
collected as equal time fractions.  These fractions were lyophilized and recombined into 10 equal 
mass fractions (described in Chapter 2) for protein digestion.  Once back in solution, these 10 
fractions underwent in-solution protein digestion (Table 3.2) and resulting peptides processed 
using Setup 1 and Setup 2 (Figure 3.13).  The described protein workflow is outlined in Figure 
3.14. 
For both setups the column was held at 65°C.  Mobile phases consisted of water and 
acetonitrile with 0.1% formic acid (Optima grade, Fisher Scientific) and a gradient of 4 - 40% 
organic was run over 100 min.  Therefore a 36 μL gradient was loaded corresponding to a 4% 
change in B per column volume.  The flow rate was measure to be ~305 nL/min.  The column 
(109 cm column, 1.7 μm, 130 Å BEH C18) was connected by a fluoropolymer tube to a “pigtail” 
(20 μm I.D. open tube capillary).  This pigtail was connected to a silica nanospray emitter with a 
20 µm I.D. and a 10 µm I.D. tip (New Objective, Woburn, MA).  Peptides were detected using a 
QTof PremierTM mass spectrometer (Waters Corp.) operated in MSE mode21 performing parent 
ion scans from 50 to 1990 m/z over 0.6 sec at 5.0 V.  The collision energy ramped from 15 to 40 
V over 0.6 sec.  Data was collected using MassLynx V4.1 SCN 872 and processed via ProteinLynx 
Global Server 2.5 (PLGS, Waters Corporation) set to a 4% false positive rate with a 1 X 
randomized yeast proteome database obtained from Uni-Prot protein knowledgebase 
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(www.uniprot.org) on 2/3/2011 (Table 3.3).  If the same proteins/peptides were identified in 
multiple fractions within the 10 sample set, only the fraction with the highest identification 
score (confidence) was counted.  Therefore, a protein was only counted once despite whether the 
protein/peptide was split into multiple fractions during the first dimension separation.   
3.2.5 Post Column Connection and Bleed Valve 
 Described above, the post column connection to the “pigtail” was originally performed by 
a piece of fluoropolymer tubing manually drilled to 360 μm I.D.  During the gradient storage 
loop analysis, the PicoClearTM union from New Objective was introduced to the lab.  Used 
previously for UV detection studies, this union was compared to the prior fluoropolymer tube 
union for mass spectral analysis.  Using Setup 2 (Figure 3.13), the same standard digest of BSA 
(bovine serum albumin) was processed using the fluoropolymer tubing connection and by the 
PicoClearTM union.  Both unions were placed at the end of the column heater, which was at 65°C.   
 To accommodate the instantaneous release of pressure from the system shown in Setup 
2 (Figure 3.13), a bleed valve was employed (Figure 3.15).  The bleed valve consisted of a 40 kpsi 
mechanical pin valve connected to a low volume tee.  The valve was operated via a solenoid valve 
controlled by the nanoAcquity software.  After the chromatographic run was complete, this valve 
was opened and the pressure was released slowly.  The outlet of the pin valve was connected to 1 
m of 20 μm I.D. capillary.  
3.3 Results and Discussion 
3.3.1 Freeze/Thaw Valve 
After the freeze thaw valve was manufactured, it was tested (Figure 3.11) to determine 
the pressure limitations.  Originally the temperature controller was set to -50°C with a ± 20°C 
dead band.  A mixture of 50:50 acetonitrile:water was tested and a 50 μm I.D. capillary (360 μm 
O.D., 1 m in length) was placed in the FT valve.  Preliminary studies indicated that as the 
diameter of the capillary increases beyond 50 μm, the frozen plug cannot seal against high 
pressure.1  Flow of liquid was sent though the capillary and then stopped to allow for freezing.  
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Once frozen, the pressure on the pneumatic amplifier was slowly ramped to 30 kpsi.  However, 
on the UHPLC system the pressure does not slowly ramp, it is instantly initiated.  Therefore, this 
was repeated except the pressure was instantly applied at 30 kpsi to the FT valve.  The valve 
successfully held for 30 min at 30 kpsi in 50:50 water:acetonitrile, both with ramped and 
instant pressure application.  Both of these conditions (ramped and instant pressure) were also 
tested at 60 kpsi and held successfully for 30 min each. 
Next, 99.5:0.5 (water:acetonitrile) was tested and the capillary was flushed with the new 
mobile phase.  Although this mobile phase composition held for 30 min at 30 kpsi (both with 
ramped and instant pressure application), it did not at 60 kpsi.  The dead band to the 
temperature controller was therefore lowered to ± 10°C.  This initiated cryogen flow when the 
temperature rose above -40°C instead of the previous dead band setting of -30°C.  With this 
mobile composition consisting mostly of water it was surprising that -30°C did not hold at 60 
kpsi.  Once the dead band was lowered, 99.5:0.5 held consistently at 60 kpsi when ramped and 
when instant pressure was applied.  The final mobile phase composition tested was 15:85 
(water:acetonitrile).  Keeping the same temperature control settings (-50 ± 10°C) this mobile 
phase combination held at 30 kpsi and 60 kpsi for both ramped and instantaneously applied 
pressure.  Since 60 kpsi was the highest pressure available for testing within the lab, and it is 
~30 kpsi greater than the UHPLC’s routine operating pressure, these tests validated 
implementation of the FT valve into the UHPLC system.   
The time required to operate the FT valve was monitored through this process.  Initially, 
taking the FT valve from room temperature to -50°C required the cryogenic valve to remain 
open for ~ 5 sec.  After this “initial freeze” was performed, intermittent exposures to liquid CO2 
required 1-2 sec.  The time lasting between freezes was approximately 2.5-3 min when the 
temperature controller set point was -50°C.  The 5 seconds required to initially freeze/close the 
valve greatly reduced the time from the previous Peltier system (2.5 min),17 and previous 
applications of FT valve technology within the lab (9-17 sec).1  
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Up to this point, thawing of the valve consisted of turning off the temperature controller 
and allowing room temperature to thaw the system.  This typically required between 5-7 min.  
However, as shown in Figure 3.9, a power supply and thermoelectric heater were installed to 
accelerate the thawing process.  The output temperature of the copper cup when placed on the 
thermoelectric heater was recorded with applied power (Figure 3.16).  When 0.4 W of power was 
applied for 10 sec, the valve completely thawed in 1 min.  Although the application of the 
thermoelectric heater did greatly decrease the time required to thaw the system, it was rarely 
utilized.  Most of the run times for meter long columns on the UHPLC system are 120-140 min.  
Thus, waiting 5-7 min for room temperature to thaw the FT valve is more than reasonable.  
However, if shorter run times are sought, the thermoelectric heater can be easily activated to 
reduce thawing time. 
With the FT valve successfully tested, it was initially placed behind the high pressure 
isolation mechanical pin valve (Figure 3.6).  The FT valve was to serve as a support valve to the 
high pressure isolation valve, since it was this mechanical pin valve that leaked and was 
damaged most often.  Also, the high pressure isolation valve could immediately stop flow so the 
FT valve could freeze the immobile liquid (Figure 3.17a).  It was soon discovered that if the flow 
rate from the nanoAcquity was stopped, the FT valve did not require the presence of the high 
pressure isolation valve to halt flow and could efficiently freeze the liquid inside the capillary 
itself.  Thus, although originally intended to support the high pressure isolation valve, the FT 
valve eventually replaced it altogether, and later replaced the high pressure vent valve as well 
(Figure 3.17, b and c).  These configurations were compared to the original mechanical pin valve 
system (Figure 3.1) and the resulting chromatograms are shown in Figure 3.18.  A sample of 
digested bovine serum albumin (BSA) with a gradient of 4-40% in 100 min on a 109 cm 1.7 μm 
BEH column (~4% change per column volume) was processed on all valve configurations.  The 
flow rate in all configurations was ~300 nL/min and no leaks were suspected for the mechanical 
pin valve system. 
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As shown in Figure 3.18, the region of the gradient wash (~110-150 min) contains large 
broad peaks when the mechanical pin valve system was used.  These peaks were no longer 
present when the FT valve was installed (Figure 3.18, a-c).  When the FT valve was the only valve 
source (Figure 3.18a) peaks were clearly detectable in this section of the chromatogram.  More 
peaks were also present in the beginning of the chromatograms when applying the FT valve (18-
30 min).  The peak capacity of the BSA sample for the mechanical pin valve system was 201 and 
for all cases where the FT valve was used the peak capacity increased > 240.  Therefore, 
preliminary studies indicated that the FT valve could hold pressures up to 60 kpsi and provide 
improved chromatographic results compared to the prior mechanical pin valve configuration. 
3.3.2 Gradient Storage 
It had been established that by placing 10 m of 50 μm I.D. capillary before the high 
volume stainless steel storage loop, the eluting gradient profile remained more defined.17  Using 
the narrow 50 μm capillary tubing to contain the majority of the gradient produced a more 
pristine gradient profile during loading and storage.  However, with the mechanical pin valves in 
place, pressure restrictions allowed only 10 m of capillary tubing to reduce clogging and over 
pressurizing the system.  With the FT valve, this was not an issue.  Therefore the 10 m of 50 μm 
I.D. capillary followed by the high volume stainless steel gradient storage loop was replaced with 
50 m of 50 μm I.D. fused silica capillary.  This allowed for the removal of a capillary connection 
(union between the capillary and the stainless steel) and delivered a more defined gradient 
profile due to the diameter of the capillary tubing. 
As shown in Figure 3.12, the three configurations for the gradient storage loop tested 
were (a) loop consisting of 40 m of 127 μm I.D. stainless steel tubing, (b) 10 m of 50 μm I.D. 
capillary following by 40 m of 127 μm I.D. stainless steel tubing, and (c) 50 m of 50 μm I.D. 
capillary.  With 10% acetone was added to mobile phase B (acetonitrile with 0.1% formic acid) 
UV detection was used to monitor the gradient profile during high pressure application.  Instead 
of an analytical column, a restrictor capillary of 5 μm I.D. x 50 cm was used to achieve a flow 
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rate similar to that when an analytical column is used (~300 nL/min at 30,000 psi) without 
perturbing the eluting gradient profile.  Various gradient volumes (5, 10, 20, 30, and 40 μL) 
were loaded and run through the restrictor capillary for UV detection.  The longer gradient 
volumes are more appropriate for use with the typical 1 m analytical BEH columns; however, a 
range was tested to accommodate columns of all possible lengths and sizes. 
The gradient profiles monitored by UV are shown in Figure 3.19.  Ideally the profiles 
should mirror the programed method, where there is a short hold at initial conditions (0.5% B) 
followed by a linear increase in organic to the desired percentage (40% B).  Then there is a sharp 
increase at the beginning of the wash (to 85% B) with a short hold (10 min) followed by a 
decrease back to initial conditions (0.5%).  All gradient volumes placed in the stainless steel loop 
(Figure 3.19a) produced a curved profile.  This was especially pronounced with drastic changes 
in composition such as the increase to the wash.  Therefore this loop is not desirable for 
gradients that contain extreme changes in mobile phase composition due to mixing in the larger 
diameter tubing.  As previously determined,17 placing 10 m of 50 μm I.D. capillary before the 
stainless steel loop did improve the gradient profile (Figure 3.19b).  However, when the gradient 
volumes increase beyond the capacity of the capillary tubing (>20 μL) the profile reverts back to 
curve profiles due to extending into the larger 127 μm I.D. stainless steel tubing.  Standard 
columns used for peptide studies on the UHPLC system (75 μm I.D. x 1 m x 360 μm O.D. with 
1.7 μm BEH particles) typically require 35-40 μL (or greater) volume gradients to achieve a 2-
4% change in organic per column volume. 
Therefore, by replacing the entire gradient storage loop with 50 m of 50 μm I.D. 
capillary, the gradient profile can be retained even for large volume gradients (Figure 3.19c).  It 
can also be observed in Figure 3.19 that playback time also varies between configurations.  The 
measured flow rate through the restrictor at 30,000 psi was 300 nL/min.  As shown in Table 
3.4, this flow rate would result in expected elution times for the gradient between 17 and 133 
min.  Comparing the profiles in Figure 3.19 the first three volumes (5, 10, and 20 μL) all line up 
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in the time domain.  It isn’t until the larger volumes (30 and 40 μL) when a decrease in expected 
elution time is observed for the stainless steel gradient storage loop (Figure 3.19a).  Placing the 
capillary before the stainless steel loop (Figure 3.19b) corrected this decrease in expected elution 
time; however the sharpness of the gradient profile began to suffer.  By switching to a loop 
entirely of capillary tubing (Figure 3.19c) the expected elution times were achieved and the 
gradient profile was preserved despite the gradient volume loaded.  This is more easily 
compared when one gradient volume is plotted for each configuration (Figure 3.20).  Based on 
these results the gradient storage loops for the UHPLC system remained 50 m of 50 μm I.D. 
capillary.  This provides users with ~100 μL of volume for gradient programming with a highly 
preserved gradient profile. 
3.3.3 Setup Comparison with Yeast Cell Lysate 
Assessment for the implementation of the FT valve and capillary gradient storage loop 
was performed using the standard protein bovine serum albumin (BSA) and insoluble portion of 
a yeast cell lysate consisting mostly (~60%) of membrane proteins.  The membrane protein 
sample was notorious for clogging mechanical pins valves and having high carryover in the 
previous system design.  It is well known that stainless steel can interact with sensitive biological 
compounds,6 therefore, reducing the number of stainless steel fittings/unions/valves could 
improve membrane protein recovery and biocompatibility of the system.  To compare the prior 
instrumental design (Setup 1) to the reformed (Setup 2) (Figure 3.13), samples were processed 
using both instrumental setups and their results compared.  All other parameters within the 
system (gradient program, column temperature, mass spectrometer settings, processing 
parameters, etc.) were kept constant.  Setup 1 consisted of the prior instrumental design 
containing three mechanical pin valves and a gradient loop consisting of 10 m of 50 μm i.d 
capillary followed by 40 m of 127 μm I.D. stainless steel tubing.  Setup 2 consisted of the FT 
valve in place of two mechanical pin valves and a gradient storage loop of 50 m of 50 μm I.D. 
capillary.  When standard protein BSA was processed using Setup 1 and 2, the FT valve design 
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had a higher PLGS score (confidence), peptide identifications, and number of digest peptides 
(Table 3.5). 
For the yeast sample, an example chromatogram from each setup is shown in Figure 
3.21.  Distinguishable peaks span the entire chromatogram for Setup 2.  In Setup 1, peaks are 
not present in the beginning of the chromatogram and cannot be distinguished from the large 
peaks present in the wash towards the end of the chromatogram.  The wash for all runs on Setup 
1 contained large, broad peaks which masked the presence of desired analytes.  This was 
possibly due to the massive carryover inherent to the system utilizing mechanical pin valves.  
Improved peak shape is further highlighted in Figure 3.22, with areas of enhanced resolution 
emphasized.  It is obvious from the chromatogram that the peak shape is greatly improved, 
specifically in areas where overlapping peaks in the pin valve system are completely baseline 
resolved in the FT system (72 to 77 min).  At unit resolution the peaks present in the FT valve 
chromatogram had a peak capacity of 448 while the pin valve chromatogram was 412.   
The increase in peak capacity can have a dramatic effect on protein and peptide 
identifications.  The software (PLGS) used to make protein identifications uses parameters such 
as chromatographic peak shape to detect the probability of each ion.  Therefore, better resolved 
peaks should result in more protein identifications.  This is exactly what was determined via 
data processing.  Data for all 10 fractions analyzed using Setup 1 and Setup 2 is compared in 
Figure 3.23.  Setup 2, utilizing the FT valve along with the capillary storage loop, identified 271 
proteins (5510 peptides) while the original configuration (Setup 1) identified 90 proteins (936 
peptides).  For membrane proteins specifically, Setup 2 identified 91 proteins (1388 peptides) 
and Setup 1 identified 27 proteins (246 peptides).  For the 62 commonly identified proteins the 
ratio of the percent coverage was plotted versus the protein’s molecular weight (Figure 3.24). 
Out of the 62 proteins, 45 have a higher percent coverage in Setup 2 while only 17 had higher 
coverage for Setup 1.   
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3.3.4 Post Column Connection and Bleed Valve 
Preserving the chromatography achieved by the separation for mass spectral detection is 
crucial.  The connection of the column to the pigtail capillary was traditionally done with a small 
piece of fluoropolymer tubing manually drilled out to 360 μm I.D.  Over time and with exposure 
to organic solvents and high temperature this tubing can become malleable and eventually cause 
leaks and/or gaps.  Even a small gap in this material between the column and the pigtail would 
ruin peak resolution.  Since the tubing consisted of a somewhat flexible fluoropolymer, the 
capillaries themselves were difficult to seat inside the tubing.  When placed inside the tubing the 
capillaries would often break from rough handling or core the inside of the tube itself.  Coring 
the tubing can also produce leaks and damage the column’s outlet frit.  A commercial 
replacement for this connection from New Objective is the PicoClearTM union.  Although not 
specifically for high pressure or temperature (65°C) applications, the elastomer core with 
compression end fittings was ideal for a low pressure post-column connection to the pigtail 
capillary.  This provided a true zero dead volume connection preserving the chromatography 
after separation.  Using standard protein BSA, all reported values from the PLGS software were 
higher when BSA was analyzed with the PicoClearTM union in place of the fluoropolymer tubing 
(Table 3.6). 
One of the major issues with the UHPLC system is column longevity.  Because the ferrule 
compresses on the top of the column’s inlet, the frit present at the inlet rarely survives being 
taken on/off the system.  Therefore, when a column is used, it is typically used repeatedly many 
times, as it is not easy to rotate columns in and out of the system.  The application of high 
pressure itself can also damage column inlet frits.  Occasionally, the rapid depressurization of a 
column when the valve releases system pressure can cause the inlet frit to extrude from the 
column itself.  This releases particles from the head of the column into the system which can 
clog unions/connections.  The depressurization can also cause gaps to form along the length of 
the column bed, rendering the column inoperable. 
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To extend the life of the columns, application of a bleed valve was investigated.  This 
valve would release the pressure on the system slowly, decreasing the pressure seen by the 
column itself.  It was designed and implemented according to Figure 3.15.  The bleed valve 
consisted of a mechanical pin valve with 1 m of 20 μm I.D. open tube capillary.  Smaller 
diameters of capillary (5 and 10 μm) were tested yet routinely clogged due to difficulties making 
high pressure connections with small diameter tubing.  The 20 μm I.D. capillary served as a less 
resistive path for the pressure prior to valve release.  After the chromatographic run was 
complete, this valve was opened and the pressure was released slowly.  After the bleed valve was 
opened, the FT valve was turned off (thawed) and the flow rate monitored over time.  Flow rates 
were monitored out of the analytical column and the bleed valve to determine the pressure drop 
of the UHPLC system over time (Figure 3.25).  Almost instantly the pressure begins to decrease, 
falling to ~ 7,000 psi after ~ 5 min.  Three columns (75 μm I.D., ~1 m length, 360 μm O.D., 1.7 
μm BEH C18) were tested with the bleed valve in place.  Each column was pressurized for 30 min 
then pressure was released with the aid of the bleed valve.  This process was repeated 3 times for 
each column.  None of these columns experienced damage (gapping or loss of packed bed) due 
to depressurization.  However, with repeated use the bleed valve did require maintenance due to 
observed leaking.  This is an inherent problem with the mechanical pin valves with repeated use 
at high pressure.  Therefore, even though the columns remained intact with multiple 
pressurizations, addition of the unions/fittings/valve required by the application of a bleed valve 
was not advantageous due to development of leaks with repeated use.  A more reliable high 
pressure valving system is required to implement the application of a bleed valve into the 
UHPLC system.  It is possible a FT valve could be utilized for this purpose, however, a more 
practical approach would be to better outfit the column inlets themselves for repeatedly being 
taken on/off the system. 
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3.4 Conclusions 
 Performing optimum separations and retaining resolution is crucial for liquid 
chromatographic instrumentation.  Reported here are the advancements implemented to the 
UHPLC gradient system assembled in the Jorgenson lab.  Over the years this system has 
performed high resolution ultra-high pressure (40 kpsi) separations on meter long capillary 
columns.  Although operational, the system’s mechanical valves experienced difficulties, 
especially with complex and difficult samples such as membrane proteins.  The mechanical pin 
valves encountered clogging and leaks when operated for long periods at high pressures.  
Replacing the pin valves with a freeze/thaw valve allows for pressures up to 60 kpsi to be 
realized.  This is 20 kpsi higher than the mechanical pin valves are rated.  Therefore this newly 
devised system has potential to reach even higher pressures than before.  Introducing a FT valve 
to the UHPLC reduced the number of capillary connections, dead volume within the system, and 
subsequent leaks compared to the prior UHPLC design.  In addition, the previous gradient 
storage loop, which was a combination of capillary and stainless steel tubing, was replaced with 
50 m of 50 μm I.D. capillary.  This eliminated a union and provided storage of pristine, large 
volume gradient profiles.  When the newly designed system was compared to the previous 
configuration, more proteins were identified and the peak capacity was increased.  Overall, a 
more robust UHPLC system was developed with the ability to obtain higher pressure 
separations and increased peak capacities compared to previous designs. 
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3.5 TABLES 
 
Table 3.1 nanoAcquity software program for gradients.  The highlighted rows are 
controlling the gradient volume.  A curve of 11 is immediate; a curve of 6 is a linear 
change.  This is specifically for the 5 μL gradient volume, however changing the time 
between 2.8 and 3.8 min was used to increase the gradient volume to 10, 20, 30, and 40 
μL when desired. 
Gradient Loading Method 
Time (min) 
Flow Rate 
(μLmin) 
% A % B Curve Volume (μL) 
Initial 2.5 99.5 0.5 Initial 1.25 
0.5 2.5 99.5 0.5 11 1.25 
1 2.5 99.5 0.5 11 2.5 
2 5 15 85 11 4 
2.8 5 60 40 11 5 
3.8 5 99.5 0.5 6 0.5 
3.9 5 99.5 0.5 11 5.5 
5 4 99.5 0.5 11 2 
5.5 3 99.5 0.5 11 1.5 
6 2 99.5 0.5 11 1 
6.5 1 99.5 0.5 11 0.5 
7 0.001 99.5 0.5 11 2 
Sample Loading Method 
Time (min) 
Flow Rate 
(μL/min) 
% A % B Curve Volume (μL) 
Initial 0.001 99.5 0.5 Initial 0.0001 
0.1 5 99.5 0.5 11 0.5 
0.2 5 99.5 0.5 11 0.5 
0.3 5 99.5 0.5 11 0.5 
0.4 5 99.5 0.5 11 0.5 
2.2 5 99.5 0.5 11 9 
2.3 0.001 99.5 0.5 11 0.0001 
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Table 3.2  Default in-solution digestion protocol adapted from: 
(http://www.genome.duke.edu/cores/proteomics/sample-preparation)22 
 
Procedure: 
 
a) Perform Bradford assay to determine protein concentration of each solution.   
 
b) In order to maximize solubility of proteins, add calculated volume of Waters 
RapiGest to have 0.15 % RapiGest in final concentration pre-digestion.  Make up 
RapiGest with 50 mM AmBic.   
 
c) Heat at 40°C for 10 minutes.  Spin down condensate. 
 
d) Make up 100 mM DTT in 50 mM AmBic for reduction step.  Add DTT to each 
solution to make the final DTT concentration 10 mM. 
 
e) Heat solution at 80°C for 15 minutes. 
 
f) Remove from heat and cool for 5 minutes (to room temp).  Spin down 
condensate. 
 
g) Make up 200 mM iodoacetamide (IAM) in 50 mM AmBic for alkylation step.  
Add IAM to each solution to make the final IAM concentration 20 mM (2X molar 
excess of DTT). 
 
h) Incubate the solutions in the dark at room temperature for 30 minutes. 
 
i) Add trypsin to each solution at 1:30 trypsin:protein concentration.  Make trypsin 
stock in 50 mM AmBic. 
 
j) Digest overnight at 37°C. 
 
k) Following digestion, centrifuge condensate to bottom of vial.  Add TFA and 
MeCN to give 1.0 % TFA and 2 % MeCN by volume. 
 
l) Samples sit for 2 hours at 60°C.  Centrifuge at 15,000 rpm for 5 min, and pipette 
supernatant into an autosampler vial. 
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Table 3.3  Software Processing Parameters 
Processing Parameters in PLGS V2.5 
Chromatography peak width automatic  
MS TOF resolution automatic 10,000 
Lock Mass 1 785.84265 Da/e Glu-1-Fibrinopeptide 
Lock Mass 2 556.2771 Da/e Leucine Enkephalin 
Lock Mass Window 0.5 Da 
Low Energy Threshold 150 counts 
Elevated Energy Threshold 50 counts 
Intensity Threshold 750 counts 
Workflow Template in PLGS V2.5 
Databank S.cerevisiae from 2/3/11 
http://www.expasy.org/proteomics 
Peptide tolerance automatic* 
Fragment tolerance automatic* 
Minimum fragment ion matches per 
peptide 
3 
Minimum fragment ion matches per 
protein 
7 
Minimum peptide matches per protein 1 
Maximum hits 20 
Maximum Protein Mass 250,000 
Primary Digest Reagent trypsin 
Secondary Digest Reagent none 
Missed Cleavages 1 
Fixed Modifications Carbamidomethyl C 
Variable Modifications Oxidation M, Deamidation N, Deamidation Q 
False Positive Rate 4 
* When “automatic” is selected the proprietary PLGS algorithm interrogates each data set to 
determine an ideal value for the analysis. 
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Table 3.4  Expected elution time of 
programed gradients for restrictor flow rate of 
300 nL/min at 30,000 psi.  Restrictor was at 
room temperature (25°C). 
Programmed 
Volume (μL) 
Expected Elution 
Time (min) 
5 17 
10 33 
20 67 
30 100 
40 133 
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Table 3.5 Results comparing FT valve to Pin valves using standard protein BSA.  Setups 
refer to those outlined in Figure 3.13. 
Configuration PLGS Score Peptides ID 
Percent 
Coverage 
Digest 
Peptides 
Setup 1, Pin Valves 12,493 169 78 66 
Setup 2, FT Valve 15,879 217 81 76 
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Table 3.6 Comparison of post column-pigtail connections using standard protein BSA. 
Union Fitting 
PLGS 
Score 
Identified 
Peptides 
Percent 
Coverage 
Identified 
Product Ions 
Digest 
Peptides 
New Objective 
PicoClearTM union 
11,879 155 77 1819 62 
Polymer Tubing 
union 
3,261 50 59 551 37 
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3.6 FIGURES 
 
 
 
Figure 3.1  Original Ultra-High Pressure Liquid Chromatography (UHPLC) instrument design.  
The commercial nanoAcquity pump was used to push mobile phase and sample into the 
gradient storage system.  Three mechanical pin values were used to control the direction of flow 
within the system (high pressure vent valve, nanoAcquity vent valve, high pressure isolation 
valve).  All plumbing consisted of 50 μm I.D. silica capillary connected to unions via proprietary 
capillary connections. 
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Figure 3.2  Chromatographic results for Enolase standard protein digest with: (a) no leaks 
present, (b) leak is present resulting in lower flow rate (longer retention times) and lower 
intensity peaks (less protein identifications), and (c) over time the leak worsens resulting in even 
lower intensities and longer retention times. 
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Figure 3.3  Gradient loading profile example for the nanoAcquity pump.  The wash (i.e. high 
organic/B) is loaded first, followed by the gradient in reverse order (high percent B to low 
percent B), and finally the sample itself.  The sample is sandwiched between two plugs of 
aqueous solvent to deter mixing prior to separation.  Typical loading flow rates for the 
nanoAcquity are 3-5 μL/min. 
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Figure 3.4  Gradient and sample loading configuration for UHPLC analysis.  The commercial 
system loads the gradient (in reverse) followed by the sample into the gradient storage loop.  
Mechanical pin valves are used to direct flow of liquid through the 50 μm I.D. external capillary 
plumbing.  For the gradient and sample loading configuration shown here, the nanoAcquity vent 
valve is closed while the high pressure vent valve and high pressure isolation valve are open. 
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Figure 3.5  UHPLC high pressure run configuration.  In this configuration the nano Acquity 
vent valve is open to allow the commercial system an open flow path to avoid going over 
pressure.  The high pressure vent valve and the high pressure isolation valve are closed, allowing 
the pneumatic amplifier to engage, pushing the sample followed by the gradient onto the 
analytical column for mass spectral detection. 
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Figure 3.6  Original setup for implementation of the freeze/thaw valve.  In this configuration 
the mechanical pin valve would immediately halt flow to allow the FT valve to freeze a plug of 
liquid inside of the capillary. 
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Figure 3.7  Original configuration of the gradient storage loop consisting of 40 m of 127 μm 
I.D. stainless steel tubing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
107 
 
 
 
Figure 3.8  FT valve designed from Waters Patent No. US 7,841,190 B2.11  Top and bottom are 
the UltemTM plastic housing (the “hive”).  There is a hole in the top where the liquid CO2 enters. 
In the middle is the copper cup with a 10 μm sintered stainless steel filter cup placed inside 
(steel cup not shown in figure).  The bottom is held in place with two screws. 
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Figure 3.9  Schematic of the setup for the UHPLC FT Valve.  The nanoAcquityTM software 
activates external MOSFET switches which drive 24 V DC loads.  When a high pressure run is 
active the temperature controller is turned on.  The switch in the temperature controller turns 
off/on an external solenoid valve which allows liquid CO2 into the system.  This freeze the liquid 
inside of the capillaries running through the base of the copper cup.  When rapid cycling is 
required a second MOSFET switch allows the power from an external DC power supply to a 
thermoelectric heater to thaw the system. 
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Figure 3.10  FT valve setup as implemented on the UHPLC system. 
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Figure 3.11  Setup for testing the pressure limitations of the FT Valve.  For this purpose, the 
injector valve was used only to vent pressure between trials. 
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(a) 40 m of 127 μm stainless steel (S.S.) tubing 
 
(b) 10 m of 50 μm capillary followed by 40 m of 127 μm S.S. 
 
(c) 50 m of 50 μm I.D. capillary (360 μm O.D.) 
 
 
Figure 3.12  Gradient storage loop experimental setup (a) the loop consisted of 40 m of 127 μm 
stainless steel tubing (b) 10 m of 50 μm capillary follow by 40 m of 127 μm of stainless steel 
tubing and (c) 50 m of 50 μm capillary tubing.  
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SETUP 1 
 
SETUP 2 
 
Figure 3.13  Setup 1 (Pin valve configuration) and Setup 2 (FT valve implemented). 
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Figure 3.14  Workflow for sample processing.  A sample of 0.5 mg of protein underwent 
acetone precipitation and proteins were separated on a PLRP-S reverse phase column (300 Å, 5 
µm, 250 x 4.6 mm).  Elution of the proteins was monitored at 214 nm via UV and collected as 
equal time fractions.  These fractions were lyophilized and recombined into 10 equal mass 
fractions for protein digestion.  Once back in solution, these 10 fractions underwent in-solution 
protein digestion.  Final fractions were processed using Setup 1 and Setup 2 outlined in Figure 
3.13. 
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Figure 3.15  Implementation of the bleed valve to slowly release the pressure from the system.  
The outlet of the bleed valve consisted of 1 m of 20 μm I.D. capillary (not shown to scale in 
figure). 
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Figure 3.16  Temperature recorded for the copper cup placed on top of the thermoelectric 
heater with varying power applied. 
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Figure 3.17  Freeze thaw valve configurations. (a) FT valve serving as a support for the high 
pressure isolation valve, (b) FT valve replacing the high pressure isolation valve, and (c) FT 
valve replacing both the high pressure isolation valve and the high pressure vent valve. 
(a) 
(b) 
(c) 
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Figure 3.18  Comparison chromatograms for 4 configurations: (a) FT valve replaces two pin 
valves as in Figure 3.17c (b) FT valve replaces the high pressure isolation valve as in Figure 
3.17b, (c) FT valve is placed behind the high pressure isolation valve as in Figure 3.17a, (d) and 
only mechanical pin valves are utilized as in Figure 3.1.  Analyte is a BSA digest. 
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Figure 3.19  Organic gradient profiles: (a) 40 m of 127 μm stainless steel gradient storage loop, 
(b) 10 m of 50 μm capillary followed by 40 m of 127 μm stainless steel gradient storage loop, and 
(c) 50 m of 50 μm capillary.  The organic mobile phase (acetonitrile) was spiked with 10% 
acetone and monitored with UV at 265 nm.  An open tubular restrictor capillary (5 μm I.D. x 50 
cm) was used in place of the column. 
(a) 
(b) 
(c) 
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Figure 3.20  The gradient profiles compared for the 30 μL gradient volume.  The expected 
elution time for a 30 μL gradient volume was ~100 min. 
 
 
 
 
 
 
 
 
 
 
 
120 
 
 
 
Figure 3.21  Example chromatogram from two experimental designs.  Setup 1 consisted of the 
prior instrumental design containing three mechanical pin valves and a gradient loop consisting 
of 10 m of 50 μm capillary followed by 40 m of 127 μm stainless steel tubing.  Setup 2 consisted 
of the FT valve replacing two mechanical pin valves and a gradient storage loop of 50 m of 50 
μm capillary. 
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Figure 3.22  Comparison of peak shape comparing Setup 1 to Setup 2 with highlighted areas of 
increased resolution.  Setup 1 consisted of the prior instrumental design containing three 
mechanical pin valves and a gradient loop consisting of 10 m of 50 μm capillary followed by 40 
m of 127 μm stainless steel tubing.  Setup 2 consisted of the FT valve replacing two mechanical 
pin valves and a gradient storage loop of 50 m of 50 μm capillary. 
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Figure 3.23  Venn diagrams comparing results from Setup 1 (red) and Setup 2 (black).  
Proteins and peptides identified in both configurations are displayed in gray.  Proteins/peptides 
were identified as “membrane” if they were in any way associated with the cell membrane 
according to the UniProKB/Swiss-Prot protein sequence database. 
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Figure 3.24  The ratio of the percent coverage for the FT valve/Pin valve vs. protein molecular 
weight (Da).  Data above the line (45 data points) had higher percent coverage when analyzed on 
Setup 2 (FT valve system), and below the line (17 data points) in Setup 1 (Pin valve system). 
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Figure 3.25  Release of pressure over time for bleed valve.  Pressure values were obtained via 
flow rate measurements. 
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CHAPTER 4. Characterization of an Immobilized Enzyme Reactor (IMER) 
for On-line Protein Digestion 
 
4.1  Introduction 
Due to the importance of proteins in metabolic pathways, their identification, structure 
and function are a major focus of discovery.1,2  Proteomics encompasses a wide field, ranging 
from comprehensive studies which identify proteins within a complex mixture to more targeted 
approaches where specific proteins can be selected via liquid chromatographic (LC) and mass 
spectrometric (MS) techniques.2  Regardless of the type of study, “shotgun” approaches are the 
most common, where proteins are first digested into peptides prior to MS analysis.  This is 
accomplished through the addition of an enzyme to the sample.  Traditionally high quality 
trypsin is used for this purpose since it hydrolyzes peptide bonds fairly reproducibly on the 
carboxy side of a lysine or an arginine residue, producing peptides within a desirable mass range 
for protein sequencing.3  The digestion of the proteins into peptides is one of the most time 
consuming sample preparation steps, as it is typically performed as an overnight in-solution 
reaction.  That being said, it is also the most important step for proper proteomic analysis.3-5  
The proteomic community is continuously demanding improved methods to increase sample 
throughput for proteomic workflows while maintaining high accuracy digestions. 
The instrumentation and hardware involved in the LC separations and MS techniques 
continue to improve.  Fast LC separation procedures and high resolution MS detection methods 
are commercially readily available.  In addition, multi-dimensional LC can allow for an 
abundance of separation space for complex proteomic samples and electrospray ionization (ESI) 
has allowed for easy coupling of LC to MS for rapid protein/peptide identification.  Although 
these LC and MS techniques have been greatly improved over the past 30 years, becoming faster 
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and more efficient, the sample treatment for enzymatic digestion has remained relatively the 
same.6,7  A small amount of trypsin is added to the protein solution to reduce trypsin autolysis, 
however, this results in long incubation periods for complete protein digestion.  The 5-24 h in-
solution trypsin digestion is typically the slowest part in the sample workflow.  One method to 
increase the speed and efficiency of the digestion is to immobilize the trypsin onto a substrate.4,5  
Trypsin can be covalently bonded or physically adsorbed onto silica or organic materials such as 
polystyrene divinylbenzenes, polyacrylamides, and methacrylates.6  This can provide 
immobilized trypsin on membranes,8-11 modified silica capillaries,12-14 microchips,15,16 gel 
networks,17,18 etc.7  Utilizing immobilized trypsin for a protein digestion provides advantages 
such as a high enzyme-to-substrate ratio, shorter digestion times, less trypsin auto-lysis, and 
low reagent consumption while maintaining highly efficient digestions.4-7,12,19  While the high 
abundance of trypsin allows for less competition for catalytic sites, the decrease in trypsin 
autolysis provides less complex mass spectra for analysis.  Bound to a substrate, trypsin can also 
be easily added and removed from the sample prior to LC-MS analysis20 and reused.21  Overall, 
immobilization has been found to provide quick proteolysis of protein samples which are easily 
transferred to LC-MS/MS platforms.5,7 
4.1.1 Immobilized Trypsin Digestion Strategies 
Many configurations for immobilized trypsin for a variety of applications have been 
discussed in the literature.5  Off-line configurations include trypsin membrane cartridges, 
magnetic or glass beads, agarose gel beads, spin-columns, etc. while on-line approaches tend to 
immobilize trypsin in either porous monolithic materials20,22,23 or particle supports packed into 
LC columns or CE setups.5,24-26  One promising approach to increasing the proteomic workflow 
is to create a flow-through enzyme reactor, where the proteins pass through the reactor and are 
digested into peptides immediately on-column.  This idea removes many laborious manual steps 
involved with the off-line digestion process, potentially eliminating sources of error.  Although 
the idea of immobilized enzyme reactors (IMERs) is not new,27 recent developments in their 
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ease of manufacture and potential for increasing the speed of the workflow has gained in 
popularity.  The majority of works published for IMER digestion either place the IMER before a 
separation method (LC or CE) followed by mass spectral analysis in a true on-line fashion,21,28,29 
or use the IMER to digest peptides followed by fraction collection prior to peptide analysis.30-32  
Although many studies focus on model proteins, IMER systems need to be tested with large 
sample amounts and more realistic samples to determine whether they are a promising tool for 
proteomic studies.3,21 
4.1.2 Immobilization of Trypsin 
Before implementing an IMER into our digestion scheme, a successful trypsin 
immobilization protocol needed to be determined.  In the literature, an immobilization protocol 
from Ahn, et al.33 was used as an appropriate starting point.  In Ahn, et al., silica particles 
consisting of bridged ethyl hybrid (BEH) 5 μm 300 Å material was used as a substrate for pepsin 
immobilization.  These pepsin immobilized particles were then packed into 2.1 x 30 mm column 
housing for on-line digestion, specifically for hydrogen-deuterium exchange chromatography.  
For the immobilization reaction, a primary amine in the pepsin enzyme reacts with the aldehyde 
group of the triethoxysilyl butyraldehyde crosslinker.  The reaction occurs at pH 5, forming a 
temporary Schiff base which is quickly reduced with sodium cyanoborohydride.  The other end 
of the crosslinker, containing the siloxane groups, undergoes hydrolysis and condensation 
reactions with the silanols on the particle surface.  Therefore, triethoxysilyl butyraldehyde 
provides a bridge for immobilizing an enzyme onto the BEH particle surface. 
The BEH silica particle is extremely robust, possessing high mechanical strength 
properties,33 making it an ideal candidate for implementation into our workflow.  Since trypsin 
also contains primary amines, it can undergo the same immobilization reaction outlined in Ahn 
et al.33 (Figure 4.1) to produce immobilized trypsin BEH particles.  Therefore, the published 
protocol from Ahn, et al.33 was used to develop a batch of immobilized trypsin for analysis.  This 
protocol, however, had room for improvement and a revised protocol was developed.  For the 
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revised (UNC) protocol, the order of the immobilization reaction was reversed so that the 
particles were first bonded to the crosslinker (Figure 4.2, Step 1) and lastly the enzyme was 
added (Figure 4.2, Step 2).  By adding the enzyme to the crosslinker first, such as in Ahn et al.’s 
published protocol (Figure 4.1), multiple crosslinkers can attach to the enzyme.  This could 
possibly inhibit the active site of the enzyme itself when bound.  Therefore, in the revised 
protocol (Figure 4.2) the enzyme was added second, after the crosslinker was attached to the 
particle surface.  In addition, the pH of the reaction was increased.  Since Schiff base formation 
can occur at high pH with good efficiency, the pH of the reaction was raised from 5 to 9 to 
promote the bond between the crosslinker and the enzyme (Figure 4.2, Step 2).  Although a pH 
of 9 lowers the efficiency of trypsin digestion (compared to pH 7.8), this is actually beneficial so 
trypsin does not undergo considerable autolysis during the immobilization process.   
4.1.3 Characterization of Immobilized Trypsin Particles 
To compare between protocols for the immobilization of trypsin onto BEH particles, it 
was necessary to compare trypsin activity.  Nα-Benzoyl-L-arginine ethyl ester (BAEE) is a 
common substrate used to measure trypsin activity and compare between trypsin types (i.e. 
trypsin purities).  In the presence of trypsin, BAEE is hydrolyzed producing Nα-benzoyl-L-
arginine (BA) and ethanol at a specific rate (Figure 4.3).  As this reaction occurs, for every one 
BAEE unit of trypsin there is a measurable increase in absorbance at 253 nm of 0.001 per 
minute.  The absorbance is recorded at 1 min intervals and plotted versus time (Figure 4.4).  The 
slope of the line represents a change in absorbance per minute.  The slope of the blank (typically 
zero) and trypsin sample can then be substituted into the equation (4-1) below to obtain an 
activity in BAEE units/mL.34  In the case of the immobilized enzyme particles this can be 
considered BAEE units/mL slurry.   
    
BAEE units
m  slurry
   
(
 A253
minanalyte
 - 
 A253
minblank
)
0.001 * 0.0 5
    (4-1) 
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Because the concentration of the slurry is known, the equation below (4-2) can then be 
used to calculate BAEE units/mg of particles.  This can provide a simple and reproducible 
method for determining and comparing the activity of immobilized trypsin particles in solution. 
   
BAEE units
mg particles
    
(
BAEE units
m  slurry
)
(
mg particles
m  slurry
)
 (4-2) 
BAEE is also a convenient substrate for on-line flow through experiments involving the 
packed IMER column itself.  As BAEE flows through the column and reacts with the IMER, the 
elutant can be concentrated on a reversed phase column and the presence of BAEE and/or BA 
monitored by UV absorbance.  By injecting a specific amount of BAEE onto an IMER column, 
various flow rates and mobile phase compositions can be tested in this manner to determine 
their effect on the tryptic activity of the IMER. 
Thus, determining the activity using BAEE provides valuable data on the activity of the 
immobilized trypsin and a measurement for comparison between batches of immobilized 
particles.  However, not all of the trypsin immobilized could express activity.  If the crosslinker 
binds to trypsin in or around its active site, the activity of the trypsin could be reduced.  This 
could result in trypsin being present (successful immobilization of the enzyme) but not active.  
Therefore, knowing the total amount of trypsin (active and inactive) would be beneficial to 
guiding the immobilization procedure.  A simple method for determining the amount of protein 
present is the bicinchoninic acid assay (BCA assay).  For this analysis, reagents are combined to 
produce an alkaline copper solution.  In the presence of protein, CuII is reduced to CuI by the 
nitrogen present in the protein's peptide bond.  When CuI becomes available it complexes with 
bicinchoninic acid (BCA) present in the reagent solution turning the solution from green to 
purple.  This change in color is easily measured via absorption monitored at 562 nm.  The 
amount of enzyme on the particles is calculated from a calibration plot of sample absorbance 
utilizing a standard free enzyme of choice.35   
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By identifying the total amount of trypsin on the particles using the BCA assay, and 
knowing the reported activity of the trypsin from the manufacturer, the expected activity of the 
immobilized trypsin can be determined.  For example, if the manufacturer reported the trypsin 
used for immobilization had an activity of 10,000 BAEE units/mg trypsin, and the BCA assay 
determined there was 60 mg of trypsin per gram of BEH particle, then 0.2 g of particles would 
be expected to have 120,000 BAEE units.  However, we understand that all trypsin bound may 
not be active due to the immobilization procedure.  For this example, if the experimental BAEE 
assay for 0.2 g of particles produced an activity of 60,000 BAEE units then 50% of the activity 
was retained post immobilization (4-3). 
                      
                                            
                                           
       (4-3) 
Assuming trypsin can either immobilize (1) with the active site accessible or (2) with the 
active site inaccessible with a 50:50 probability, 50% retained activity is likely the maximum 
value expected for immobilization when digesting large protein molecules. 
4.1.4  Implementation of an IMER into a Proteomic Workflow 
When working with a complex proteomic sample, there are many strategies for 
increasing the number of protein identifications.  While shotgun analyses are most common,36 
incorporating a multidimensional LC approach with a prefractionation step allows an increase 
in peak capacity37 and protein identifications.38-41  For the multidimensional prefractionation 
scheme implemented in our lab, proteins are first separated on a first dimension reverse phase 
column, fractions are collected and digested, then the resulting peptides are separated on a 
second dimension reverse phase column (Figure 4.5).  This setup currently employs the 15 h in-
solution protein digestion used by most laboratories; however, it is a prime candidate for the 
implementation of an IMER.  Therefore, one application of this work was to develop and 
characterize a highly active trypsin IMER that can be placed after the first dimension separation 
column (Figure 4.6).  This would result in the eluting proteins from the first dimension 
immediately digested into peptides and would not require the 15 h digestion step in the 
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workflow.  Both model proteins and complex yeast (Saccharomyces cerevisiae) cell lysate were 
digested using the IMER setup and compared to our previous method utilizing an in-solution 
digestion.  For analysis, both sequence coverage (SQ %) and number of protein identifications 
will be compared to determine whether the IMER can provide an on-line digestion equivalent or 
superior to the traditional overnight protocol. 
4.2  Materials and Methods  
4.2.1  Immobilization Protocols 
 The published protocol from Ahn, et al.33 was followed (Figure 4.1) to produce a batch of 
trypsin immobilized particles.  The published protocol involved 40 mg of trypsin (TPCK treated, 
Sigma Aldrich P/N T1426) in 2 mL of 50 mM trisodium citrate at pH 5.0.  This was added to a 5 
mL round bottom flask with 1 mL of ALD coupling solution (Sterogene Bioseparations, 
Carlsbad, CA) which contained 1 M sodium cyanoborohydride.  The crosslinker (110 μ  of 
triethoxysilyl butyraldehyde Tech-90, Gelest Inc.) was added and the mixture was rotated for 2 
hr at room temperature.  After 2 hr, 0.3 g of non-bonded bridge ethyl hybrid (BEH) silica 
particles from Waters Corporation was added and the mixture was rotated for 30 min.  
Approximately 1 mL of 2 M sodium sulfate in 50 mM trisodium citrate (pH 5) was used to salt 
out the reaction as it was left to rotate overnight at room temperature.  The next day the reaction 
was quenched with 1 mL of 1 M ethanolamine and rotated for 2 hr.  Finally the particle slurry 
was washed with 2 aliquots of 5 mL 50 mM trisodium citrate followed by 2 aliquots of 5 mL 1 M 
sodium chloride.  A final wash with water (at pH 4 with trifluoroacetic acid) was performed and 
the slurry was stored at 5°C. 
For the UNC revised trypsin immobilization protocol (Figure 4.2), approximately 0.3 g of 
non-bonded bridged ethyl hybrid (BEH) silica particles (5 µm, 300 Å) from Waters Corporation 
(Milford, MA) were added to a 5 mL round bottom flask and kept under a constant flow of 
nitrogen.  Then 110 μ  of triethoxysilyl butyraldehyde (Tech-90, Gelest Inc., Morrisville, PA) in 
2 mL of ethanol (Fisher Scientific, Pittsburgh, PA) was added.  This was allowed to rotate for 2 
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hr at room temperature.  The particles were rinsed with pH 9, 50 mM ammonium bicarbonate 
(Sigma Aldrich, St. Louis, MO) to remove excess linker and 40 mg of trypsin (Sigma Aldrich, 
TPCK treated, P/N T1426) in 2 mL 50 mM ammonium bicarbonate was added.  The ALD 
coupling solution (1 mL of 1 M NaCNBH3, Sterogene Bioseparations, Carlsbad, CA) was added 
and the solution was allowed to rotate for 2 hr at room temperature.  Afterwards, 1 mL of 1 M 
ethanolamine was added to quench the reaction and stirred for 30 min at room temperature.  
The particles were washed with 50 mM ammonium bicarbonate to remove excess trypsin and 
ethanolamine then stored in water brought to pH 4 with trifluoroacetic acid (TFA, Sigma 
Aldrich) at 5°C.  
4.2.2 Determining Trypsin Activity of Particles in a Slurry 
To determine activity of the immobilized trypsin, standard trypsin substrate BAEE (Nα-
benzoyl-L-arginine ethyl ester hydrochloride, Sigma Aldrich, P/N B4500) was used.  A 1 min in-
solution digestion was performed with 1.5 m  of 0.25 mM BAEE and 100 μ  of particle slurry 
(slurry concentration was 30 mg particles per milliliter of water).  This was compared to a 1 min 
digestion of trypsin in solution (50 μg) with 1.5 m  of 0.25 mM BAEE.  When the digestion 
times were complete the samples were centrifuged at 15,000 rpm (1 min) and the supernatant 
was injected onto a PLRP-S reverse phase column (300 Å, 5 µm, 250 x 4.6 mm, Agilent 
Technologies, Santa Clara, CA) for UV analysis of BAEE (Figure 4.7).  Although the free 
(unbound) trypsin sample did not contain particles it followed the same centrifugation protocol 
for consistency.  Trypsin hydrolyzes BAEE producing Nα-benzoyl-L-arginine (BA) and ethanol. 
BAEE and BA were chromatographically separated on the PLRP-S reversed phase column at 
80°C and observed at 253 nm (Figure 4.8).  The mobile phase for the reverse phase separation 
of BAEE/BA consisted of water and acetonitrile with 0.1% trifluoroacetic acid (TFA, Fisher) and 
the gradient is outlined in Table 4.1.  
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4.2.3 Determining the Amount of Trypsin Immobilized 
In order to determine the amount of enzyme immobilized on the silica substrate, a 
bicinchoninic acid (BCA assay) was performed according to the Pierce Micro BCA Protein Assay 
Reagent Kit (#23235).35  For the procedure, 1 mL of each standard (solutions of known free un-
bound trypsin concentrations 0 to 50 μg/m ) and unknowns (slurries of known particle 
concentration, stored as 0.6 g particles/10 mL solution) were combined with 1 mL of working 
reagent from the assay kit.  The samples were placed on a shaker for 2 hr at room temperature, 
centrifuged, and the absorbance measured at 562 nm.  By plotting the calibration curve for the 
absorbance with known trypsin concentration, the concentration of trypsin on the particles can 
be determined.35  An example calibration curve is shown in Figure 4.9. 
4.2.4 Packing the Trypsin IMER 
Once the particles produced by the UNC immobilization procedure were determined to 
be the most active, the protocol was scaled up by a factor of 2 (0.6 g of particles) to pack into a 
chromatographic column.  An Isco D-Series syringe pump module (Model 260D, Teledyne 
ISCO, Lincoln, NE) was used to pack the particles into an empty HPLC column assembly (2.1 
mm x 30 mm x ¼” O.D., Restek, Bellefonte, PA).  The syringe pump was connected to a 
pressure vessel which held the particles in a slurry (60 mg/mL in 50 mM ammonium 
bicarbonate, pH 8).  The column was placed on top of the vessel with the outlet frit in place.  The 
entire apparatus was rinsed with 50 mM ammonium bicarbonate prior to column packing. The 
column was packed at 3,000 psi for 30 min and the pressure was increased to 5,000 psi for 30 
min to ensure proper packing for a range of HPLC pressures.  When not in use the column was 
rinsed with water (pH adjusted to 4 with trifluoroacetic or formic acid) and stored at 5°C.  At 
this pH and temperature, the trypsin activity can be conserved. 
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4.2.5 Determining the Activity of the IMER 
The IMER was tested at a variety of flow rates.  These flow rates were converted to a 
“volumetric residence time.”  The volumetric residence (4-4) time is defined as the column 
volume divided by the flow rate.   
  olumetric  esidence Time in min   
Column  olume in m  (    r2  )
Flow  ate through IME  in m /min
  (4-4) 
 
Therefore it is the amount of time eluent is exposed to the IME ’s packed bed based on 
the calculated column volume and designated flow rate.  The column volume is defined as the 
product of the length of the column (L), pi, the radius (r) squared, and mobile phase fraction ( ).  
Packed with BEH particles, the IME ’s mobile phase fraction was assumed to be 0.78.  To 
determine the activity of the IMER, BAEE was again used as a model substrate.  The IMER was 
placed before the analytical column (PLRP-S) and 20 μ  injections of 2.5 mM of BAEE were 
made (Figure 4.10).  The flow rate through the IMER determined the volumetric residence time 
for digestion. The effluent from the IMER was preconcentrated directly onto the PLRP-S 
column.  The mobile phase for the IMER was 50 mM ammonium bicarbonate, pH 8.  The 
gradient for the PLRP-S column consisted of water and acetonitrile, both with 0.1% TFA (Table 
4.1).  Flow rates through the IMER from 10 μ /min up to 1 m /min were tested, corresponding 
to 8 min and 5 sec volumetric residence times for digestion respectively. 
Although the IMER appeared to produce adequate digestions, the goal of the IMER is to 
ultimately sit behind the analytical column (Figure 4.6), digesting the eluting proteins over a 
gradient run.  Therefore, the IMER would be exposed to varying degrees of organic content 
combined with the 50 mM ammonium bicarbonate throughout the first dimension run.  To 
determine the effect of organic mobile phase on the IME ’s digestion, a combination of mobile 
phases ranging between 5-85% organic were combined (Table 4.2) in a 2:1 ratio with the 50 mM 
ammonium bicarbonate, pH 8.  Mobile phase A consisted of 80% water, 10% isopropanol, 10% 
acetonitrile, and 0.1% TFA while mobile phase B was 50:50 acetonitrile:isopropanol with 0.1% 
TFA.  This was tested since it is the standard mobile phase used for elution of proteins from a 
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yeast cell lysate within our lab.  This experiment had to be performed in an off-line fashion since 
the resulting elutant required dilution (1:10) with water prior to injection onto the PLRP-S 
column for proper preconcentration of BA/BAEE (Figure 4.11).  Standard solutions of BAEE and 
BA (without IMER exposure) were used to verify peak placement of the analytes in the presence 
of high organic upon injection. 
4.2.6 Prefractionation Workflow 
The prefractionation workflow established for protein and peptide separation utilized by 
our lab is an off-line two dimensional system (Figure 4.5).  For the first dimension, proteins are 
placed in 80% formic acid (MS grade, Fluka Analytical, Sigma Aldrich) and injected onto a 
PLRP-S (300 Å, 5 µm, 250 x 4.6 mm) polymeric reverse phase column at 80°C.  The formic acid 
is added to aid in solubilization and avoid clogging the LC column. The sample is not allowed to 
sit idle for more than 2 min in formic acid to avoid protein formylation (+28 Da)42 prior to 
separation.  The IMER was implemented after the PLRP-S column as depicted in Figure 4.6.  To 
accommodate the IMER, a buffer pump (Waters 600E pump consisting of 100mM ammonium 
bicarbonate pH 8) was added to preserve the IMER at ~pH 8 during the entire gradient run.  As 
depicted in Figure 4.6 the buffer flow was added after the PLRP-S column and prior to the 
trypsin column.  Therefore a combination of flow rates from the gradient pump (HP 1050) and 
the buffer pump control the volumetric residence time through the IMER.  The IMER itself was 
connected in a way that it could be easily taken off-line with the presence of a valve.  This made 
the comparison with and without the IMER easier and allowed to avoid exposure of the IMER to 
the formic acid used to solubilize the yeast sample onto the PLRP-S column.  After the IMER, 
the eluting peptides were collected into fractions.  When the IMER was taken off-line with the 
control valve then the eluting proteins were collected into fractions.  The progress of 
peptide/protein elution was monitored via UV detection (Waters CapLC2487) at 214 nm and 1 
mL fractions were collected.  Once the fractions were collected they were flash frozen and 
lyophilized to concentrate the sample and remove MS-incompatible solvents.  These fractions 
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were recombined post lyophilization to allow for a more manageable number of samples for the 
second dimension analysis.  When the IMER was taken off-line and proteins were fractionated, 
the resulting recombined fractions were digested in-solution overnight following the standard 
digestion protocol43 (Table 4.3) for our lab utilizing free (unbound) trypsin. 
For the second dimension, all resulting peptides (in-solution and IMER digestions) were 
analyzed and identified using a modified UHPLC coupled to MS.44  In this modified high 
pressure separation system, the LC gradient and sample are placed into a gradient storage loop 
using a commercial nanoAcquityTM UPLC system (Waters Corporation).  The ultra-high pressure 
(30,000 psi) is achieved by pushing the gradient and sample from the loop using a pneumatic 
amplifier (DSHF-300, Haskel  International LLC, Burbank, CA).  The peptides were separated 
on a  5 μm I.D. x 8  cm (manufactured in-house) capillary column packed with 1.7 µm 130 Å 
BEH C18 particle size (Waters Corporation).  The column was held at 65°C and the eluting 
peptides were detected using a QTof PremierTM mass spectrometer (Waters Corp).  Mobile 
phases of the second dimension consisted of water and acetonitrile with 0.1% formic acid 
(optima grade, Fisher Scientific) and a gradient of 4 - 40% organic was run over 110 min.  The 
column was connected to a silica nanospray emitter with a 20 µm I.D. and a 10 µm tip (New 
Objective, Woburn, MA).  The mass spectrometer operated in MSE mode45 performing parent 
ion scans from 50 to 1990 m/z over 0.6 sec at 5.0 V.  The collision energy ramped from 15 to 40 
V over 0.6 sec.  Data was collected using MassLynx V4.1 SCN 872 and processed via ProteinLynx 
Global Server 2.5 (PLGS, Waters Corporation) set to a 4% false positive rate with a 1 X 
randomized yeast proteome database obtained from Uni-Prot protein knowledgebase 
(www.uniprot.org) on 2/3/2011.  Mass spectrometer processing parameters are outlined in 
Table 4.4.  If the same proteins were identified in multiple fractions within a sample set, the 
protein fraction with the highest identification score was counted.  Therefore, a protein was only 
counted once despite whether the protein was split into multiple fractions during the first 
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dimension separation.  Each fraction was processed 3 times in the second dimension and a 
protein was required to be identified in at least 2 of the 3 replicate runs to be counted. 
4.2.7 Analysis of Model Protein Bovine Serum Albumin (BSA) 
First a solution of bovine serum albumin (BSA, Sigma Aldrich, P/N A0281) was reduced 
and alkylated following the standard protocol (Table 4.3).43  One hundred microliters of a 0.070 
µg/µL solution was injected onto the PLRP-S column followed by online IMER digestion (Figure 
4.6).  The first dimension reverse phase gradient is outlined in Table 4.1 and consisted of water 
and acetonitrile with 0.1% TFA.  The flow rate was varied to test a range of analyte residence 
times (10 sec to 8 min) corresponding to trypsin exposure but the ratio of the gradient mobile 
phase flow rate to buffer flow rate was kept consistent at 2:1 (gradient:buffer) to guarantee the 
IMER remained at ~pH 8 despite the desired volumetric residence time on column.  Fractions 
were collected over the UV peak (at 214 nm) observed for BSA, lyophilized, and recombined into 
one sample for UHPLC analysis (settings previously described).  For comparison, the same 
amount of BSA was injected onto the PLRP-S column without the IMER present (off-line) 
following the same procedure.  Fractions containing the BSA peak were lyophilized, recombined, 
and digested in-solution following the standard digestion protocol43 (Table 4.3).  Both samples, 
collected with and without the IMER, were processed on the previously described UHPLC 
system.   
4.2.8 Analysis of Yeast Cell Lysate  
Saccharomyces cerevisiae (strain BY4741) was grown on glucose media until stationary 
phase was achieved (optical density >2).  Cells were washed, resuspended in 50 mM ammonium 
bicarbonate pH 8 and protease inhibitors (Pierce Protease Inhibitor Mini Tablets) were added 
and prepared to the manufacturer’s recommendations.  Pressure assisted cell lysis utilized a 
French press cell, where the entire 25 mL sample was passed dropwise at 20,000 psi 3 times 
through the cell.  The cell itself was chilled (4°C) and elutant was kept on ice throughout the 
process.  Each lysis sample was centrifuged at ~1,200 g for 10 min at 4°C to remove unbroken 
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cells (Beckman, L8-70 Ultracentrifuge).  The supernatant was isolated and underwent 
ultracentrifugation at ~120,000 g (38,000 rpm Beckman 60Ti rotor) for 90 min at 4°C twice 
before the pellets (insoluble portions) were collected.  To determine the amount of protein 
present a Bradford assay46 (Coomassie Protein Assay Kit, Thermo Scientific) was performed 
once the pelleted proteins were resuspended in 50 mM ammonium bicarbonate buffer pH 8. 
Two milliliters of insoluble yeast cell lysate were removed (~4.4 mg of protein) and diluted to 
perform the reduction and aklyation step according to protocol.43  Once the entire sample was 
reduced and alkylated, 550 µL of protein solution (~1.2 mg protein) was injected onto the 
prefractionation setup (Figure 4.6) with and without the IMER on-line.  For yeast cell lysate 
analysis, mobile phase A consisted of 80% water, 10% isopropanol, 10% acetonitrile, and 0.1% 
TFA.  Mobile phase B consisted of 50% isopropanol, 50% acetonitrile, and 0.1% TFA.  Beginning 
at 0% B, the gradient ramped to 60% B in 100 min followed by a further increase to 90% at 110 
min where it held for 10 min before returning and stabilizing at 0% B.  The total run time was 
150 min, allowing for formic acid elution for the first 10 min prior to gradient start time and 
ending with 20 min column re-equilibration (Figure 4.12).  During the gradient, 100 mM of 
ammonium bicarbonate, pH 8, was plumbed into the fluidics after the PLRP-S column and prior 
to the trypsin column.  The flow rate of the pump controlling the mobile phase gradient was 0.3 
mL/min and the buffer pump was set to 0.2 mL/min.  This resulted in a flow rate of 0.5 mL/min 
through the IMER for a volumetric residence time for digestion of ~10 sec.  Two minute wide (1 
mL) fractions for each setup (with and without the IMER on-line) were collected, lyophilized, 
and recombined into 15 equivalent time fractions.  Although 15 fractions were recombined, only 
fractions 1-9 (outlined in Figure 4.13) were ultimately compared due to the lack of protein 
present in fractions 10-15.  Once the fractions were recombined, the on-line IMER digested 
fractions were immediately ready for UHPLC peptide separation and protein identification 
(settings previously described).  However, the 15 fractions collected without the IMER present 
were digested in-solution according to protocol43 described in Table 4.3 with free (unbound) 
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trypsin.  Both fraction sets, collected with and without the IMER, were processed on the 
previously described UHPLC system. 
4.3 Results and Discussion 
4.3.1  Immobilization of Trypsin  
 After the trypsin was immobilized onto the 5 µm 300 Å BEH particles following the 
published and revised protocols, a particle slurry containing ~30 mg of immobilized trypsin 
particles was reacted with 1.5 mL of 0.25 mM BAEE for 1 min.  The two slurry batches were 
compared to an identical reaction with 50 µg of free (unbound) trypsin.  As shown in Figure 
4.14, the BAEE peak for all samples where trypsin was present decreased and the BA peak 
appeared at ~6 min.  This confirmed the hydrolysis of BAEE in all samples which contained 
trypsin.  This experiment was performed merely to determine whether active trypsin persisted 
on the BEH particles after immobilization and which immobilization protocol provided the 
immobilized trypsin with the highest activity.  As shown in Figure 4.14, the revised protocol had 
a significantly larger BA peak and smaller BAEE peak compared to the trypsin immobilized via 
the publish protocol.  Since activity for the revised UNC protocol was confirmed to be higher, a 
larger batch of immobilized trypsin particles (0.6 g of particles) was produced and packed into a 
2.1 x 30 mm column resulting in the IMER. 
4.3.2 Immobilized Trypsin Reproducibility and Retained Activity 
 For the majority of the work presented in this chapter, only two IMERs were used.  Each 
IMER was used for approximately 6 months without showing any signs of degradation 
(digestion efficiencies remained high).  Over the course of the project, however, a total of 8 
IMERs were ultimately developed to determine reproducibility of immobilization.  The slurries 
from these immobilized trypsin particles were tested via the BCA and BAEE assay (Table 4.5).  
The BCA assay determined the amount of trypsin present on the particles, while the BAEE assay 
determined the activity.  Knowing the reported activity of the trypsin (provided by the 
manufacturer to be 10,350 BAEE units/mg trypsin) and the amount of trypsin present on the 
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particles via the BCA assay, then the expected activity of the particles can be determined.  The 
experimental activity of the particles was determined by the BAEE assay.  These two values can 
then give the percent of expected activity the immobilized trypsin particles exhibit.  The average 
percent expected activity for 8 batches of immobilized trypsin particles was 40%.  Previously 
stated, if the trypsin has a 50:50 chance of binding to the particle in an active configuration (i.e. 
the active site accessible) or binding with an inactive configuration (i.e. active site inaccessible), 
then the maximum percent expected activity would be 50%.  Therefore, the immobilization 
protocol provided here with 40% expected activity is reasonable.  It is important to note, 
however, that the experimental activity determined with the BAEE assay utilizes the particles in 
solution (not packed into columns) which may not allow high trypsin activity.  Thus, the 
experimental activity of the particles, when packed into a column, may produce even higher 
activity than the immobilized trypsin particles in solution. 
4.3.3 Proteomics Perspective 
 In order to fully appreciate the activity of an IMER packed with highly active trypsin 
immobilized particles, one needs to compare it to an in-solution digestion.  A typical protein in-
solution digestion for a nano-flow system (capillary columns,  5 μm i.d. x 25 cm) contains 50-
100 μg of protein per digestion.  For injection onto this column, a solution concentration of 1 
μg/μ  is reasonable.  When performing an in-solution digestion, trypsin can be added anywhere 
from 1:20 to 1:100 trypsin:protein ratio.  This gives 1 to 5 μg of trypsin per digestion.  If the 
manufacturer reports 10,000 BAEE units/mg trypsin then there will be 10-50 BAEE units per 
in-solution digestion.  Although this is not much activity, in-solution samples are allowed to 
react for 15 hr to achieve adequate digestion results. 
 On the other hand, IMERs react in seconds by exposing the sample to massive amounts 
of immobilized trypsin.  Reported in Table 4.5 for the batches of immobilized trypsin, the 
average experimental activity was 309,500 BAEE units/g immobilized trypsin particles.  If an 
IMER column (2.1 x 30 mm) contains 0.2 g of particles then these columns will have an activity 
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of ~60,000 BAEE units.   Therefore, the same sample that would be exposed to 10-50 BAEE 
units of activity during an in-solution digestion can be injected onto an IMER that is 1,200-
6,000 times more active, finishing the digestion in seconds. 
4.3.4 IMER characterization 
 Once the IMER was packed it was initially tested with BAEE at multiple flow rates to test 
digestion speed.  This was performed by placing the IMER before the PLRP-S analytical column 
so the reverse phase column could separate BA from BAEE (Figure 4.10).  The effluent from the 
IMER was preconcentrated directly onto the reverse phase column via a valve, switching the 
analytes quickly and reproducibly onto the PLRP-S column.  Buffer was allowed to flow through 
the IMER from 10 µL/min to 1 mL/min corresponding to a volumetric residence time for 
digestion between 8 min and 5 sec respectively.  As shown in Figure 4.15, only the fastest speed 
tested (1 mL/min) resulted in a small amount of BAEE present. For all other digestion speeds 
tested no BAEE was observed. 
 The ultimate objective for the workflow configuration (Figure 4.6) would implement the 
IMER after the protein separation column and it would experience the gradient as the proteins 
elute.  This means that the digestion efficiency is required to remain constant despite the 
presence of organic solvents.  To test the effect of organic solvents on the IMER digestion, varied 
amounts of mobile phase (5-85% B) were combined with the buffer flowing through the IMER at 
a flow rate of 1 mL/min (Table 4.2).  The resulting effluent was collected in a vial and underwent 
a 1:10 dilution (Figure 4.11).  This was required for preconcentration of the sample onto the 
PLRP-S column for BA/BAEE analysis.  As shown in Figure 4.16, no unreacted BAEE was 
observed regardless of the level of organic solvent present in the buffered mobile phase.  The 
concerning peak shape of BA (5-7 min, Figure 4.16) during this experiment could suggest that 
BA was not preconcentrating, or that BAEE was not preconcentrating at the higher percent 
organic loading conditions.  To verify that BAEE was still preconcentrating (and not eluting 
earlier to contribute to the peak shape of BA) standard mixtures of BA and BAEE were 
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combined with 5, 37, and 85% mobile phase B.  Despite the percent organic present (Figure 
4.17), BAEE did not shift in retention, and therefore was not the cause of BA’s peak shape.  The 
retention of BA, on the other hand, was affected by organic content.  This did not affect the 
IMER results shown in Figure 4.16, but needed to be verified to confirm that BAEE was expected 
at ~17 min despite the presence of organic content.  It is important to note that although this 
experiment refers to the mobile phase B as “organic,” mobile phase A in the first dimension 
protein separation also contains 20% organic (50:50 ACN:IPA).  Therefore, the actual percent 
organic in each combination of mobile phase tested was 24, 50, 88% (Table 4.6).   
4.3.5 Model Protein Results 
 Initial protein tests were performed using bovine serum albumin (BSA).  The workflow 
outlined in Figure 4.6 was implemented and BSA was injected with and without the IMER on-
line.  The fractions collected were combined into one sample and analyzed via the UHPLC 
system.  Flow rates of 10 µL/min (8 min IMER volumetric residence time), 100 µL/min (48 sec 
IMER volumetric residence time), and 0.5 mL/min (10 sec IMER volumetric residence time) 
were tested.  As shown in Table 4.7, the percent coverage and number of digest peptides for the 
10 µL/min flow rate compared well to that for an in-solution digestion.  For the faster flow rates 
tested (100 μ /min and 0.5 mL/min) the percent coverage and number of digest peptides did 
decrease slightly, however, the volumetric residence time was greatly reduced as well. 
Since missed cleavages have been reported to be common with accelerated trypsin 
digestion via the use of immobilized enzyme,7 this was also investigated.  Triplicate in-solution 
15 hr digestions resulted in 33 (± 6) missed cleavages.  With the flow rates discussed above, 
individual IMER digestions at 10 µL/min (8 min IMER volumetric residence time) had 10 
missed cleavages, the 100 µL/min (48 sec IMER volumetric residence time) had 8, and the 0.5 
mL/min (10 sec IMER volumetric residence time) had 19.  Therefore, by utilizing the trypsin 
IMER a decrease in missed cleavages was observed for the range of flow rates tested.   
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4.3.6 Yeast Cell Lysate Comparison 
 There are few reports in the literature of complex sample analysis (such as cell lysates) 
via on-line IMER digestion.13,21,26,32  Therefore, the insoluble portion of a yeast cell lysate was 
processed using the workflow outlined in Figure 4.6.  This was performed both with and without 
the IMER on-line.  The process was monitored by UV and fractions were combined into 15 equal 
time fractions.  These fractions were then processed in the second dimension using the UHPLC 
system.  It was quickly determined that no proteins were present after fraction 9, so only 
fractions 1-9 were analyzed for both the IMER and in-solution digestion experiments.  The UV 
trace and fractionation outline are shown in Figure 4.13.  As shown in Figure 4.18, both 
experiments had roughly the same number of protein identifications.  With the IMER on-line, 
the system identified 507 proteins (134 membrane associated). With the IMER removed and 
applying in-solution digestion instead the system identified 490 proteins (141 membrane 
associated).  Therefore, both types of digestion produced similar results for both the total 
number of proteins and membrane protein identifications.  The similarities are more apparent 
when the protein identifications are plotted according to molecular weight and isoelectric point 
(Figure 4.19).  As shown in Figure 4.19, there was no serious bias for digestion method based on 
molecular weight or isoelectric point.  Possibly the IMER was slightly more effective with lower 
molecular weight proteins and higher pI values, but overall the digestions were generally 
equivalent. 
 Examining the 370 total proteins identified in both the IMER and in-solution digestion, 
percent coverages were compared (Figures 4.20 and 4.21).  In Figure 4.20, the proteins are 
plotted based on molecular weight versus percent coverage.  Overall, the IMER and the in-
solution digestion had relatively similar coverage and this is further reflected in the average and 
median percent coverage values.  The IMER had an average percent coverage of 47.5% and a 
median of 45.4% while the in-solution digestion had an average percent coverage of 46.2% and a 
median of 46.4%.  Taking the log of the ratio of the individual percent coverage values for each 
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of the 370 total proteins and 94 membrane proteins identified in both methods (Figure 4.21), 
further displayed the similarity between the digestion methods.  As shown in Figure 4.21, points 
appear evenly distributed above and below the axis, suggesting similar percent coverage values 
were obtained for the IMER and in-solution digestions.  Summarizing Figure 4.21, out of the 
370 total proteins identified, the in-solution digestion had 169 instances where it produced 
higher coverage of the proteins.  The IMER had 200 occurrences where it produced higher 
coverage and there was one instance where the coverage was identical between digestion 
methods.  For the 94 commonly identified membrane proteins, 46 membrane proteins had 
higher coverage for the in-solution digestion, 47 for the IMER digestion, and 1 with equivalent 
coverage.  The IMER digestion presented in this study was faster than previous reports for on-
line yeast cell lysate digestion21,47,48 and identified approximately the same number of yeast 
proteins (541 reported in Feng, et al.21 compared to 507 found in this study).  It is important to 
note that the sample used in this study was the insoluble portion of a yeast cell lysate, typically 
containing approximately 25-40% proteins that are identified as membrane-associated. 
4.4 Conclusions 
Despite the developments for faster liquid chromatographic and mass spectral detection 
techniques, the standard in-solution protein digestion for proteomic analyses has remained 
relatively unchanged.  The typical in-solution trypsin protein digestion is usually the slowest 
part of the workflow, albeit one of the most important. The development of a highly efficient 
immobilized enzyme reactor (IMER) with rapid performance for on-line protein digestion would 
greatly decrease the analysis time involved in a proteomic workflow.  Presented here is the 
development of a silica based IMER for on-line protein digestion, which produced rapid 
digestions in the presence of organic mobile phase for both model proteins and a complex 
sample consisting of the insoluble portion of a yeast cell lysate.   
Overall, the percent coverage and number of protein identifications between the IMER 
and in-solution digestions were comparable.  Initially the IMER demonstrated promise through 
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the hydrolysis of substrate BAEE for flow rates up to 1 mL/min (5 sec IMER volumetric 
residence time) and in the presence of high organic (85%) mobile phase.  Initial studies with 
BSA provided percent coverages that were comparable to in-solution trypsin digestion.  The 
final comparison utilized a complex sample consisting of the insoluble portion of a yeast cell 
lysate.  With only a 10 sec IMER volumetric residence time, the IMER identified 507 proteins 
while the in-solution digestion identified 490.  There were no significant differences observed 
based on protein molecular weight or pI between the two digestion methods.  In addition, the 
percent coverages achieved using both methods were essentially equivalent.  Therefore, the 
implementation of the IMER into the proteomic workflow provided similar protein 
identification results, automation for sample analysis, and reduced the analysis time by 15 hr.  
Future directions include fully implementing the IMER into a two dimensional on-line 
workflow.  In this new workflow, the eluting peptides from the IMER will flow directly onto a 
second dimension LC column for immediate MS analysis.  This will eliminate the use of 
fractionation, lyophilization, and further decrease analysis time. 
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4.5  TABLES 
Table 4.1 Gradient method on PLRP-S column for 
BAEE analysis and BSA elution.  Mobile phases 
consisted of water (A) and acetonitrile (B) with 0.1% 
trifluoroacetic acid (TFA). 
t (min) % Acetonitrile (B) 
0 5 
5 5 
20 21 
25 85 
27 85 
30 5 
35 5 
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Table 4.2 Various percent organic combinations 
tested on the IMER.  Both mobile phases contained 
0.01% trifluoroacetic acid. 
% A 
80:10:10 
Water:ACN:IPA  
% B  
50:50 
ACN:IPA  
95 5 
75 25 
55 45 
35 65 
15 85 
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Table 4.3 Default in-solution digestion protocol adapted from: 
(http://www.genome.duke.edu/cores/proteomics/sample-preparation)43 
Reduction and alkylation steps (d through h) were also performed on IMER samples. 
 
Procedure: 
 
a) Perform Bradford assay to determine protein concentration of each solution.  
Normalize concentrations for samples within a group using 50 mM AmBic. 
 
b) In order to maximize solubility of proteins, add calculated volume of Waters 
RapiGest to have 0.1-0.2 % RapiGest in final concentration pre-digestion.  Make 
up RapiGest with 50 mM AmBic.   
 
c) Heat at 40°C for 10 minutes.  Spin down condensate. 
 
d) Make up 100 mM dithiothreitol (DTT) in 50 mM AmBic for reduction step.  Add 
DTT to each solution to make the final DTT concentration 10 mM. 
 
e) Heat solution at 80°C for 15 minutes. 
 
f) Remove from heat and cool for 5 minutes (to room temp).  Spin down 
condensate. 
 
g) Make up 200 mM iodoacetamide (IAM) in 50 mM AmBic for alkylation step.  
Add IAM to each solution to make the final IAM concentration 20 mM (2X 
molar excess of DTT). 
 
h) Incubate the solutions in the dark at room temperature for 30 minutes. 
 
i) Add trypsin to each solution at 1:30 trypsin:protein concentration.  Make 
trypsin stock in 50 mM AmBic. 
 
j) Digest overnight at 37°C. 
 
k) Following digestion, centrifuge condensate to bottom of vial.  Add TFA and 
MeCN to give 0.5-1.0% TFA and 2% MeCN by volume. 
 
l) Samples sit for 2 hours at 60°C.  Centrifuge at 15,000 rpm for 5 min, and pipette 
supernatant into an autosampler vial. 
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Table 4.4 Software Processing Parameters 
Processing Parameters in PLGS V2.5 
Chromatography peak width automatic  
MS TOF resolution automatic 10,000 
Lock Mass 1 785.84265 Da/e Glu-1-Fibrinopeptide 
Lock Mass 2 556.2771 Da/e Leucine Enkephalin 
Lock Mass Window 0.5 Da 
Low Energy Threshold 150 counts 
Elevated Energy Threshold 50 counts 
Intensity Threshold 750 counts 
Workflow Template in PLGS V2.5 
Databank S.cerevisiae from 2/3/11 
http://www.expasy.org/proteomics 
Peptide tolerance automatic* 
Fragment tolerance automatic* 
Minimum fragment ion matches per 
peptide 
3 
Minimum fragment ion matches per 
protein 
7 
Minimum peptide matches per protein 1 
Maximum hits 20 
Maximum Protein Mass 250,000 
Primary Digest Reagent trypsin 
Secondary Digest Reagent none 
Missed Cleavages 1 
Fixed Modifications Carbamidomethyl C 
Variable Modifications Oxidation M, Deamidation N, Deamidation Q 
False Positive Rate 4 
* When “automatic” is selected the proprietary P GS algorithm interrogates each data set to 
determine an ideal value for the analysis. 
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Table 4.5  Retained Percent Activities for 8 IMERs. Manufacturer reported trypsin activity 
of 10,350 BAEE units/mg trypsin. 
IMER 
BCA Assay Result 
mg trypsin/g 
particle 
Expected Activity 
(from BCA Assay) 
BAEE units/g 
particle 
Experimental 
Activity 
(from BAEE Assay) 
BAEE units/g 
particle 
% 
Retained 
Activity 
1 70 724,500 350,000 48 
2 80 828,000 222,000 27 
3 86 890,100 381,000 43 
4 50 517,500 266,000 52 
5 89 921,159 317,000 34 
6 54 558,900 333,000 60 
7 92 952,200 311,000 33 
8 86 890,100 296,000 33 
 
Average 76 785,307 309,500 40 
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Table 4.6 Mobile phase composition compared to 
actual percent organic present. 
% A 
80:10:10 
Water:ACN:IPA 
% B 
50:50 
ACN:IPA 
% Organic 
95 5 24 
63 37 50 
15 85 88 
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Table 4.7 Analysis of BSA on pre-fractionation workflow with and without IMER 
digestion. 
Flow Rate Digestion Time Coverage (%) Digest Peptides 
10 µL/min 8 min 96 % 124 
100 µL/min 48 sec 93 % 108 
0.5 mL/min 10 sec 93 % 110 
In-solution 15 hr 99 % 111 
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4.6  FIGURES 
 
 
 
 
 
Figure 4.1  Scheme for trypsin immobilization onto BEH particles adapted from Ahn, et al.33 
(Step 1) The primary amine from the enzyme forms a temporary Schiff base with the crosslinker 
triethoxysilyl butyraldrhyde.  This is immediately reduced in the presence of sodium 
cyanoborohydride.  (Step 2) The enzyme-crosslinker complex is then introduced to the BEH (5 
μm, 300 Å) particles.   
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Figure 4.2 Scheme for trypsin immobilization onto BEH particles via the revised (UNC) 
protocol.  (Step 1) The BEH particles are exposed to the crosslinker which undergoes hydrolysis 
and condensation reactions binding to the particle surface.  (Step 2) The particle-crosslinker 
complex is exposed to the enzyme (trypsin) and is reduced.  This reaction occurs in ammonium 
bicarbonate (ABC). 
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Nα-Benzoyl-L-arginine Ethyl Ester                             Nα-Benzoyl-L-arginine                   Ethanol 
                     (BAEE)      (BA)  
 
 
Figure 4.3  Reaction of Nα-Benzoyl-L-arginine ethyl ester (BAEE) with trypsin producing Nα-
benzoyl-L-arginine (BA) and ethanol.  This reaction is monitored at 253 nm where the 
absorbance changes 0.001 per minute. 
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Figure 4.4  Example of change in absorbance over time for a sample containing trypsin 
(green) and without trypsin (BAEE Blank, blue).  The slopes of these lines are then 
substituted into equation 4-1. 
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Figure 4.5  Standard workflow for experiments utilizing a 15 hr in-solution trypsin digestion.  
Initially proteins are separated in the first dimension and the elution monitored by UV detection 
(214 nm).  The fractions are collected in the time domain and are then lyophilized to be 
reconstituted into fractions of equal mass.  The equal mass fractions are digested in solution 
with trypsin and the resulting peptides are analyzed in the second dimension on the UHPLC 
instrumentation described in Chapter 3.  Proteins are identified using software provided by the 
manufacturer. 
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Figure 4.6  IMER experimental workflow.  The IMER was placed after the protein separation 
column via a valve so that both experiments (on-line IMER digestion and off-line IMER in-
solution digestion) could be easily compared. 
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Figure 4.7  Experimental setup for determining which protocol provided the most active 
trypsin immobilized particles.  Particles were centrifuged prior to injection of supernatant. 
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Figure 4.8  Samples containing BAEE and BA were easily separated on the PLRP-S reversed 
phase column using the gradient outlined in Table 4.1.  Peak identities were confirmed via 
standard solutions. 
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Figure 4.9  Example calibration curve for BCA protein assay.  The blue data points represent a 
series of calibrants consisting of free (unbound) trypsin in solution at various concentrations.  
The red data point is from a sample of immobilized trypsin particles in a slurry.  This assay 
determined the amount of protein (trypsin) present on the particles. 
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Figure 4.10  Experimental setup for determining possible flow rates through the IMER.  The 
effluent from the IMER preconcentrates onto the PLRP-S reverse phase column.  The valve is 
then switched and a gradient is run to separate any BA from BAEE. 
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Figure 4.11  Experimental setup for determining the effect of organic mobile phase on IMER 
digestion.  BAEE was injected and sent through the IMER in a variety of organic mobile phase 
compositions (Table 4.2).  Gradient for the reverse phase separation is shown in Table 4.1 and 
the actual organic content of the combined mobile phases is shown in Table 4.6. 
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Figure 4.12  Gradient profile for separation of proteins on the first dimension reverse phase 
column. For yeast cell lysate analysis, mobile phase A consisted of 80% water, 10% isopropanol, 
10% acetonitrile, and 0.1% TFA.  Mobile phase B consisted of 50% isopropanol, 50% 
acetonitrile, and 0.1% TFA. 
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Figure 4.13  UV absorbance trace of analysis with (black) and without (red) the IMER on-line. 
The fractions combined after lyophilizations are segmented via the red lines.  Although 15 
fractions were initially combined over the entire run (gradient and wash), only the 9 combined 
fractions outlined above were analyzed. 
 
168 
 
 
 
Figure 4.14  Slurry of trypsin immobilized particles from revised (blue) and published (red) 
digestion of BAEE for 1 min compared to free unbound trypsin in-solution (purple). The bottom 
(black) trace is a blank of BAEE solution that underwent the same protocol without trypsin 
present.  Collected utilizing the setup described in Figure 4.7. 
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Figure 4.15 BAEE injected onto the IMER with variable buffer flow rates. The effluent of the 
IMER was preconcentrated directly onto the PLRP-S column (Figure 4.10) and analyzed for the 
presence of BA by UV detection.  As shown, only a small amount of BAEE was observed at 1 
mL/min. 
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Figure 4.16  Comparison of organic content on IMER digestion efficiency. BA elutes at ~ 6 min 
and BAEE elutes at ~ 17 min. 
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Figure 4.17  BA and BAEE standards injected onto the PLRP-S column without IMER 
exposure.  Standards were injected in a variety of organic mobile phase compositions to verify 
peak placement. 
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Figure 4.18  Venn diagram comparing the proteins identified with (green) and without (blue) 
the IMER on-line: (a) total protein identifications and (b) membrane protein identifications. 
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Figure 4.19  The proteins identified by both the IMER and in-solution digestions plotted (a) by 
molecular weight and (b) by isoelectric point. 
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Figure 4.20 The percent coverage for the 370 total proteins identified by both the IMER 
(green) and in-solution (blue) digestions plotted against molecular weight. 
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Figure 4.21 The ratio of percent coverage found in the 370 total proteins and 94 membrane 
proteins identified by both the IMER and in-solution digestions.  The ratio was IMER/in-
solution, therefore positive values indicate the IMER digestion had a higher percent coverage 
than the in-solution digestion and negative values indicate the in-solution percent coverage was 
higher. 
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CHAPTER 5. Fully Automated LC-IMER-LC-MS On-line Digestion  
 
5.1 Introduction 
 The implementation of the immobilized enzyme reactor (IMER) in the previous chapter 
significantly increased the throughput of the proteomic workflow (Figure 5.1).  Performing 
protein digestions in seconds in an on-line fashion reduced the analysis time by 15 hours 
without sacrificing digestion efficiency.  Off-line (or in-solution) proteomic workflows can suffer 
from sample loss, require lengthy digestion periods, and are difficult to automate.1  For the 
workflow outlined in Figure 5.1, the digestion itself is considered on-line; however, the workflow 
still requires off-line manipulation.  For example, after UV detection of the eluting peptides, 
fractionation and lyophilization are completely off-line techniques.  Both require manual sample 
handling and preparation prior to the second-dimension ultra-high pressure liquid 
chromatographic mass spectrometric (UHPLC-MS) analysis.  The off-line sample handling 
could introduce contamination, especially since the fractions are collected over an extended 
period of time.  Fractions are collected in a tray and remain open to the lab environment for 
hours throughout the run before they are collected and capped.  During this time, common 
protein contaminants such as keratins within the lab can be especially troublesome for bottom-
up analysis of peptides by electrospray ionization (ESI).  Keratins are a class of structural 
proteins, which include over 30 variants.  These proteins are constantly being shed from human 
or animal hair and skin debris.2  Specifically, human keratin contamination can mask the 
presence of lower abundance proteins and peptides due to its high intensity and ionization 
efficiency.3, 4  Although gloves are always used to prepare samples, it is difficult to remove 
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keratin contamination since it is always present in the lab and can readily move about as dust on 
surfaces.   
Additionally, the act of fraction collection and lyophilization itself can be detrimental.  
Proteins and peptides, being of amphiphatic nature, readily adsorb to most surfaces.5  This can 
be especially problematic for low abundance proteins such as membrane proteins.  During the 
fractionation step, proteins are collected in plastic centrifuge tubes.  Once the proteins are 
fractionated, they are lyophilized and later recombined into a more manageable number of 
second-dimension samples.  Recombining the fractions involves manually transferring analytes 
between centrifuge tubes.  Ultimately, it would be beneficial to reduce this interaction of 
peptides with plastic surfaces such as the centrifuge tubes, so the likelihood of contamination, 
adsorption, and loss of peptides from the sample can be decreased.   
In addition, both fractionation and lyophilization require time.  For fractionation, 
fractions are collected throughout the first-dimension run time.  This can be from 40 minutes 
(standard protein analysis) to 2 hours (complex analysis of a yeast cell lysate).  Lyophilization is 
typically performed overnight after the fractions have been flash frozen in liquid nitrogen.  This 
process adds yet another lengthy and labor-intensive step to the workflow.  The focus of this 
work was to develop a fully on-line automated two-dimensional reverse phase system (RPLC-
IMER-RPLC) with IMER digestion.  Proteins from the first-dimension will be immediately 
passed to the IMER and then to second-dimension RPLC separation prior to mass spectral 
analysis.  This will eliminate the need for fraction collection and lyophilization, saving an 
additional 15-17 hours while removing possible avenues for contamination and sample loss.  The 
concept of protein separation, digestion, followed by peptide separation is analogous to MS/MS 
strategies (Figure 5.2), in which an ion is sent into the mass spectrometer, fragmented, and the 
products are detected.  In this case, proteins are being sent into a reactor, digested, and the 
resulting peptides are detected. 
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5.1.1 Previous 2D On-line Digestion Strategies 
 Currently, there are several platforms that utilize on-line digestion with IMERs.  Mainly 
these consist of a one-dimensional separation, in which a protein sample is injected onto the 
IMER followed by peptide separation and protein identification (IMER-HPLC-MS or IMER-CE-
MS) (Figure 5.3b).  Separations for these workflows consist primarily of capillary 
electrophoresis (CE) and liquid chromatography (LC) with one-dimensional analysis (Figure 
5.3a-c), rather than the highly complex two-dimensional setup (Figure 5.3d).  However, having 
only a one-dimensional separation does not produce the resolving power and peak capacity 
necessary for proteomic study.1   
Difficulties arise when placing LC separation columns before and after the IMER.  Prior 
to digestion, the separation conditions (specifically mobile phase composition and pH) must be 
compatible for proteolytic digestion.  In addition, all connections after the analytical column 
should be configured to reduce the amount of band broadening as much as possible.6  The 
effluent from the IMER also must be efficiently preconcentrated for second-dimension analysis 
and acidified for ionization.  Consequently, multiple valves, fittings, and pumps are required for 
a fully on-line configuration.  As a result, the majority of the multidimensional workflows in the 
literature that constitute on-line protein and peptide separation (HPLC-IMER-HPLC-MS) are 
configured with off-line sample collection prior to the second-dimension analysis, such as the 
workflow developed in Chapter 4.   
Despite the difficulties, there are a few on-line multidimensional systems that have been 
developed.  One example from the Zhang group involved a mixed weak anion and weak cation 
exchange microcolumn (WAX/WCX) followed by IMER digestion and RPLC-ESI-MS/MS.  The 
second-dimension consisted of two parallel C8 precolumns for trapping and desalting prior to 
the RP separation.  This system displayed good reproducibility, high sequence coverage, and 
high resolution while being completely automated.1  This application was later applied to nano-
flow LC columns and evaluated with a whole cell lysate.  Overall, a 6% increase in identified 
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proteins and a decrease of 14-38 hours in analysis time were achieved compared to the shotgun 
approach.7   
Another example of a true on-line workflow was developed in the Greibrokk lab.  
Combining the separation with sample preparation techniques, strong anion exchange 
chromatography was followed by on-line reduction and alkylation of proteins on trap columns.  
These alkylated proteins were then separated on a RP column followed by on-line IMER 
digestion and ESI-MS detection (SAX         
          
RP-IMER-ESI-MS).  However, the complexity of the 
system and unsatisfactory tryptic digestion for all proteins analyzed, left this system lacking.8 
The Greibrokk lab also configured this workflow for protein and peptide separations with SAX 
followed by IMER digestion (SAX         
          
IMER-RP/WCX-ESI-MS).  The effluent of the IMER was 
diluted and peptides were separated on a column containing a mixture of RP and WCX prior to 
ESI-MS.  For this system, the on-line digestions were successful in high percent organic, and 
peptides were effectively trapped for second-dimension analysis.  However, the 
multidimensional setup remained extremely complex.9 
Although LC techniques are more common,6 there has been success with two-
dimensional CE analysis at varying pH to separate proteins with low detection limits.10  It is 
likely that, due to the speed of CE separations, IMERs will eventually see more application with 
this technique.  Traditionally, pairing IEC with RPLC has been the most popular 
multidimensional proteomic approach.  This is mainly due to the solvent compatibility between 
the modes and RPLC adaptability for subsequent MS detection.11  The selectivity of IEC and 
RPLC are also complementary and thus satisfy Giddings’ requirements for orthogonality (see 
Chapter 1).  As demonstrated previously by the Jorgenson lab, having reverse phase separations 
in both dimensions, first for separation of proteins then for peptides, also provides orthogonality 
between modes.  Utilizing reverse phase in the first-dimension better utilized the separation 
space and produced more protein identifications when compared to anion-exchange in the first-
dimension.12  Therefore, the focus of this Chapter is to modify the previous workflow (Figure 5.1) 
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by placing it entirely on-line with reverse phase columns in both dimensions (Figure 5.4).  This 
RPLC-IMER-RPLC-ESI-MS configuration is the first fully automated on-line digestion system 
utilizing reverse phase in both dimensions.   
5.1.2 IMER On-line Workflow Considerations 
 As shown in Figure 5.4, four HPLC pumps would be required for the multidimensional 
workflow.  The first would control the protein gradient (HPLC Gradient Pump 1), and separate 
the proteins on the first-dimension reverse phase column.  A second pump (HPLC Buffer Pump) 
is required to adjust the pH from ~2 to ~ 8 to provide compatibility with on-line trypsin 
digestion.  As the proteins elute from the first-dimension they are instantly digested by the 
IMER resulting in peptides.  These peptides, which were previously fractionated by the prior 
workflow, would be preconcentrated onto the second-dimension reverse phase column.  In 
order to preconcentrate the peptides, a third pump (Dilution/Acidification Pump) would dilute 
the mobile phase with water to return the mobile phase to initial conditions (~4-5% organic).  
This pump would also contain 0.1-0.2% formic acid to provide acidification for electrospray 
ionization.  The fourth and final pump (HPLC Gradient Pump 2) provides the gradient for the 
second-dimension.  In the second-dimension two alternating reverse phase columns are 
responsible for peptide separation.  While one column is preconcentrating peptides from the 
IMER, the other is undergoing gradient elution of peptides.  After the gradient is complete, 
these columns would switch, and the column that had been preconcentrating peptides would 
experience the gradient and vice versa.   
When developing such system, there are many considerations.  It is important that all 
solvents are compatible for downstream applications.  For example, the acidic mobile phase of 
the first-dimension separation must be pH adjusted prior to entering the IMER.  At a pH of less 
than 2, trypsin will irreversibly denature which would destroy the IMER.  Also, the protein 
sample is typically injected in 80% formic acid to aid in solubilization13, 14 and this unretained 
acid must be diverted from the IMER.  Therefore a valve was installed after the first-dimension 
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separation to divert flow from the IMER when necessary.  After the sample is injected, this valve 
is switched to waste until the unretained formic acid is removed from the first-dimension. 
Additionally, the frequency of alternation between the two second-dimension columns 
can be tuned to fit the specific needs of the experiment.  It is important that these columns are 
short and can separate peptides with fast gradient profiles.  Due to the diameter and flow rate 
requirements for the IMER and the first-dimension column, the second-dimension must also be 
standard bore columns with standard flow ES ionization.  Although the mass spectrometer 
standard ESI spray source can operate up to 1 mL/min the optimum flow rate is ~0.6-0.8 
mL/min.  To promote fast second-dimension separations, 0.8 mL/min was selected for the 
second-dimension flow rate, with an aggressive 15 min gradient from 4-50% organic. 
5.1.3 Actual Residence Time 
The frequency of alternation between the two second-dimension peptide separation 
columns is, in practice, replacing the fractionation step from the previous workflow.  Typically, 
an increased number of off-line fractions collected from the first-dimension results in more 
protein identifications.15  For the on-line multidimensional separation, the faster the second-
dimension columns alternate, the more “fractions” are collected.  This is limited by how quickly 
an operational gradient can be performed in the second-dimension.  For this purpose, it is 
important to know how long proteins remain on the IMER to better understand how the 
peptides are proportioned in the second-dimension.  Although the volumetric residence time for 
a sample in the IMER is ~10 s (for 0.5 mL/min flow rate), due to interactions between the 
bound trypsin and the proteins of interest the actual residence time is expected to be longer.  To 
determine the actual protein residence on the IMER, model proteins were injected directly onto 
the IMER and the eluting peptides were monitored over time (Figure 5.5).  Experiments were 
conducted by either collecting individual fractions for analysis of peptides in time (Figure 5.5a) 
or by directly preconcentrating peptides onto a reverse phase column to compare the effects of 
protein concentration (Figure 5.5b).  This was performed to determine the protein’s actual 
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residence time on the IMER column for digestion and to develop a better understanding for the 
time required to collect peptides in the second-dimension.  As expected, exposure time to the 
IMER itself (i.e. the flow rate) and the injected protein concentration can have effects on 
residence time in the column.  Therefore, these parameters were also investigated. 
5.1.4 Analysis of Standards and Yeast Cell Lysate 
 Standard proteins are useful for comparison purposes since many IMER publications list 
their digestion results, specifically coverage.  Typically these proteins include cytochrome C, 
myoglobin, RNAse A, and bovine serum albumin.  Myoglobin is used most frequently since it 
typically (species dependent) does not contain a cysteine residue and therefore no disulfide 
bonds need to be reduced or alkylated prior to IMER injection.  Injecting such standards and 
comparing sequence coverage, number of digest peptides, and speed of digestion across 
publications is useful; however, the system must be evaluated with a real proteomic sample in 
order to determine whether the application is promising.4  Therefore, the insoluble portion of a 
yeast cell lysate was also analyzed and compared to an equivalent in-solution digestion (Figure 
5.6).  Comparing IMERs to a corresponding in-solution digestion is a commonly recognized 
method for evaluating IMER performance.6   
5.2 Materials and Methods 
5.2.1 Actual Residence Time Evaluation 
In order to track the actual residence time of the model proteins on the IMER, four 
standard proteins (BSA, RNAase A, cytochrome C, and myoglobin) were reduced and alkylated.  
This was performed by heating the proteins to 80°C with 10 mM dithiothreitol (DTT) for 15 min, 
cooling the solutions, followed by alkylation with 20 mM iodoacetamide (IAM) in the dark for 
30 min.  When not in use, solutions of each protein were stored in the refrigerator (4°C).  A 
variety of concentrations were injected ranging from 10 nM to 25 μM (resulting in nanograms to 
micrograms of protein injected on column).  Proteins were individually injected onto the IMER 
and effluent was collected for five 1 minute wide fractions (Figure 5.5a).  This off-line fraction 
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collection allowed for samples to be saved in time for individual analysis of each fraction.  
Proteins were also injected onto the IMER and directly preconcentrated for 1 min onto a peptide 
separation column (XbridgeTM, 4.6  x 50 mm, BEH 3.5 µm, 300 Å Waters Corp.) and 
subsequently eluted with the gradient outlined in Table 5.1.  This method provided a simple, 
quick, and reproducible way to test mobile phase conditions and protein concentrations (Figure 
5.5b) without tedious fraction collection.  The peptide separation column for both scenarios was 
coupled to a standard flow ESI source on a QTof PremierTM mass spectrometer.  The mass 
spectrometer operated in MSE mode performing parent ion scans from 50 to 1990 m/z over 0.6 
sec at 5.0 V.  The collision energy ramped from 15 to 40 V over 0.6 sec.  The lock spray was 
leucine enkephalin and human glu-1-fibrinopeptide B at 400 fmol/μL and 500 fmol/μL 
respectively.  Data was collected using MassLynx V4.1 SCN 872 and processed via ProteinLynx 
Global Server 2.5 (PLGS, Waters Corporation) set to a 4% false positive rate with a protein 
database obtained from UniProt protein knowledgebase (www.uniprot.org).  Additional 
software processing parameters are outlined in Table 5.2.  To evaluate peak dispersion due 
solely to the IMER, model trypsin substrate Nα-benzoyl-L-arginine ethyl ester (BAEE) and 
hydrolysis product Nα-benzoyl-L-arginine (BA) where monitored at 253 nm with and without 
the IMER present according to the setups described in Figure 5.7. 
5.2.2 RPLC-IMER-RPLC-MS 
 The two-dimensional on-line setup is shown in Figure 5.4.  The HPLC Gradient Pump 1 
was an HP1050 (Agilent Technologies) pump used to perform the gradient outlined in Table 5.3.  
The gradient was 200 min long, but with washing and conditioning steps the entire first-
dimension run was 4 hr.  The 20 min hold in the beginning of the run allowed for formic acid 
injection with the sample to elute from the first-dimension column and exit out of a waste valve 
to avoid degradation of the IMER.  The first-dimension column was a PLRP-S (300 Å, 5 μm, 4.6 
x 250 mm) polymeric reverse phase column held at 80°C.  The flow rate through this column 
was 0.15 mL/min.  The injector valve was a two position air actuator with a high speed switching 
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accessory.  This was connected to a digital valve interface (DVI) for automatic triggering and 
positioning control (VICI Valco).  To divert flow from the IMER a 4 port valve (VICI, Model 
#EHMA) was connected after the first-dimension separation and one port was blocked.   
A low volume tee (1/32” stainless steel nanovolume 0.15 mm bore, VICI Valco) 
connected the outlet from the first-dimension column to a HPLC Buffer Pump (Waters 600E).  
This pump held 100 mM ammonium bicarbonate (ABC) and flowed at 0.2 mL/min.  After the 
tee was the IMER (preparation previously described in Chapter 4), which was 2.1 x 30 mm with 
5 μm 300 Å bridged ethyl hybrid (BEH) trypsin immobilized particles, held at 37°C in a column 
heater (Waters Temperature Control Module II).  With the combined flow rates of 0.15 mL/min 
for both the first-dimension gradient and 0.2 mL/min for the buffer pump, the resulting 
volumetric residence time for the IMER was ~14 s.   
After the IMER, another low volume tee connector allowed for dilution and acidification.  
The Dilution/Acidification Pump (Waters 600E) flowed at 1.5 mL/min water with 0.1% formic 
acid (FA).  This allowed preconcentration of the peptides onto the alternating second-dimension 
columns.  A fourth pump (HPLC Gradient Pump 2, Waters 600E) produced the gradient for the 
second-dimension (Table 5.1) and flowed at 0.8 mL/min.  The second-dimension columns were 
XbridgeTM 4.6 x 50 mm, 3.5 μm BEH C18, 300 Å specifically for peptide separations.  Columns 
were configured with the proper direction of flow by installing a 10 port valve (VICI, Model 
#EHMA).  In order to block flow from specific ports of the 10 port valve a final valve was 
installed, utilizing only two positions (Rheodyne, Model #EV501-104).  This ensured that while 
one column was preconcentrating peptides, the other column was running the second-
dimension gradient (Table 5.1).   
All VICI valves were controlled using two position microelectric valve actuators (VICI, 
Model #EHCA-CE) which allowed a 24 V DC signal to change valve position.  In order to get one 
microelectric valve actuator to control two valve positions the actuators were connected to 
double pull double throw general purpose relays (DPDT, 15 A, 24V, Digikey Electronics).  Pulses 
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from the nanoAcquity console fed into a MOSFET switch board, which allowed the ±5 V pulse 
from the nanoAcquity to control the relays and thus the valves.  All pumps utilized operated on 
±5 V contact closures, and therefore could be directly controlled by the nanoAcquity without the 
MOSFET switch.  The mass spectrometer contained the same settings as described above.  By 
allowing the nanoAcquity console to control all valves and pumps, MassLynx software was used 
to completely automate the multidimensional system.  Therefore, after an initial injection, the 
desired number of subsequent second-dimension runs was programed into the software and the 
user was not required after initiating the start of the run.  For a 3.3 hr first-dimension gradient, 
10 second-dimension (20 min runs each) were performed.  Typically up to 12 second-dimension 
runs were collected to ensure no proteins remained on the column or eluted from the IMER 
during the wash. 
5.2.3 Comparison to In-solution Digestion 
 To compare the IMER on the multidimensional platform (Figure 5.4) to a comparable 
in-solution digestion, the setup described in Figure 5.6 was employed.  The first-dimension 
gradient was identical to the IMER setup previously described and 36, 1 mL fractions were 
collected.  Since the on-line 2D workflow had a flow rate of 0.15 mL/min in the first-dimension, 
this corresponded to 3 mL of effluent for every 20 min second-dimension run time.  For the off-
line in-solution digestion, the 36 fractions collected were lyophilized and recombined into 12 
fractions.  These 12 fractions (corresponding to the 12 second-dimension run times for the 2D 
IMER setup) were digested following the in-solution protocol16 outlined in Table 5.4.  The 
resulting peptides were then processed on a second-dimension column (XbridgeTM, 4.6 x 50 
mm, 3.5 μm BEH C18, 300 Å) for mass spectral analysis.  Thus, the same first-dimension, 
second-dimension, and MS detector was used for the on-line IMER digestion and in-solution 
digestion. 
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5.2.4 Sample Preparation and Analysis 
 As a proof of concept, standard proteins BSA, myoglobin, cytochrome C, and RNAse A 
were tested on the on-line multidimensional setup (Figure 5.4).  Standard proteins were reduced 
and alkylated (Table 5.4, steps c-h) and injected onto the first-dimension as a mixture (2 μg 
each) for a 3.3 hr first-dimension run.  The gradient used for this run was slightly different than 
the primary protein gradient (Table 5.3) since it only contained 4 standard proteins.  Mobile 
phases were water (A) and acetonitrile (B) with 0.1% trifluoroacetic acid (TFA) and the initial 
condition was 5% acetonitrile.  Although the samples were not injected using 80% formic acid, 
the 20 min hold was still applied.  After the 20 min hold, the gradient increased to 45% B at 120 
min, and then rose to 85% at 145 min, held for 10 min, then reduced back to 5% B at 200 min. 
Once the system was setup and demonstrated to operate with standard analytes, a more 
complex sample was required.  Saccharomyces cerevisiae (strain BY4741) was grown on glucose 
media until stationary phase was achieved (optical density >2).  Cells were washed, resuspended 
in 50 mM ammonium bicarbonate pH 8, and protease inhibitors (Pierce Protease Inhibitor Mini 
Tablets) were added prepared according to the manufacturer’s recommendations.  Pressure 
assisted cell lysis utilized a French press cell, in which the entire 25 mL sample was passed 
dropwise at 20,000 psi 3 times through the cell.  The cell itself was chilled (4°C) and effluent 
was kept on ice throughout the process.  Each lysis sample was centrifuged at ~1,200 g for 10 
min at 4°C to remove unbroken cells (Beckman, L8-70 Ultracentrifuge).  The supernatant was 
isolated and underwent ultracentrifugation at ~120,000 g (38,000 rpm Beckman 60Ti rotor) for 
90 min at 4°C twice before the pellets were collected.  To determine the amount of protein 
present a Bradford assay17 (Coomassie Protein Assay Kit, Thermo Scientific) was performed 
after the pelleted proteins were resuspended in 50 mM ammonium bicarbonate buffer pH 8.  
Samples for analysis were reduced and alkylated (Table 5.4, steps c-h).  Half of the sample was 
injected onto the IMER on-line setup (Figure 5.4) and the other half was analyzed via the off-
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line in-solution protocol (Figure 5.6).  Due to the complexity of the workflow, a small amount of 
protein was initially tested (0.25 mg) followed by 0.5 mg. 
5.3 Results and Discussion 
5.3.1 Actual Protein Residence Time 
Previously in Chapter 4, the concept of volumetric residence time was introduced.  This 
is the residence time of the mobile phase in the column based on the column volume and flow 
rate.  Since proteins can interact extensively with the trypsin immobilized substrate of the 
IMER, their actual residence time is expected to vary from the volumetric residence time.  
Because the multidimensional on-line digestion workflow involves alternating second-
dimension columns, it is important to understand the actual residence time of proteins in the 
IMER compared to the volumetric residence time.  This provides a better understanding of how 
long proteins remain on the IMER to determine an appropriate time for the second-dimension 
columns to alternate.  When injected onto the IMER (Figure 5.5a) with a flow rate of 0.5 
mL/min, three small standard proteins (myoglobin, cytochrome c, and RNAase A) eluted from 
the column completely in 2 min (Figure 5.8).  While the majority of BSA had eluted within this 
same time frame, small amounts were also identified in later fractions.  This is possibly due to 
the large protein size (BSA ~66.5 kDa) and higher number of cleavage sites.   
It is well known for in-solution digestions that by increasing the protein concentration 
the number of protein identifications will increase as well.  This was identical for IMER 
digestions whereby injecting higher protein concentration, higher percent coverage and number 
of digest peptides were identified (Figure 5.9).  However, by injecting larger amounts of protein 
onto the IMER (> 1 μM), the protein is detected eluting from the IMER for longer amounts of 
time and increases carryover.  In order to avoid carryover, yet obtain high percent coverage and 
number of digest peptides, concentrations ranging from 500 nM to 1 μM (low micrograms of 
protein injected) are ideal.  For a flow rate of 0.5 mL/min (10 s volumetric residence time) BSA 
(66.5 kDa) had an average percent coverage of 84% (n=3) when 500 nM (~7 μg) was injected 
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with no observed carryover.  Myoglobin (a smaller protein of ~16.7 kDa) had an average percent 
coverage of 77% (n = 3) for 500 nM (~2 μg).   
As expected, with the same concentration injected at a variety of flow rates (i.e. residence 
times), the coverage and number of digest peptides increased as the flow rate through the IMER 
decreased due to the lengthened exposure time to the trypsin substrate.  Therefore, by varying 
the concentration of the sample and the flow rate, workflows can be targeted to receive optimal 
protein coverage for an analyte of interest.  Overall, at a volumetric residence time of 10 sec, the 
IMER produced rapid digestions while retaining high percent coverage compared with literature 
studies,18-26 where typical reported volumetric residence times are between 1.5-30 min.  When 
shorter digestion times (< 1 min) were reported in the literature,25, 27-30 the resulting percent 
coverage was relatively low (30 – 55% for BSA) compared to the IMER presented in this study 
(53-84% for BSA) for similar concentrations of analyte. 
By placing an analytical column in front of the IMER (Figure 5.7b) elution can be 
monitored and compared to peaks detected without the IMER present (Figure 5.7a).  This would 
aid in identifying any peak dispersion due to the presence of the IMER column itself.  Since we 
are already aware of peak dispersion due to the interaction of proteins with the trypsin 
substrate, hydrolysis of Nα-benzoyl-L-arginine ethyl ester (BAEE), which requires very little 
trypsin interaction, can tell us whether the presence of the IMER column itself is adding to the 
peak dispersion.  With UV detection, model trypsin substrate BAEE and hydrolysis product Nα-
benzoyl-L-arginine (BA) were monitored (Figure 5.10) at 253 nm.  BA is the product of BAEE 
when trypsin is present.  Therefore, if BA is injected onto an IMER column, it should not 
interact with the trypsin substrate since it is already the product of hydrolysis.  BAEE on the 
other hand, would interact with trypsin and undergo hydrolysis.  In this experiment a mixture of 
BA and BAEE standards were injected onto the setups described in Figure 5.7.  An iterative 
statistical moments (ISM) algorithm was applied to the resulting chromatograms from the UV 
trace (Figure 5.10).  This algorithm provided the temporal variance, width of the base, and skew 
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(peak asymmetry) for the BA and BAEE peak from both the runs without the IMER and with 
IMER implemented (Table 5.5).  The BA peak would experience dispersion from the IMER 
column and not from interaction with trypsin.  The BAEE peak (hydrolyzed into BA upon 
introduction to the IMER) would experience the same dispersion as BA from the IMER column, 
as well as from its interaction with trypsin.  There was not a significant change in peak shape for 
either the peak at 17.5 min (BA which did not interact with trypsin) or the peak at 21 min 
(BAEE/BA which interacted with the trypsin surface).  Suggesting that by implementing the 
IMER into the workflow, peak dispersion is not expected to noticeably increase simply due to 
the insertion of the column.  Although the column itself does not seem to add substantial 
dispersion, we can still expect peak dispersion from protein interactions with the trypsin 
substrate (as previously discussed), which has been shown to be much greater than that for the 
simple model substrate BAEE. 
5.3.2 LC-IMER-LC-MS 
To test the fully on-line two-dimensional configuration (Figure 5.4), standard proteins 
(~40 μg each) were injected and processed.  First the proteins were injected onto the analytical 
column and detected with the mass spectrometer (as in Figure 5.7a) to determine elution times 
for an extended 5-45% organic (acetonitrile) 100 min long gradient (Figure 5.11).  This gradient 
was shorter than the intended gradient for a yeast cell lysate (Table 5.3), but it provided 
retention times amenable for second-dimension analysis for the four standard proteins.  Once 
the two-dimensional setup was complete, this run was repeated and the expected divisions for 
the second-dimension runs are outlined in red on Figure 5.11.  Thus, estimating the valve timing, 
RNAse A and cytochrome C were expected to be detected in second-dimension run 4 while BSA 
and myoglobin were expected on run 5.  These expected elution times are merely based on the 
programmed valve times; however, the instrumentation itself (as it progresses through 
programmed run cycles) has built in delay times prior to valve switching.  This could alter the 
expected second-dimension run in which peptides for a specific protein are expected to elute.  
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Taking this into account, peptides are primarily expected (and proteins identified in) runs 4-6.  
Chromatographic results for the second-dimension peptide separations on the alternating 
columns are shown in Figure 5.12.  The resulting percent coverage, number of digest peptides, 
and reported missed cleavages are displayed in Table 5.6.  Although small peaks are seen in runs 
1-3 no peptides, including tryptic peptides, were identified in these chromatograms.  As 
expected, peptides from proteins were detected in runs 4 and 5; however, due to the actual 
residence time of the proteins and the large amount injected, proteins were also identified in 
runs 6-9.  By run 10, all proteins were removed from the system.  Although proteins were 
detected in more than one second-dimension run, when the total peptide intensities were 
plotted versus the second-dimension number (Figure 5.13) it is obvious that proteins were 
primarily detected in second-dimension runs 4-6 as expected. 
5.3.3 Analysis of the Insoluble Portion of a Yeast Cell Lysate 
 Due to the success of the standard proteins, a sample of 0.25 mg and 0.5 mg of the 
insoluble portion of a yeast cell lysate was processed with the multidimensional on-line 
digestion system.  These were performed as two separate experiments.  More than 0.5 mg of cell 
lysate was attempted, but resulted in operating pressures greater than 6,000 psi.  The pumps 
used for the on-line two-dimensional workflow have a maximum pressure value of 6,000 psi.  
Injecting greater than 0.5 mg resulted in tubing, column frits, and other fittings clogging over 
the course of the gradient elution.  This caused the system to go over pressure resulting in HPLC 
pump shutdown.  Therefore, if more than 0.5 mg is desired, pumps with greater pressure 
capacities are required.  For soluble proteins, up to 2 mg was injected without exceeding the 
6,000 psi pressure limit.  Although soluble proteins are not the focus of the work in this 
dissertation, fewer issues are experienced during their chromatographic separation and analysis 
since they are less likely to precipitate and clog tubing, valves, or column frits during the 
experiment.  
195 
 
For the 0.25 mg sample, the second-dimension peptide profiles are displayed in Figure 
5.14 with the first-dimension gradient overlaid.  Although the first two runs displayed peaks in 
the second-dimension chromatograms, no proteins were identified.  The presence of the peaks 
was due to the contamination of the pump system with polyethylene glycol and otherwise did 
not interfere with the analysis.  As shown in Figure 5.15, proteins were initially identified in 
second-dimension run 3, increasing to a maximum at run 4, and then slowly declining as the 
first-dimension gradient continued.  There were no proteins identified in runs 11 or 12.  For the 
off-line in-solution digestion comparison, the workflow outlined in Figure 5.6 was followed.  A 
comparison of the results between the IMER and in-solution digestions is shown in Figure 5.16. 
Although this was a small amount of yeast cell lysate injected, it was interesting that 
many of same trends repeated from the off-line experiment outlined in Chapter 4.  Overall, the 
protein coverage was relatively equivalent (Figure 5.16a) with perhaps slightly better coverage of 
lower molecular weight proteins with the IMER and higher molecular weight proteins with the 
in-solution digestion.  This is also expressed as protein identifications (Figure 5.16b), with more 
low molecular weight proteins identified with the IMER.  This reoccurring trend for the IMER to 
favor proteins with lower molecular weights is possibly due to the pore size (300 Å) of the 
immobilized particles.  Selecting a particle with larger pore sizes in the future may allow the 
IMER to include proteins with larger molecular weights.  Also, as observed previously in 
Chapter 4, the IMER seemed to slightly favor proteins with higher isoelectric points (5.16c).  
With the IMER at pH 8 during digestion, proteins with higher pI values will be more positively 
charged.  If there are exposed areas of the BEH particles that did not interact with the 
crosslinker during the trypsin binding process, the silanol surface of BEH will be negatively 
charged.  Therefore, the IMER could prefer positively charged analytes due to the protein’s 
attraction to potentially bare surfaces on the BEH particle surface.  This would explain the 
IMER’s preference to proteins with high pI values, a trend that is not observed with digestions 
performed in-solution.  Overall, the IMER identified 56 unique proteins, the in-solution 
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protocol identified 42, and there were 32 commonly identified proteins between the two 
digestion methods (Figure 5.17).  As for membrane proteins, the IMER identified 22 and the in-
solution digestions identified 19.  Thus, for both methods approximately 25% of the proteins 
were membrane or membrane-associated.  However, this sample may not have been large 
enough to detect a significant difference, so the injection of more protein was attempted. 
 For the 0.5 mg protein sample the results are shown in Figure 5.18.  Since more protein 
was injected, more proteins were ultimately identified.  The IMER again expressed equivalent 
coverage (Figure 5.18a) to the in-solution digestion with a higher number of lower molecular 
weight (Figure 5.18b) and higher pI (Figure 5.18c) proteins identified.  Overall, the IMER 
identified 217 unique proteins, the in-solution digestion identified 64 unique proteins, and 46 
proteins were commonly identified between the two methods (Figure 5.19).  Since this sample 
contained more proteins, it was interesting to investigate the 46 commonly identified proteins.  
As shown in Figure 5.20, the 46 commonly identified proteins for both the IMER and in-
solution digestions are plotted according to molecular weight.  In Figure 5.20a the log of the 
ratio of the percent coverage (IMER/in-solution) is plotted on the y-axis.  Therefore, any points 
above this line expressed a higher percent coverage in the IMER digestion and points below the 
line expressed a higher percent coverage in the in-solution digestion.  Out of the 46 values, only 
17 had a higher percent coverage for the in-solution digestion (29 for the IMER digestion).  For 
Figure 5.20b the values are plotted versus the log of the ratio of summed peptide intensity.  All 
proteins except 7 had a higher summed peptide intensity for the IMER digestion.  For the IMER, 
25% of the proteins identified were membrane or membrane-associated, where the in-solution 
digestion only contained 15% membrane or membrane-associated.  Out of the 46 commonly 
identified proteins only 5 were membrane proteins, yet out of the 5, 4 proteins had 5-8 times the 
mass spectral peptide intensities when digested by the IMER.   
Since more proteins (and more membrane proteins) are identified utilizing the 
automated on-line multidimensional workflow compared to an equivalent off-line in-solution 
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workflow, it can be assumed that less sample loss is occurring by removing the fractionation and 
lyophilization steps.  In addition, the digestion itself is being performed at a higher pressure 
(~5-6 kpsi) which could aid in membrane protein solubility and trypsin accessibility to cleavage 
sites.  Although the protein identifications in this study were not abundant, this can be improved 
by either reducing the multidimensional separation scheme to the capillary scale to improve 
efficiency or injecting more sample onto a standard scale system with greater pressure 
capabilities.  Currently the IMER is packed into a standard bore column; however, capillary 
IMERs are an alternative in order to achieve higher pressure applications and obtain proper 
flow rates for more efficient second-dimension capillary peptide separations.  Developing a 
multidimensional platform for the capillary scale, however, can be difficult due to the number of 
valves and connections required.  Such fittings are difficult to implement into a capillary 
workflow and preserve the efficiency of the separation.  However, with the on-line 
multidimensional IMER workflow presented here consistently outperforming equivalent off-line 
two-dimensional in-solution digestions, future multidimensional on-line digestion 
configurations are worth pursuing. 
5.4 Conclusions 
 Overall, the fully automated two-dimensional separation with on-line digestion was 
successful.  Depending on the concentration of protein injected, proteins can remain on the 
IMER longer than the calculated volumetric residence time.  But as long as this is realized, the 
appropriate concentration can be employed and the second-dimension analysis times can be 
adjusted to accommodate protein and peptide elution.  By being able to remove fraction 
collection, lyophilization, and in-solution trypsin digestion steps, the proteomic workflow is 
shortened by more than 35 hours without a loss in digestion efficiency compared to an off-line 
in-solution analysis.  A greater number of proteins were routinely identified utilizing the on-line 
multidimensional technique compared to in-solution digestion and no fraction collection or 
lyophilization was required.  Removing these steps from the protocol not only decreases the 
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amount of time required for the analysis but also decreases the likelihood of sample 
contamination and loss of proteins and peptides via adsorption to exposed surfaces during the 
fractionation/lyophilization process.  Between the on-line multidimensional IMER and off-line 
multidimensional in-solution workflow, membrane proteins are more likely to be identified (and 
with higher intensity) with the fully automated on-line method. 
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5.5 TABLES 
 
Table 5.1 Gradient method on XBridgeTM 
column(s) for peptide separation post-IMER.  
Mobile phases consisted of water (A) and 
acetonitrile (B) with 0.1% formic acid (FA). 
t (min.) % Acetonitrile (B) 
0 4 
15 50 
15.5 80 
16 80 
17 4 
20 4 
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Table 5.2 Software Processing Parameters 
Processing Parameters in PLGS V2.5 
Chromatography peak width automatic  
MS TOF resolution automatic 10,000 
Lock Mass 1 785.84265 Da/e Glu-1-Fibrinopeptide 
Lock Mass 2 556.2771 Da/e Leucine Enkephalin 
Lock Mass Window 0.5 Da 
Low Energy Threshold 150 counts 
Elevated Energy Threshold 50 counts 
Intensity Threshold 750 counts 
Workflow Template in PLGS V2.5 
Databank S. cerevisiae from 2/3/11 
http://www.expasy.org/proteomics 
Peptide tolerance automatic* 
Fragment tolerance automatic* 
Minimum fragment ion matches per 
peptide 
3 
Minimum fragment ion matches per 
protein 
7 
Minimum peptide matches per protein 1 
Maximum hits 20 
Maximum Protein Mass 250,000 
Primary Digest Reagent trypsin 
Secondary Digest Reagent none 
Missed Cleavages 1 
Fixed Modifications Carbamidomethyl C 
Variable Modifications Oxidation M, Deamidation N, Deamidation Q 
False Positive Rate 4 
* When “automatic” is selected the proprietary PLGS algorithm interrogates each data set to 
determine an ideal value for the analysis. 
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Table 5.3 Gradient method on PLRP-S column for 
standard protein analysis in the first-dimension.  Mobile 
phase A consisted of water:acetonitrile:isopropanol 
(80:10:10) and mobile phase B consisted of 
acetonitrile:isopropanol (50:50) with 0.1% 
trifluoroacetic acid (TFA). 
t (min.) 
% B 
50:50 
acetonitrile:isopropanol, 0.1 % TFA 
0 0 
20 0 
220 60 
230 90 
240 90 
245 0 
250 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
202 
 
Table 5.4 In-solution digestion protocol adapted from: 
(http://www.genome.duke.edu/cores/proteomics/sample-preparation)16 
 
Procedure: 
 
a) Perform Bradford assay to determine protein concentration of each solution.  
Normalize concentrations for samples within a group using 50 mM AmBic. 
 
b) In order to maximize solubility of proteins, add calculated volume of Waters 
RapiGest to have 0.1-0.2 % RapiGest in final concentration pre-digestion.  Make 
up RapiGest with 50 mM AmBic.   
 
c) Heat at 40°C for 10 minutes.  Spin down condensate. 
 
d) Make up 100 mM dithiothreitol (DTT) in 50 mM AmBic for reduction step.  Add 
DTT to each solution to make the final DTT concentration 10 mM. 
 
e) Heat solution at 80°C for 15 minutes. 
 
f) Remove from heat and cool for 5 minutes (to room temp).  Spin down 
condensate. 
 
g) Make up 200 mM iodoacetamide (IAM) in 50 mM AmBic for alkylation step.  
Add IAM to each solution to make the final IAM concentration 20 mM (2X molar 
excess of DTT). 
 
h) Incubate the solutions in the dark at room temperature for 30 minutes. 
 
i) Add trypsin to each solution at 1:30 trypsin:protein concentration.  Make trypsin 
stock in 50 mM AmBic. 
 
j) Digest overnight at 37°C. 
 
k) Following digestion, centrifuge condensate to bottom of vial.  Add TFA and 
MeCN to give 0.5-1.0% TFA and 2% MeCN by volume. 
 
l) Samples sit for 2 hours at 60°C.  Centrifuge at 15,000 rpm for 5 min, and pipette 
supernatant into an autosampler vial. 
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Table 5.5 Peak parameters calculated with BA/BAEE.  The values are the average of three 
runs on each configuration (PLRP or PLRP-IMER). 
Parameter BA BA/BAEE 
PLRP-IMER (37 °C) 
variance (min2) 0.011 0.026 
width base (sec) 24.8 38.5 
skew 0.87 0.69 
PLRP  
variance (min2) 0.016 0.022 
width base (sec) 30.7 35.3 
skew 0.86 0.70 
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Table 5.6 Second-dimension peptide results for analysis of four standard peptides. 
Column – 
Run Number 
Protein ID Percent 
Coverage 
Digest 
Peptides 
Missed 
Cleavages 
 
Column A – 1 
 
None None None None 
 
Column B – 2 
 
None None None None 
 
Column A – 3 
 
None None None None 
Column B – 4 
RNAse A 
Cytochrome C 
BSA 
53 
47 
15 
5 
7 
7 
1 
1 
3 
Column A – 5 
Cytochrome C 
BSA 
Myoglobin 
65 
82 
18 
16 
12 
9 
4 
3 
0 
Column B - 6 
Cytochrome C 
BSA 
Myoglobin 
64 
41 
92 
9 
26 
17 
2 
7 
6 
 
Column A – 7 
 
Cytochrome C 
Myoglobin 
38 
82 
7 
11 
1 
3 
Column B – 8 
Cytochrome C 
BSA 
Myoglobin 
35 
14 
38 
5 
8 
6 
0 
3 
1 
 
Column A – 9 
 
Myoglobin 18 3 1 
 
Column B – 10 
 
None None None None 
 
Column A – 11 
 
None None None None 
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5.6 FIGURES 
 
 
Figure 5.1  Multidimensional proteomic workflow resulting from IMER implementation.  The 
fractions are collected off-line and lyophilized followed by UHPLC-MS analysis. 
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Figure 5.2  Comparison between fully automated on-line digestion and MS/MS application. 
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(a) 
 
 
 
(b) 
 
 
 
(c) 
 
 
 
(d) 
 
Figure 5.3  Configurations for interfacing IMERs for separation and identification: (a-c) one-
dimensional analyses and (d) represents a two-dimensional analysis.  Image adapted from Ma, 
et al.6  
208 
 
 
 
Figure 5.4  Fully automated RPLC-IMER-RPLC-ESI-MS on-line digestion workflow. 
 
 
 
 
 
 
 
 
 
 
 
 
HPLC Buffer Pump 
100 mM ABC, 0.2 mL/min 
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Figure 5.5  Experimental protocol for determining the actual residence time of model proteins 
BSA, RNAse A, myoglobin, and cytochrome C.  (a) Proteins were injected, digested on-line, and 
collected into 5 fractions.  These fractions were not lyophilized, but were injected on a standard 
ESI-MS for protein detection.  Flow rate through the IMER was 0.5 mL/min. (b) Proteins were 
injected, digested on-line, and preconcentrated directly onto a second-dimension reverse phase 
column for ESI-MS detection. 
(a) 
(b) 
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Figure 5.6  Method for off-line multidimensional workflow with in-solution digestion.  This 
was a fair comparison to the on-line multidimensional IMER workflow since it utilizes the same 
first and second-dimension columns and flow rates. 
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Figure 5.7  Configurations for monitoring dispersion due to IMER implementation: (a) no 
IMER present (b) IMER placed after separation column to determine dispersion effects. 
 
(a) 
(b) 
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Figure 5.8  Detection of proteins over time after eluting from the IMER at 0.5 mL/min.  
Fractions were collected as depicted in Figure 5.5a. 
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Figure 5.9  Results for percent coverage and number of digest peptides for BSA and myoglobin 
while varying the concentration injected on the IMER.  Data was collected using the 
configuration outlined in Figure 5.5b. 
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Figure 5.10  Monitoring peak dispersion through IMER using model substrate BAEE and 
hydrolysis product BA. 
 
 
 
 
 
 
 
 
 
215 
 
 
Figure 5.11  Protein elution on the PLRP analytical column with an extended first-dimension 
gradient.  Four standard proteins were injected (RNAse A, cytochrome C, BSA, and myoglobin) 
to determine if the two-dimensional setup was operational.  The gradient was extended so that 
the proteins would be separated on the second-dimension alternating columns. 
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Figure 5.12  Second-dimension base peak intensities (BPIs) from injection of four standard 
proteins (RNAse A, cytochrome C, BSA, and myoglobin) onto the LC-IMER-LC-MS workflow. 
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Figure 5.13  Summed peptide intensity for four standard proteins (RNAse A, cytochrome C, 
BSA, and myoglobin) plotted against second-dimension run number. 
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Figure 5.14  Second-dimension peptide separations from 0.25 mg of yeast cell lysate.  Each 
second-dimension run was 20 min (not shown on axis).  It is plotted aligning with the second-
dimension run, such that peptides which eluted between 20-40 min (y-axis) eluted during run 1, 
40-60 run 2, 60-80 run 3, etc.  The first-dimension gradient profile is overlaid on the x and y 
axes.  The x-axis corresponds to the first-dimension gradient (percent organic) during which the 
peptides would elute to the second-dimension.  For example 0-7%B would correspond to run 1, 
7-15% run 2, 17-20% run 3, etc. 
 
219 
 
 
Figure 5.15  Number of unique protein identifications plotted versus second-dimension run 
number. 
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Figure 5.16  Proteins identified for 0.25 mg insoluble portion of a yeast cell lysate plotted vs. 
(a) percent coverage, (b) molecular weight, and (c) isoelectric point. 
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Figure 5.17  Total protein identification results for the 0.25 mg sample for the IMER (green) 
and the in-solution (blue) digestions. 
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Figure 5.18  Proteins identified for 0.5 mg insoluble portion of a yeast cell lysate plotted vs. (a) 
percent coverage, (b) molecular weight, and (c) isoelectric point. 
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Figure 5.19  Total protein identifications for the 0.5 mg sample injected for the IMER (green) 
and the in-solution (blue) digestion. 
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Figure 5.20  For the 46 commonly identified proteins for the 0.5 mg sample injected (a) the 
log of the ratio of the percent coverage vs. molecular weight and (b) the log of the ratio of the 
summed peptide intensity vs. molecular weight. 
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